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Abstract 
 
Background. Unlike adult mammals, zebrafish can regenerate their heart. Several 
mechanisms are essential to achieve regeneration; these include: 
 the de-differentiation and proliferation of cardiomyocytes contributing to new 
myocardium,  
 angiogenesis to provide a blood supply to the injured area  
 epicardial activation, leading to the establishment of a scaffold for the 
proliferating cardiomyocytes, vessel supporting mural cells and cytokine 
secretion.  
Platelet-derived growth factor (Pdgf), Vascular endothelial growth factor (Vegf), 
Transforming Growth Factor beta (Tgfβ) and Fibroblast growth factor (Fgf) signalling play 
critical roles in the zebrafish heart regeneration. Neuropilins (NRPs) are cell surface co-
receptors that have been implicated in VEGF, PDGF, FGF, TGFβ signalling.  
Aims. I hypothesised that neuropilins are required for the regenerative response, and 
investigated the role of neuropilins in zebrafish heart regeneration following cryoinjury.  
Results. Zebrafish have four neuropilins isoforms, nrp 1a, 1b, 2a and 2b. I found that all 
isoforms were upregulated in the ventricle following cardiac cryoinjury. Neuropilins 
were strongly expressed, at both the mRNA and protein level, by the activated 
epicardium and endocardium and at the injured/healthy myocardium border. 
Neuropilin upregulation coincides with leucocyte infiltration to the injured area, 
epicardial activation and initiation of neovascularisation, implicating a role of nrps in 
these processes. A nrp1a mutant, encoding a truncated, non-functional protein, showed 
a significant delay in heart regeneration in comparison to wild type fish. Furthermore, 
epicardial cells from nrp1a mutant zebrafish heart explants displayed an impaired 
response to activation by cryoinjury.  
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Conclusions. Nrp1 plays a key role in zebrafish heart regeneration, mediated through 
epicardial activation and migration and likely contributes to further physiological 
processes in other cardiac cell-types. This is the first report of an injury-induced 
epicardial activation phenotype caused by the disruption of a single allele in zebrafish. 
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1 Introduction  
Myocardial infarction (MI) is the leading cause of death worldwide (Kabir et al., 2007; 
Sidney et al., 2013; Unal et al., 2005). MI is commonly referred to as a heart attack, and 
results from coronary artery occlusion consequently restricting blood supply to the 
cardiac tissue. Insufficient blood flow causes tissue ischaemia and leads to the death of 
the cardiac cells in the affected area. In adult mammals, damaged cardiac tissue is 
replaced with a fibrotic scar that does not possess the electrical or contractile properties 
of the healthy cardiac tissue (Laflamme and Murry, 2011; Pfeffer and Braunwald, 1990). 
Scar formation increases the risk of MI recurrence, sudden cardiac death, and heart 
failure, amongst other accompanying complications (Bui et al., 2011; Gaziano, 2007). 
Medical interventions have increased MI patient survival rates (Bui et al., 2011; Hardoon 
et al., 2011; Kabir et al., 2007; Unal et al., 2005); however no cure exists to reverse the 
permanent damage of a patient’s heart other than heart transplant. Understanding 
cardiac repair mechanisms could identify therapies to stimulate heart regeneration and 
alleviate secondary complications in MI survivors. Neonatal mammals (Porrello et al., 
2011b; Zogbi et al., 2014), urodele amphibians (Oberpril.Jo and Oberpril.Jc, 1974; 
Rumyantsev, 1977) and zebrafish (Poss et al., 2002) possess the remarkable ability to 
fully regenerate their heart after cardiac injury as well as removing scar tissue. The 
zebrafish in recent years has emerged as a valuable model organism for studying 
cardiovascular development and regeneration, and has provided promising insights into 
the cellular and molecular mechanisms that orchestrate endogenous heart 
regeneration, as yet unachievable in humans. 
1.1 Zebrafish as a model to study cardiovascular biology 
The zebrafish, Danio rerio, is a tropical freshwater fish native to North Indian Rivers. It is 
approximately 3.5 – 4.5 cm in length and readily identified by its distinctive striped scales 
pattern. Studying zebrafish has many advantages. They are vertebrates with a high 
number of conserved human-related genes; thus, at least one zebrafish ortholog exists 
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for 71.4% of human protein encoding genes (Howe et al., 2013). Zebrafish embryonic 
development is external, fast and the transparency of the eggs and early embryos 
provide an optically accessible means to visualise development. Additionally, an 
expanding range of genetic tools is readily available to manipulate the zebrafish 
genome. Furthermore, the zebrafish is practically and economically advantageous, given 
that large numbers of animals can be kept in a relatively small space at low cost.  
The extraordinary regenerative capacity of the zebrafish has attracted great scientific 
interest. The zebrafish can regenerate multiple organs and appendages, such as, fins 
(Johnson and Weston, 1995), maxillary barbel (LeClair and Topczewski, 2010), retinae 
(Vihtelic and Hyde, 2000), optic and spinal nerves (Becker et al., 1997; Bernhardt et al., 
1996). In 2002, Kenneth Poss and colleagues discovered the zebrafish could also 
regenerate the heart after amputation of 20% of the ventricle. This section will describe 
the similarities and differences between the zebrafish and human heart and highlight 
the relevance for using the zebrafish as a model organism to study cardiac function and 
disease. 
 Zebrafish Cardiogenesis 
Mechanisms governing regenerative events often recapitulate developmental 
processes. The heart is the first organ to fully develop and function during vertebrate 
embryogenesis, a process that occurs by 2 days post fertilization (dpf) in zebrafish, 12 
days in mice and 35 days in humans (Stainier, 2001). Several cardiac developmental 
processes and cardiac structural features are conserved between all vertebrate species 
and thus, zebrafish has been used to model cardiac development in humans. Zebrafish 
have proven a valuable tool to the development community as optical clarity allows 
detailed imaging of developmental processes. Zebrafish embryos can survive for up to 5 
days post fertilisation (dpf) with severe cardiac phenotypes because they are able to 
obtain oxygen by passive diffusion (Hu et al., 2001). This has permitted large-scale 
forward and reverse genetic screening and phenotypic characterisation of genes 
influencing cardiac development, to an advanced stage, that would otherwise be 
embryonic lethal in mammals. Thus, several genes orchestrating different aspects of 
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cardiac development in the zebrafish have been characterised, many of which parallel 
those implicated in mammalian cardiogenesis.   
Cardiac progenitor cells can be identified in the late blastula, upon expression of 
transcription factor (TF) gata5, at 5 hours post fertilisation (hpf) in the developing 
zebrafish embryo (Figure 1A) (Reiter et al., 1999). Expression of the vertebrate early 
myocardial gene nkx2.5 is targeted by gata5 just before gastrulation in mesodermal 
progenitor cells (Kishimoto et al., 1997; Reiter et al., 1999). The zebrafish genome 
encodes two orthologs of mammalian Nkx2.5, nkx2.5 and nkx2.7 (Lee et al., 1996), that 
drive expression of myocardial genes such as troponin T and tropomyosin (Stainier, 
2001). By 15 hpf (the 14-somite stage), two bilaterally aligned cell populations of cardiac 
fate form, called the cardiac primordia (or the first heart field) (Yelon et al., 1999) (Figure 
1B). The two primordia contain future ventricular cardiomyocytes on the internal lateral 
side closest to the mid-line and cells destined for the atrium are on the external margin 
of the fields (Stainier et al., 1993). The ventricular and atrial cardiac progenitor cells 
remain distinctly separated throughout the entirety of cardiogenesis, and express 
chamber specific sarcomeric myosins; the ventricular cells express my7 at an earlier 
stage (16hpf) and atrial progenitors express my6 (22hpf) (Berdougo et al., 2003; Yelon 
et al., 1999). The two parallel populations of progenitor cells migrate towards the 
midline and fuse (Figure 1D). This process requires hand2 expression and 
lysosphingolipids to regulate extracellular fibronectin for correct fusion(Garavito-Aguilar 
et al., 2010), similar to mammalian heart morphogenesis that demonstrates reliance on 
fibronectin deposition (George et al., 1997). Additionally, the second heart field 
(consisting of mesodermal progenitor cells intended as ventricular and smooth muscle 
cells of the outflow tract) merge with the migrating bilateral cardiac primordia to form 
the cardiac cone in a process known as asymmetric involution (Rohr et al., 2008) (Figure 
1D). Between 24 and 28 hpf the heart cone elongates along the middle of the fish 
forming the primitive structure of the heart, the heart tube, and begins spontaneous 
peristaltic contractions (Figure 1E). Islet1 is required for an initial phase of 
cardiomyocyte differentiation starting at the ventricle and terminating at the atrial 
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portion of the heart tube (de Pater et al., 2009). Following heart tube formation, the 
organ migrates to the left and begins to loop giving rise to two distinct compartments 
by 36 hpf (Figure 1F)(de Pater et al., 2009; Lu et al., 2016). Second heart field populations 
are added to the heart (described in 1.1.1.2), valvugenesis takes place and the 
proepicardium adheres (see 1.1.1.4) to give rise to a mature heart (Figure 1G). 
1.1.1.1 Endocardium morphogenesis  
In mammalian development, endocardial precursors give rise to the endothelial layer 
lining the lumen of cardiac chambers and a subpopulation create the septum and cardiac 
valves (Eisenberg and Markwald, 1995). The population of blastula cells (blastomeres) 
that give rise to zebrafish endocardium can be identified at 5 hpf at the anterior lateral 
plate mesoderm in close proximity to the cardiac progenitor cell population. Endocardial 
precursors migrate to the midline at 15 hpf (preceding heart tube formation) at the 
location where bilateral primordia fuse (Bussmann et al., 2007)( Figure 1C). Endocardial 
progenitor establishment at the midline is crucial for heart tube formation, and the 
interaction between myocardial progenitors and endocardial progenitors is critical for 
heart development (Holtzman et al., 2007). Endocardial progenitor cell migration to the 
midline is governed in part by a slit1/roundabout (Robo)/Vascular endothelial growth 
factor (VEGF) axis essential for heart tube formation (Fish et al., 2011; Schoenebeck et 
al., 2007). 
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Figure 1 Zebrafish heart morphogenesis 
Schematic representation of zebrafish heart development. (A) Cardiac progenitors are 
identified from 5 hours post fertilisation (hpf), located bilaterally in the lateral marginal 
zone. Atrial precursors are positioned more ventral (v) and ventricular precursors lie 
more dorsal (d) (B) At 15hpf cardiac primordia are bilaterally aligned at the anterior 
lateral plate mesoderm (ALPM) proximal to the mid-hind brain (C) Endocardial 
progenitors are established at the midline before the primordia that (D) migrate towards 
the midline and fuse to form the heart cone via asymmetrical involution, with ventricular 
cells at the apex and atrial cells  at the wider base. (E) The heart elongates giving rise to 
the heart tube that begins peristaltic contractions. (F) The heart tube undergoes looping 
morphogenesis to form distinct atrium and ventricle compartments by 36 hpf. (G) 
Cardiac maturation occurs; cell populations from the second heart field increase heart 
size, valvugenesis takes  place  and  proepicardium  adhere  to  heart  surface.  Image 
modified from Bakkers (2011) 
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The endocardium is subject to hydrodynamic forces that stimulate endocardium 
maturation and morphogenesis. Mechanisms that allow the endocardium to detect 
different fluidic forces exerted by blood flow are largely unknown. Platelet endothelial 
cell adhesion molecule-1 (PECAM-1) and vascular endothelial cadherin (VE-cadherin) 
stimulate VEGF-independent VEGF receptor (VEGFR) 2 and VEGFR3 
autophosphorylation and signalling in response to fluidic flow forces (Baeyens et al., 
2016). The biological function associated with VEGF-independent VEGFR stimulation is 
not clearly defined, however in the zebrafish it is proposed to influence cardiac looping 
and cell-cell junctions (Mitchell et al., 2010). 
1.1.1.2 Second heart field 
The four-chambered mammalian heart develops from two distinct populations of 
cardiac progenitor cells: the first heart field develops from cells at the lateral 
mesodermal plate early in development and contributes to the left ventricle (see 1.1.1), 
and the second heart field derived from cells at the pharyngeal mesoderm contribute to 
the atria and outflow tract (Cai et al., 2003; Waldo et al., 2001). Zebrafish do not have a 
right atrium, rather, the simple cardiac structure of the zebrafish only contains an 
outflow tract, raising initial scepticism whether the zebrafish contained a second heart 
field during development. A second heart field has been observed in the zebrafish and 
contributes to development of the arterial pole, particularly the distal ventricle and 
outflow tract (de Pater et al., 2009; Hami et al., 2011). Homeobox transcription factor, 
islet-1, is expressed by all second heart field progenitor cells in mammals, however 
zebrafish do not (de Pater et al., 2009). Instead, cells positive for latent transforming 
growth factor beta (TGFβ) binding protein 3 (ltbp3) and nkx2.5 expression were 
identified as zebrafish second heart field cardiac progenitor cells that are located at the 
pharyngeal mesoderm (Zhou et al., 2011b). The second heart field contributes 
cardiomyocytes for heart tube elongation at the venous pole from 28 hpf, simultaneous 
to cardiac looping (Figure 1E) and outflow tract endothelium (Lazic and Scott, 2011). 
Fibroblast growth factor (Fgf)8 signalling is required for second heart field 
cardiomyocyte addition at the arterial pole via Bmp4 signalling (Reifers et al., 2000; 
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Sorrell and Waxman, 2011). Additionally, myocyte enhancer factor 2cb (Mefc2b), sonic 
hedgehog (Shh) and T-box1 (Tbx1) signalling have also been described to mediate 
second heart field cardiomyocyte contribution to the heart (de Pater et al., 2009; Dyer 
and Kirby, 2009; Lazic and Scott, 2011; Xu et al., 2004), in line with mammalian second 
heart field signalling, supporting the existence of conserved mechanisms in higher and 
lower vertebrates despite the latter’s overall simpler cardiac structure.  
1.1.1.3 Cardiac maturation  
At 48 hours post fertilisation, the zebrafish heart is fully functional and made of two 
defined chambers, the ventricle and atrium, however at this stage, the heart is formed 
by only two layers; the endocardium and the myocardium (Stainier et al., 1993). Outflow 
tract (bulbus arteriosus) formation, epicardial layer establishment and trabeculation of 
the myocardium are required to complete cardiac maturation after cardiac looping.  
The myocardium expands and chambers trabeculate during cardiac maturation; 
trabeculae are muscular projections lined with endocardium that protrude into the 
cardiac chambers in a seemingly irregular manner (Gupta and Poss, 2012; Staudt et al., 
2014). The trabeculae serve to increase chamber surface area, contribute to electrical 
signal conductivity and enhance contraction. Absence of trabeculae lead to 
cardiomyopathies, severely impaired cardiac function and potential lethality in both 
humans and zebrafish (Jenni et al., 1999; Liu et al., 2010). An overwhelming body of 
studies indicate that the endocardium strongly influences myocardial morphogenesis 
through a variety of signals that are observed in zebrafish and higher vertebrates 
(Gassmann et al., 1995; Kramer et al., 1996; Lai et al., 2010; Lee et al., 1995; Liu et al., 
2010; Peshkovsky et al., 2011). Endocardium-derived FGF and neuregulin signals induce 
cardiomyocyte proliferation, differentiation and trabeculation of the embryonic 
mammalian heart (de Pater et al., 2009; Molina et al., 2009). This interaction is 
recapitulated in the zebrafish, where the endocardium influences cardiomyocyte 
maturation via Brg1 (a chromatin remodelling protein) and bone morphogenic protein 
(Bmp) 10 production (Samsa et al., 2013; Stankunas et al., 2008). Trabeculae fail to 
develop in zebrafish cloche mutants that lack endocardium, leading to the conclusion 
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that endocardial maturation precedes cardiac maturation (Stainier et al., 1995; Suri et 
al., 1996). Cardiomyocytes that provide the cell population for trabeculae are stimulated 
to proliferate by Fgf. The cardiomyocytes of the heart tube express Fgf receptors (Fgfrs) 
simultaneous to epicardial maturation, whereby the epicardium produces Fgf9 (see 
1.1.1.4) (Lavine et al., 2005). 
The zebrafish outflow tract comprises the bulbus arteriosus and ventral aorta and forms 
after 48 hpf (Grimes and Kirby, 2009). The development of the bulbus arteriosus remains 
largely uncharacterised. Humans do not have a bulbus arteriosus, but it is considered 
analogous to the arterial trunk (conotruncus) observed during higher vertebrate 
development (Brown et al., 2016). The bulbus arteriosus expresses a specific elastin 
extracellular matrix (ECM) protein eln2, ortholog of tropoelastin, that possesses 
mechanical properties to protect gills from fluctuating forces generated during systole 
(see 1.2.1).  
1.1.1.4 Epicardium in heart development 
The epicardium is the final layer of the heart to form; it is essential for full cardiac 
development and function (Manner, 1993), contributing to non-myocardial lineage 
resident cardiac cells and central to injury response (Kikuchi et al., 2011a; Manuel 
Gonzalez-Rosa et al., 2012). It begins to form at embryonic day (E) 9.75 (until E11) in the 
mouse, Hamburger Hamilton (HH) stage 18 in the chick, and 72 h post fertilisation (hpf) 
in the zebrafish (Masters and Riley, 2014). The epicardium is a heterogeneous 
mesothelial monolayer that forms from epicardial precursors sourced from two distinct 
populations of spherical cells during zebrafish development. The predominant source of 
epicardial precursors is the proepicardium that is located in the inner lining of the 
pericardial wall close to the atrioventricular canal (Serluca, 2008). Movement from the 
contracting heart releases epicardial precursors into the pericardial cavity that then 
circulate within the pericardial fluid until they eventually adhere to the myocardium 
(Peralta et al., 2013) (Figure 2). A second population of epicardial precursors arises from 
the cranial pericardial mesothelium and migrates as a cellular bridge to the heart and 
directly adheres to the myocardium (Plavicki et al., 2014) (Figure 2). Once adhered to 
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the myocardial surface, epicardial cells expand and migrate over the surface of the 
underlying myocardium. Epicardium establishment in the zebrafish differs to that of the 
mammalian heart, in that the epicardium forms during mid-gestation concomitantly 
with cardiac looping (Masters and Riley, 2014). After cardiac development, embryonic 
developmental markers (such as TBX18 and Wilm’s tumor 1 (WT1)) of the epicardium 
are switched off and the epicardium enters a quiescent state (Chen et al., 2002). 
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Figure 2 Proepicardium adherence to developing zebrafish heart 
Diagrammatic representation of epicardial progenitor cell attachment to the 
developing zebrafish heart. Epicardial precursors are released (small grey 
arrows) from proepicardium (PE) clusters (green) in the pericardial wall and 
circulate as advected PE (advPE) in the pericardial fluid (pink). Directionality and 
velocity of advPE movement is generated by heart contractions, strong fluid 
forces occur at the atrioventricular boundary (red arrow) and weaker fluid force 
at the ventricle (V) (blue arrow). Epicardial precursors eventually contact and 
adhere to the ventricle surface, once attached they proliferate and populate a 
monolayer of cells encasing the heart to form the complete epicardium. A 
population of epicardial cells originates from single cells that delaminate from 
the pericardium mesothelium (blue circle) and are transferred to the ventricle 
surface (grey arrow) via a cellular bridge. At – atrium. Image adapted from 
Peralta et al (2014). 
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It is widely accepted that epicardial-derived cells (EPDCs) contribute to fibroblasts and 
mural vascular supporting cells, but their contribution to endothelial cells and 
cardiomyocytes are still under debate (Poelmann et al., 2002; Red-Horse et al., 2010). It 
has been shown in chicken embryos that EPDCs migrate towards the myocardium and 
differentiate into coronary vascular smooth muscle cells and fibroblasts (Mikawa and 
Gourdie, 1996). EPDCs may also be driven toward a myocardial lineage in mammalians 
and zebrafish by FGF/VEGF/thymosinβ4 (Tβ4) signalling (Cai et al., 2008; Smart et al., 
2007; Wills et al., 2008; Zhou et al., 2008), and other studies suggest they can 
transdifferentiate to endothelial cells to contribute to coronary vasculature (Dettman et 
al., 1998; Perez-Pomares et al., 2002).  
 
The epicardium is an important source of trophic factors that support myocardium 
maturation and autocrine signalling to co-ordinate its own maturation and 
differentiation (Cai et al., 2008; Katz et al., 2012; Zhou et al., 2008). Retinoic acid (RA)  
(also referred to as vitamin A) is abundantly produced by the epicardium. Global knock 
out models of the retinoic acid receptor alpha (RARα) is embryonic lethal, mutants 
display abnormal epicardial adherence and deformed myocardium demonstrating an 
essential role for epicardial-derived RA for mammalian heart development (Sucov et al., 
1994). The epicardium and endocardium express retinaldehyde dehydrogenase 2 
(RALDH2) during embryogenesis in mammals and zebrafish (D'Aniello et al., 2013; 
Niederreither et al., 1999). Retinoic acid signalling in the epicardium stimulates 
epicardium-derived production of FGFs (Lavine et al., 2005); and combined with cardiac 
fibroblasts (also derived from EPDC), provides a main source of FGF to stimulate 
cardiomyocyte proliferation (Merki et al., 2005; Nag, 1980). FGF10 enhances epicardium 
epithelial to mesenchymal transition (EMT), potentially via FGFR2 stimulation 
permitting migration into the myocardium and transdifferentiate to fibroblasts (Pennisi 
and Mikawa, 2005; Vega-Hernandez et al., 2011). Failure of the epicardium to undergo 
EMT prevents coronary vessel morphogenesis implying close association of coronary 
vasculature development with epicardium dynamics and signals (Tevosian et al., 2000).   
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1.1.1.5 Coronary vessel development 
In mammals, coronary vasculature starts to develop approximately between E11.5 –
E14.5 (Gonzalez-Iriarte et al., 2003; Viragh and Challice, 1981). Some vessels originate 
at the sinus venosus and expand to encase the heart towards the apex (Red-Horse et al., 
2010), while a second population emerges from the endocardium (Tian et al., 2013; Wu 
et al., 2012). Coronary vasculature formation is governed by VEGF signalling that recruits 
existing endothelial cells to invade the subendocardial space and form vasculature; in 
particular, VEGF-C was identified to mediate this process (Chen et al., 2014; Tian et al., 
2013). VEGF-B is associated with mediation of coronary plexus tubulogenesis once 
endocardial cells have been recruited (Tomanek et al., 2006). Lastly, some contribution 
to the coronary vasculature is thought to originate from the epicardium (Katz et al., 
2012; Pennisi and Mikawa, 2005).  
In the zebrafish friend leukaemia integration 1a (fli1a) positive angioblasts can be 
detected as early as 12 hpf and mediate vasculogenesis to form the dorsal aorta and 
luminal vessels by 24 hpf (Ellertsdottir et al., 2010; Roman et al., 2002). The zebrafish 
vasculature can be readily visualised thanks to the development of a transgenic line that 
expresses EGFP downstream of the fli1a promoter (Lawson and Weinstein, 2002) 
expressed in all endothelial cells (Melet et al., 1996; Thompson et al., 1998). This model 
has led to extensive characterisation of the zebrafish cardiovascular system, and it was 
described that the coronary vessel cell population primarily originates from the 
endocardium (Harrison et al., 2015). Endocardial-derived cells migrate to the 
subendocardial space is driven, in part, by the Cxcr4 signalling axis to give rise to 
coronary vessels (Harrison et al., 2015).  
1.2 Adult zebrafish cardiovascular system 
 Heart structure and circulation 
The adult zebrafish heart is approximately 1mm in length and width, and, unlike the 
four-chambered hearts of mammals, is made up of two chambers consisting of a single 
atrium and ventricle (Figure 3).  The atrium is a large highly folded capacitance chamber 
with a thin muscular wall lined with pectinate muscle; when fully extended the atrium 
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can accommodate a volume larger than the ventricle (Hu et al., 2001). The atrium 
receives blood from the body via the sinus venosus (also referred to as the inflow tract) 
that itself receives blood from the cardinal and hepatic portal veins and contracts to fill 
the atrium (Figure 3). During diastole, the atrium contracts at a pressure of 
approximately 0.68 mmHg to direct blood through the four-leaflet atrioventricular valve 
into the ventricle (Figure 3) (Hu et al., 2001). The ventricular myocardium comprises two 
distinct structures: most luminal is a highly trabeculated thick muscular layer that is in 
contact with the endocardium, and externally, is a thin compact layer that runs 
perpendicular to the trabeculated layer and is connected with the epicardium. This 
differs to human hearts that are predominantly formed of a thick compact layer of 
myocardium (Sedmera et al., 2000). The highly trabeculated zebrafish ventricle is 
thought to increase surface area and contact of blood with cardiomyocytes, thus 
reducing dependence on coronary vasculature for nutrition and oxygen; whereas, higher 
vertebrates depend on coronary blood delivery to cardiomyocytes. During diastole, the 
ventricular pressure is approximately 0.42 mmHg allowing the blood to enter the 
chamber from the atrium. The ventricle then exerts a pressure of approximately 
2.5mmHg during systole to direct blood through a bicuspid bulbo-ventricular valve into 
the bulbus arteriosus (also referred to as the outflow tract) towards the gills (Hu et al., 
2001) (Figure 3). The bulbus arteriosus is a collagenous, pear-shaped appendage, rich in 
smooth muscle cells and connects the ventricle to the ventral aorta. It is thought to serve 
as a buffering chamber preventing the entry of blood under high pressure into the gills 
during systole, and to be comparable to the arterial trunk in higher vertebrates. The 
bulbus arteriosus is formed of three layers: an intima, media and externa layer.  The 
intima layer is predominantly formed from smooth muscle cells, collagen and elastin 
fibers, the media layer is formed from helically arranged smooth muscle cells encircling 
the intima layer and the externa layer comprises elastic lamina.  The ventral aorta has a 
total of 8 bifurcations that deliver blood for reoxygenation from the ventricle (via the 
bulbus arteriosus) to gills either side of the zebrafish (Hu et al., 2001), thus, the zebrafish 
heart is described as a ‘venous’ heart that receives and pumps deoxygenated blood. 
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Figure 3 Adult zebrafish heart 
Schematic representation of the adult zebrafish heart. Deoxygenated blood returning in veins 
from the body is collected in the sinus venosus and then fills the atrium. Blood is pumped into the 
ventricle from the atrium via the four-leaflet atrioventricular valve. During systole, blood exits the 
ventricle via the bicuspid bulbo-ventricular valve into the bulbus arteriosus that direct blood 
around the body via the gills for reoxygenation. Image modified from Leong et al. (2010) 
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 Electrical properties and conduction of the zebrafish heart  
The heart rate and electrophysiological properties of cardiomyocytes in the adult 
zebrafish heart more closely resemble that of humans than mice. The adult zebrafish 
heart beats at approximately 120-180 beats per minute, which is closer to the 60-100 
beats per minute in humans than the rapid 600 beats per minute in mice (Milan et al., 
2006b; Sun et al., 2009b). The pacemaker cell population of the zebrafish heart was 
identified as a group of islet-1, tbx2b positive cells arranged in a circular orientation 
between the sinus venosus and atrium interface (Tessadori et al., 2012) (Figure 4). The 
pacemaker electrophysiological properties are comparable to mammalian pacemaker 
cells and the location is analogous to the sinoatrial node in mammals, although the ion 
channels permitting electrical conductance in the pacemakers remain unknown (Poon 
and Brand, 2013). A delay in impulse propagation at the atrioventricular canal (termed 
slow conduction) has been observed to allow ventricle chamber filling from as early as 
40 hpf (Chi et al., 2008; Milan et al., 2006a). This is followed by a fast conduction impulse 
relayed through trabeculae to achieve apex to base conduction during systole (Liu et al., 
2010; Sedmera et al., 2003). Electrical impulse propagation in the zebrafish ventricle 
trabeculae is analogous to His-purkinje fiber conductance observed in mammals and 
coordinates contraction in a similar manner. Action potential amplitude and 
cardiomyocyte resting membrane potential are comparable between zebrafish and 
humans (Sedmera et al., 2003). Zebrafish electrocardiogram measurements display a 
defined P-wave, QRS-complex and T-wave and each QT interval lasts a similar amount 
of time as in humans (200-290 vs 300-450 ms, respectively) (Figure 4) (Milan et al., 
2006b). Furthermore, sodium, calcium and potassium channel currents generate action 
potentials in a similar manner, although the ion channels that mediate the electrical 
conductance differ between the two species (Brette et al., 2008; Haverinen et al., 2007; 
Rottbauer et al., 2001). The cardiac electrophysiological properties of the zebrafish 
therefore support its use as a model to study cardiac physiology and disease. 
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Figure 4 Cardiac electrophysiological properties human, zebrafish and mouse 
Diagrammatic representative traces of electrocardiograms (ECG) from human (left), zebrafish (middle) and mice 
(right). The ECG of zebrafish hearts better resembles the shape and duration of one human electrical cycle (P‐wave 
(atrial depolarization) QRS‐complex (ventricular depolarization) and T wave (ventricular repolarisation)) than the ECG 
of mice. QT‐interval encompasses the beginning of the QRS‐complex to the end of the T‐wave. Image modified from 
Leong et al. (2010)  
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1.3 Use of zebrafish to study cardiac disease 
Well established techniques that allow zebrafish genome editing, and embryo optical 
clarity to monitor cardiac development, have paved the way for genetic screens and 
resulted in identification of several mutations causing phenotypes resembling human 
cardiomyopathies. Additionally, transgenic fluorescent reporter lines that specifically 
identify endothelium (Lawson and Weinstein, 2002), cardiomyocytes (Burns et al., 
2005), epicardium (Peralta et al., 2013), and blood (Long et al., 1997) have been 
developed allowing visualisation of cardiovascular events. Below, I will describe the 
genetic manipulation techniques commonly applied to zebrafish and cardiovascular 
disease models currently established. 
 Genetic manipulation of zebrafish genome 
Reverse genetic screening has proven a useful approach to identify candidate genes 
responsible for pathological phenotypes. However, genetic manipulation can be 
somewhat complicated in the zebrafish due to evolutionary genome duplication, thus 
disruption of a single allele may not present a phenotype due to redundancy and 
compensation of the duplicated gene (Amores et al., 1998; Postlethwait et al., 1998; 
Rossi et al., 2015). Despite the challenges, several approaches to modify the genome 
have been successfully applied to the zebrafish; below I describe three of the most 
commonly practised approaches. 
1.3.1.1 Morpholinos 
For several years, the use of morpholinos was the preferred method to carry out reverse 
genetic screening approaches in the zebrafish. Morpholino technology was introduced 
by Nasevicius and Ekker in 2000 who induced gene silencing via antisense 
complementarity oligonucleotides (~25mer) to disrupt target protein synthesis (Figure 
5A). Morpholinos are nucleic acid analogs that contain methylenemorpholine rings in 
place of ribose or deoxyribose sugar in the macromolecule backbone. They can be 
designed to bind in close proximity to the ATG translation start site or other essential 
mRNA features, interfering with target gene translation or splicing to elicit target gene 
knockdown. Though this proved effective for studying gene functions and modelling 
 43 
 
diseases, the technique is limited to transient gene knockdown, restricting experiments 
to developmental stages. Additionally, more recent observations have added a level of 
scepticism towards the validity of the morpholino approach. Morpholino-induced 
phenotypes often differ from other genetic silencing techniques of the same gene (Kok 
et al., 2015; Novodvorsky et al., 2015; van Impel et al., 2014), there can be widespread 
side effects (Eisen and Smith, 2008), and non-specific gene-targeting due to the high 
relative abundance of the morpholino constructs in comparison to their target is a major 
problem (Schulte-Merker and Stainier, 2014).  
1.3.1.2 CRISPR 
Clustered regularly interspaced short palindromic repeats (CRISPR) were originally 
identified in bacteria as a defence mechanism from bacteriophages (Barrangou et al., 
2007). Bacteria store bacteriophage genomic sequences from a previous infection. Upon 
repeated infection, the bacteria generate RNA complementary to the viral genome and 
recruit Cas9 endonuclease to cleave viral DNA to prevent infection. CRISPR technology 
adapts this mechanism, using guide RNA (gRNA) that encodes a 20 base complimentary 
sequence to a target gene, and recruits Cas9 to the DNA to induce a blunt end double-
stranded break (Figure 5B). The host molecular machinery attempts to mend the break 
via non-homologous repair that is likely to trigger random insertions and deletions of 
nucleotides (indels) leading to the introduction of mutations and gene disruption (Figure 
5B). In zebrafish, this genome editing technique can be applied at the one cell stage 
during which gRNA and Cas9 (mRNA or protein) are co-microinjected into the cell, in 
order to induce gene disruption and produce a mutant line (Chang et al., 2013; Hwang 
et al., 2013). It is a highly effective genome-editing technique that achieves greater than 
75% mutagenesis efficiency (Sander and Joung, 2014). This approach can also be 
modified to insert nucleotide sequences and generate knock-in transgenic fish lines 
(Bedell et al., 2012; Chang et al., 2013; Hwang et al., 2013).  
1.3.1.3 ENU 
N-ethyl-N-nitrosourea (ENU) mutagenesis is a chemical method used to induce 
mutations that has been widely applied in zebrafish. ENU is a highly mutagenic chemical 
that triggers the transfer of an ethyl group to nucleotide bases, inducing point mutations 
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(Coghill et al., 2002) and can alter 1 in every 700 bases (Davis and Justice, 1998). 
Spermatogenesis is targeted for mutation incorporation and male zebrafish are treated 
with ENU to induce anomalies randomly throughout the DNA in gametes.  ENU-treated 
males are crossed with wild type females, and mutant founder fish are generated with 
random mutations in their genome (Figure 5C). Offspring (F1) are screened for mutations 
using a PCR and endonuclease method termed targeting-induced local lesions in 
genomes (TILLING) (McCallum et al., 2000; Wienholds et al., 2002; Wienholds et al., 
2003). Identified mutations are categorised by the function of their genetic outcome 
(e.g. nonsense mutation, loss of function, amino acid change) and F1 fish are crossed 
with wild type fish to confirm transmission of the mutation in the germline (Figure 5C). 
The heterozygous progeny (F2) are then incrossed and offspring are screened for 
phenotypes. Finally homozygous mutant fish lines can be established from the F4 
generation (Figure 5C). ENU mutant fish production and TILLING is laborious and 
expensive, additionally this approach does not allow targeted mutation of a specific 
gene, and thus this approach is more frequently carried out as part of a large-scale 
effort. 
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Figure 5 Gene expression manipulation techniques in the zebrafish 
(A) Morpholinos (red) are anti-sense oligonucleotides analogs designed to encode the 
complimentary sequence to target gene mRNA (purple). When introduced to the cell, the 
morpholino binds to target mRNA and physically inhibits translation. (B) CRISPR technology utilises 
a customised RNA termed guide RNA (gRNA), that encodes a complimentary sequence to the target 
genomic DNA sequence enabling the gRNA to bind. The gRNA also encodes a Cas9 endonuclease 
(blue) recruitment domain that directs the Cas9 enzyme to the target sequence to induce a double 
strand break (DSB) ahead of the PAM (protospacer adjacent motif) sequence (pink). The cleaved 
DNA is repaired by non-homologous end-joining, likely resulting in the incorporation or deletion of 
nucleotides (indels) and the disruption of the target gene. Image modified from (Ding et al., 2016) 
(C) Male zebrafish are treated with the mutagenic chemical N-ethyl-N-nitrosourea (ENU) to induce 
mutations during spermatogenesis. The fish is crossed with WT (+/+) females and the 
heterozygous(+/-) progeny (F1) are crossed with wild types to confirm germline transmission to the 
F2 generation. F2 fish are incrossed to establish homozygous mutants in the offspring (F3). 
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 Cardiovascular disease models in the zebrafish 
The zebrafish heart is a simpler structure to that of higher vertebrates and may not 
recapitulate complications occurring in mammals and limit identification of mechanisms 
contributing to human cardiac diseases. Indeed, as a consequence of its anatomical 
features (two chambers versus four chambered in mammals), some human congenital 
heart defects involving right and left heart septation are unable to be modelled in 
zebrafish. However, several development mechanisms (see 1.1.1) and cardiac functions 
(see 1.2) are conserved between zebrafish and human hearts, supporting the use of 
zebrafish as a model to study cardiac disease.  
Multiple mutant zebrafish lines have been developed to study human cardiovascular 
diseases. Arrhythmias have been modelled in zebrafish encoding ion channel mutations. 
For example, the tremblor zebrafish contains a mutation in the cardiac-specific sodium 
calcium exchanger, this model recapitulates ventricular fibrillation due to heightened 
intracellular calcium levels and irregular calcium transients (Langenbacher et al., 2005). 
Bradycardia is modelled using the slow mo zebrafish mutant, in which the recessive 
allele causes delayed heart rate due to impaired hyperpolarization-activated cation 
pacemaker currents (Ih) (Baker et al., 1997). The reggae (reg) zebrafish mutant encodes 
a gain-of-function mutation in the zebrafish ether-à-go-go-related gene (zERG) 
potassium channel and results in shortened action potentials that cause cardiac 
fibrillation (Hassel et al., 2008). The reg mutant closely resembles arrhythmia 
pathologies observed in human short-QT syndrome (SQTS) that can lead to sudden 
cardiac death (Schimpf et al., 2005). 
Dilated human cardiomyopathy can be effectively modelled in the zebrafish via tintin 
gene silencing which results in the disruption of the Z-line of sarcomeres and the 
impairment of cardiac function (Xu et al., 2002). During cardiac stress due to 
cardiomyopathies, the hypertrophic natriuretic peptide signalling pathway is switched 
on in both mammals and fish. A transgenic reporter zebrafish line has been developed 
that expresses luciferase downstream of the natriuretic peptide promoter, this can be 
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used to study cardiac hypertrophy in models such as the tintin mutant or environmental 
influences that elicit hypertrophic responses (Becker et al., 2012).  
 Zebrafish myocardial infarction models 
Several techniques have been developed to simulate cardiac damage sustained during 
MI in humans. They either rely on mutant or transgenic lines or physical damage by 
surgical means.  A decade and a half ago, it was found that the zebrafish could survive 
the surgical removal of up to 20% of its ventricle (Poss et al., 2002). Initially, the zebrafish 
response triggers mechanisms reminiscent of those in humans after MI, including 
inflammation and fibrosis. However, the zebrafish can then repair the damage with new 
functional myocardium during a regenerative phase. The following section addresses 
techniques developed in zebrafish to investigate heart regeneration. 
1.3.3.1 Ventricular resection 
Poss and colleagues (2002) were the first to identify the regenerative capacity of the 
zebrafish heart using ventricular resection. In this model, approximately 20% of the 
ventricle is surgically removed from the adult heart using fine iridectomy scissors (Figure 
6A). A clot forms immediately at the site of injury, followed by inflammation and fibrosis. 
The fibrotic scar is subsequently replaced by functional cardiomyocytes, completely 
regenerating the lost cardiac tissue within 60 days following amputation (Poss et al., 
2002). In mammals and amphibians the scar tissue is collagen rich (Cleutjens et al., 
1995), this is unlike the resection model in zebrafish, which results in fibrin clot 
formation without extensive collagen deposition within the injured area (Poss et al., 
2002). Furthermore, in this model, neomyogenesis predominantly produces a thick 
compact myocardial layer at the site of insult (Poss et al., 2002). The architecture of the 
myocardium of the uninjured zebrafish heart comprises a thin compact layer and a more 
prevalent trabecular layer, which suggests that resection, although achieving functional 
restoration, permanently alters the structural composition of the heart. 
The resection model has also been investigated in neonatal mice that similarly retain 
regenerative capacity until 7 days post birth (Porrello et al., 2011b). The initial response 
to injury observed in mice is similar to that of zebrafish, with initial blood clotting and 
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inflammation followed by cardiomyocyte proliferation, resulting in minimal cardiac 
hypertrophy and fibrosis and leading to restoration of cardiac function within 21 days of 
resection (Figure 6) (Porrello et al., 2011b). It has since been shown that different 
severities of resection will determine the regenerative outcome; for example, large 
apical ventricular resections (>23% ventricle damage) result in incomplete regeneration 
and the deposition of a lasting scar in contrast to the results of 15% resection (Bryant et 
al., 2015).  
1.3.3.2 Inducible genetic ablation  
Inducible genetic ablation is a non-invasive procedure that causes the death of 
cardiomyocytes. Genetically modified zebrafish expressing inducible Cre recombinase 
under the control of the cardiac myosin light chain 2 (cmlc2) promoter have been 
engineered to express the cytotoxic diphtheria toxin A (DTA) gene downstream of loxP 
sites. Tamoxifen exposure stimulates DTA production specifically in cardiomyocytes, 
resulting in the death of up to 60% of the cardiomyocyte population (Figure 6). 
Nevertheless, surviving cardiomyocytes dedifferentiate, undergo rapid proliferation 
and, within 30 days, complete regeneration of the cardiac tissue is achieved (Wang et 
al., 2011). This demonstrates the robust resilience of the zebrafish heart that, even after 
suffering a huge loss of cardiomyocytes, is able to rapidly regain full cardiac function 
(Wang et al., 2011). Despite only affecting one cardiac cell type, genetic cardiomyocyte 
ablation induces epicardium and endocardium activation and inflammation, similarly to 
other models of cardiac damage in the zebrafish. Nevertheless, the relevance of the 
genetic ablation technique to mammalian MI is limited because organ-wide 
cardiomyocyte death occurs rather than localised tissue necrosis; moreover, there is no 
scar formation. Genetic cardiomyocyte ablation results in reduced exercise tolerance 
and sudden cardiac death, mirroring some of the repercussions of heart failure, but 
weakly resembles mammalian MI. 
1.3.3.3 Cryoinjury  
Cryoinjury (also known as cryocauterisation) was developed by the group of Nadia 
Mercader and colleagues (2011) as an alternative model for myocardial infarction and 
heart regeneration in the zebrafish. A small metal filament, cooled in liquid nitrogen, is 
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pressed onto the exposed ventricle of the zebrafish. Subsequently, thermal shock-
induced necrosis and apoptosis takes place, creating a lesion of approximately 25% of 
the ventricle (Figure 6). A similar injury can also be achieved by application of dry ice to 
the ventricle (Schnabel et al., 2011). The damage is extensive and spans over the endo-
, myo- and epicardial layers. This model best recapitulates mammalian MI as it achieves 
cardiac cell death in a localised region without removal of cardiac tissue. Furthermore, 
the reparative process that subsequently occurs relies on the deposition of a fibrotic 
scar formed predominantly by a collagen-rich core and a fibrin cap. This process also 
resembles more closely the fibrotic response observed in humans after myocardial 
infarction (Chablais et al., 2011; Manuel Gonzalez-Rosa et al., 2011). The fibrotic tissue 
is gradually removed and replaced with proliferating cardiomyocytes to achieve 
complete regeneration, albeit over a longer time scale than resection, in up to 130 days 
(Figure 6)(Manuel Gonzalez-Rosa et al., 2011). Cryoinjured hearts regain reasonable 
cardiac function, however impaired ventricular contraction is evident due to 
myocardium remodelling that perturbs homogeneous contraction (Manuel Gonzalez-
Rosa et al., 2011). 
The cryoinjury procedure has been applied to the neonatal mouse (Darehzereshki et al., 
2015). The neonatal mouse heart retains some regenerative capacity for up to 7 days 
post injury (see 1.3.3.1), however varying results were observed with this model. The 
extent of cardiac damage determines the regenerative process. Transmural damage 
(throughout the endo-, myo- and epicardium) results in incomplete regeneration and 
extensive scarring, whereas, non-transmural injury restricted to epicardial and 
myocardial damage, results in regeneration with scarring to a lesser extent (Figure 
6)(Darehzereshki et al., 2015). 
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Figure 6 Myocardial infarction models in regenerative animals 
Illustrative representation of the three zebrafish (upper row) and neonatal mouse 
(lower row) myocardial infarction models. Apical resection (also known as 
ventricular resection) consists of the removal of up to 20% of the ventricle. Genetic 
ablation involves cardiomyocyte-specific death induced by tamoxifen delivery to a 
transgenic fish expressing DTA under the control of Cre recombinase. Cryoinjury of 
the ventricle is induced by the application of a metal probe cooled in liquid nitrogen 
onto the exposed ventricle. Myocardial infarction can be induced in the neonatal 
mouse via ligation of a major coronary artery. Description regarding regenerative 
capacity, cardiomyocyte (CM) proliferation and neomyocyte origin (genetic 
lineage) are listed below each MI model. Image modified from (Porrello and Olson, 
2014) 
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1.4 Mechanisms of zebrafish heart regeneration  
 Regenerative capacity of the zebrafish 
Increased survival rates following MI have been achieved with improved medical 
interventions that allow the recovery of blood supply to the ischemic area (Kabir et al., 
2007; Unal et al., 2005). However, the affected area of the heart of patients who survive 
MI does not regain full physiological function because of extensive fibrotic remodelling; 
this can result in heart failure, fatal arrhythmias amongst other secondary 
complications. Evidence exists supporting an endogenous ability to repair damaged 
cardiac tissue in humans, as observed in new-born babies who are able to recover from 
myocardial infarction; however this ability is lost within 6 months postnatally (Haubner 
et al., 2016). In contrast to zebrafish, adult mammalian hearts, once damaged, are 
unable to fully repair, limited cardiomyocyte proliferation takes place, and, instead of 
neomyogenesis, extensive collagen deposition and cardiomyocyte hypertrophy 
compensate for compromised cardiac function (Buja and Vela, 2008; Pasumarthi and 
Field, 2002; Pfeffer and Braunwald, 1990). Although the fibrotic scar prevents ventricle 
wall rupture, it does not possess the contractile properties of the myocardium. 
Furthermore, fibrotic tissue perturbs electrical conductivity that co-ordinates a 
synchronised heartbeat, promoting arrhythmias.  
Several investigations have been initiated using the different models described in the 
previous section (1.3.3), in order to understand what events govern the regenerative 
process throughout the zebrafish life span (Itou et al., 2012a). Initially, inflammation 
(inflammatory phase) occurs in the lesion, this is followed by scar deposition (reparative 
phase), and finally scar tissue removal and cardiomyocyte proliferation (regenerative 
phase) (Figure 7) (Jopling et al., 2010). A genetic profile switch occurs, whereby a 
plethora of embryonic genes are re-expressed allowing transdifferentiation and 
proliferation of cells that would otherwise be quiescent. 
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 Inflammation 
1.4.2.1 Mammalian inflammatory phase 
The death of cardiac cells following MI or cardiac insult results in the production of 
danger associated molecular patterns (DAMPs) and reactive oxygen species (ROS) that 
recruit innate immune cells to the damaged area (Timmers et al., 2012). Additionally, 
matrix metalloproteinases (MMPs) are activated, resulting in the degradation of cardiac 
matrix, further enhancing inflammation (Etoh et al., 2001; Senior et al., 1980; 
Weathington et al., 2006)). The initial inflammatory response lasts up to 4 days in adult 
mammals. It is essential for necrotic and apoptotic cell removal and central to mediating 
subsequent reparative events (Dobaczewski et al., 2010). Neutrophils and macrophages 
primarily infiltrate the ischemic tissue from the blood in response to inflammatory 
signals produced by damaged and adjacent healthy cardiomyocytes (Pfeffer and 
Braunwald, 1990). Macrophages secrete a cocktail of cytokines such as tumour necrosis 
factor alpha (TNFα), interleukin (IL)-1, IL-6, FGF and monocyte chemoattractant protein 
(MCP)-1 to stimulate fibroblast recruitment and proliferation and angiogenesis 
(Frangogiannis et al., 2003; Lambert et al., 2008).  
Macrophage colony-stimulating factor (MCSF) promotes VEGF production and 
angiogenesis that ultimately improves cardiac function following MI and enhances 
cardiomyocyte preservation (Okazaki et al., 2007). Inflammation was reported to 
support cardiac function following MI in a study by Sun and colleagues (2009). In line 
with their findings, the inhibition of inflammation via the delivery of pharmacological 
agents, has shown deleterious consequences in mammalian MI models (Mannisi et al., 
1987; Sun et al., 2009a; van Amerongen et al., 2007). This highlights the pivotal role of 
the inflammatory response following MI. Nevertheless, some conflicting results 
generated by other studies have shown that complete inhibition of the inflammatory 
response reduced infarct size and promoted cardiac healing (Oyama et al., 2004; 
Timmers et al., 2008), whereas other reports have shown no overall benefit of 
inflammation inhibition in clinical trials (Armstrong et al., 2007; Faxon et al., 2002).  
Controversy remains concerning the beneficial influence of inflammation following MI. 
It is possible that leucocytes are associated with detrimental cardiac remodelling due 
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indirect activities, such as fibroblast recruitment to the lesion and the triggering of their 
transdifferentiation into cardiac myofibroblasts. The extent of the inflammatory 
response may also contribute to pathological outcomes. Acute inflammation is 
suggested as essential in the reparative response (Hubner et al., 1996); prolonged 
chronic inflammation can reverse these beneficial effects because it potentially 
promotes cardiac remodelling (Frantz et al., 2009). The promotion of acute 
inflammation following MI and the tightly regulated clearance of immune cells via 
lymphatic vessels to reduce chronic inflammation, have been proven beneficial after MI 
(Evans et al., 2013; Henri et al., 2016).  
1.4.2.2 Zebrafish inflammatory phase 
The inflammatory phase occurs from 0 to 3 days after cryoinjury of the zebrafish heart 
(Figure 7) (Chablais and Jazwinska, 2012). The zebrafish initiates an innate immune 
response whereby, infiltrating leucocytes produce pro-inflammatory cytokines, helping 
with the removal of cellular and matrix debris and the recruitment of fibroblast-like cells 
to the injury area. Several evolutionary features of innate immunity have been 
conserved in vertebrates (Beck and Habicht, 1991). The zebrafish genome encodes 
orthologs of potent pro-inflammatory cytokines that are produced following tissue 
injury and mediate leucocyte recruitment and inflammatory responses reminiscent of 
higher vertebrates (Ogryzko et al., 2014; Stein et al., 2007). 
Acute inflammation is an essential step for cardiac regeneration, as it precedes and 
initiates the subsequent reparative phase. Huang and colleagues (2013) reported that 
pharmacological inhibition of inflammation with glucocorticoids perturbs phagocytic 
clearing of cellular debris and diminishes vegfaa and fgfr expression, thus reducing the 
revascularisation of the injured area. The anti-inflammatory treatment also attenuated 
cardiomyocyte proliferation, leaving a persistent scar and preventing the complete 
regenerative response (Huang et al., 2013). These observations were further supported 
by evidence that revealed the essential role of leukocyte-derived TGFβ signalling 
orchestrating the subsequent regenerative events. Indeed, inhibiting TGFβ signalling 
pathways during the early inflammatory phase completely inhibited cardiac 
regeneration (Chablais and Jazwinska, 2012). The TGFβ contribution to zebrafish heart 
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regeneration is dependent on activin and Smad3 signalling (see 1.5.5.5). TGFβ targets 
fibronectin, collagen and tenascin C synthesis, initiating inflammatory signals driving the 
fibrotic responses and remodelling (Chablais and Jazwinska, 2012). The resolution of the 
inflammation response is regulated, in part by, by hydrogen peroxide and Tβ4 signalling 
that inhibit pro-inflammatory interferon   (IFN) and reduce inflammatory macrophage 
infiltration (Evans et al., 2013). Although initial inflammation is a prerequisite for 
neuronal and heart regeneration in the zebrafish (Huang et al., 2013; Kyritsis et al., 
2012), it is not essential for fin regeneration (Mathew et al., 2007). These studies imply 
that acute inflammation is important for the regenerative response for both mammals 
and fish, but its pivotal role differs between regenerating organs. 
 Fibrosis 
1.4.3.1 Adult mammals 
In mammals, neutrophil apoptosis marks the resolution of the inflammation process and 
the initiation of the reparative (also referred to as the proliferative) phase. This phase 
occurs approximately 4 days following cardiac injury and continues for up to 14 days 
(Dobaczewski et al., 2010). During this phase of cardiac repair, fibroblasts are recruited 
to the lesion. Fibronectin and hyaluronan polysaccharide deposits produced during the 
inflammatory phase act as a scaffold to support cardiac structure, preventing 
haemorrhage and facilitating fibroblast and endothelial cell infiltration (Clark, 1988; 
Dobaczewski et al., 2006). TGFβ and platelet-derived growth factor (PDGF) produced by 
macrophages recruit resident cardiac fibroblasts to the injury (Yano et al., 2005), and 
induce fibroblast transdifferentiation to myofibroblasts (Brown et al., 1993; 
Dobaczewski et al., 2006; Serini et al., 1998; Ulrich et al., 1997). Myofibroblasts 
subsequently synthesise collagen deposits at the site of injury (Cleutjens et al., 1995). 
Cytokines such as basic fibroblast growth factor (bFGF) and TGFβ enhance tenascin C 
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production by fibroblasts at the injury border, thus facilitating myofibroblast migration, 
aiding delamination and cardiac tissue remodelling (Imanaka-Yoshida et al., 2001).  
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Figure 7 Phases of cardiac regeneration in zebrafish 
The inflammatory phase takes place in the first three days following cryoinjury. 
Leucocytes infiltrate to the injured area, neovessel begin to revascularise the lesion 
and fibroblasts are recruited to the damaged area. Fibroblasts synthesise and secrete 
extracellular matrix (ECM) components during the reparative (days 4-7 post cryoinjury) 
phase; a collagen core and fibrin cap are produced to provide mechanical support to 
prevent ventricle wall rupture and scaffolding for neomyocardium. During the 
regenerative phase (7-130 dpci), cardiomyocytes dedifferentiate, proliferate and 
invade the lesion; fibrotic tissue is reabsorbed to regenerate cardiac tissue. 
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Once myofibroblasts are established at the injury site, the heart progresses towards the 
maturation phase of cardiac repair that lasts from 14 to 60 days post injury (Dobaczewski 
et al., 2010). Maturation involves the cross-linking of collagen extracellular matrix 
proteins to create a permanent and stable scaffold to provide mechanical support. 
Myofibroblast and vessel infiltration diminishes over time and the maturing scar 
becomes acellular, leaving a dense collagen scar deposit (Jennings et al., 1990; Lerman 
et al., 1983; Ren et al., 2002). 
1.4.3.2  Zebrafish fibrosis 
Cardiac remodelling after injury in zebrafish, similarly to mammals, is a complex process, 
however limited studies have focused on the fibrotic response in zebrafish heart 
regeneration. The reparative phase lasts from 4-7 days post injury (Figure 7) (Chablais 
and Jazwinska, 2012). At this stage, cellular and matrix debris within the lesion have 
been cleared. Tgfβ and Activin signalling induce fibronectin and collagen matrix 
deposition by differentiated proliferating myofibroblasts (Chablais and Jazwinska, 
2012). Tgfβ type 1 receptor (Alk5/4) inhibition results in the reduction of Smad3 
phosphorylation and markedly impairs the regenerative response. Tenascin C, a de-
adhesive extracellular matrix protein, is implicated in cardiac remodelling at the injury 
border. It is essential for cardiomyocyte infiltration (Chablais and Jazwinska, 2012) which 
supports observations generated from adult mammalian models (Imanaka-Yoshida et 
al., 2001).  
A fibrin dominant scar encases a collagen core by 7 days post cryoinjury, but the exact 
mechanisms, signals and cellular processes that mediate this organised scar structure 
remain largely unclear (Manuel Gonzalez-Rosa et al., 2011). The transient scar deposited 
in the zebrafish heart is essential for full repair; perturbation of the reparative phase 
with TGFβ signal inhibitors results in incomplete cardiac regeneration and gross 
malformation of the injured hearts due to partial ventricular rupture (Chablais and 
Jazwinska, 2012). 
Additional fibronectin deposits are produced by the epicardium and are necessary for 
zebrafish heart regeneration. Fibronectin (fn), fn1 and fn1b, expression can be observed 
in epicardial cells close to the injury. Concomitantly, cardiomyocytes around the injured 
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area express integrin β3 (itgb3). Fibronectin-itgb3 interaction is required for complete 
regeneration, likely through enhancing the migratory response of cardiomyocytes, as 
proliferation was unaffected by disruption of this pathway (Wang et al., 2013b). This is 
reminiscent of embryonic heart cardiac primordia fibronectin-dependent migration 
during heart tube formation (as described in section 1.1.1) (Garavito-Aguilar et al., 2010; 
Kupperman et al., 2000). 
Remarkably, scar tissue is reabsorbed and replaced with new myocardium during the 
regenerative phase (Figure 7). The mechanisms involved in this process remain unclear. 
Understanding the endogenous events that trigger the removal of pathological scar 
tissue before maturation could help us uncover potential targets for therapies in 
humans. 
 Cardiomyocyte proliferation  
1.4.4.1 Mammalian cardiomyocyte proliferation 
The inability to replace the dead cardiomyocyte population results in the retention of 
fibrotic deposits within the lesion. Scar tissue does not possess any contractile 
properties; however, the spared myocardium must still meet cardiac demands. This 
ultimately causes hypertrophy of the surviving cardiomyocytes and the dilation of the 
ventricles, compromising heart function and leading to heart failure (Li et al., 1996). 
Mammalian cardiomyocytes become terminally differentiated shortly after birth and 
exhibit limited proliferative capacity thereafter (Li et al., 1996; Rumyantsev, 1977). Low 
homeostatic cardiomyocyte proliferation can be detected under basal conditions, 
cardiomyocyte turnover gradually declines from birth (Mollova et al., 2013) to 
approximately 0.5-1% per year in adult humans (Bergmann et al., 2009). Varying 
turnover rates are observed at different ages in other mammalian models, but mitotic 
cardiomyocytes consistently account for a minute percentage of the overall cardiac 
population (Li et al., 1996; Naqvi et al., 2014). Terminal differentiation coincides with a 
change in nuclear content (Li et al., 1998; Pasumarthi and Field, 2002). Cardiomyocytes 
of the neonatal mouse are mononuclear for the first 7 days after birth, then, the majority 
of cardiomyocytes undergo an incomplete round of cytokinesis, and remain in a 
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binucleated state (Figure 8). The loack of cytokinesis coincides with loss of neonatal mice 
regenerative capacity and upregulation of the cardiomyocyte cell cycle suppressor, 
meis1 (Li et al., 1996; Mahmoud et al., 2013; Porrello et al., 2011a; Porrello et al., 
2011b). In contrast, neonatal mouse cardiomyocytes have been demonstrated to retain 
proliferative properties up to 21 days after birth (Walsh et al., 2010). Despite disparities 
between studies, it is commonly accepted that shortly after birth, proliferative capacity 
diminishes. Similarly, in humans, a few months after birth, cardiomyocytes increase their 
DNA content and arrest in a polyploid mononuclear state (Figure 8) (Laflamme and 
Murry, 2011).  This is associated with a loss of cardiomyocyte capacity to re-enter the 
cell cycle and results in the establishment of a heart described as “post-mitotic” 
(Mollova et al., 2013). 
The number of cardiomyocytes in an adult mammal is predetermined and fixed 
postnatally; the post-mitotic human heart contains up to 9.5 billion cardiomyocytes 
(Mollova et al., 2013; Tang et al., 2009) of which up to a billion can be lost following MI 
(Murry et al., 2006). Post-mitotic mammalian cardiomyocytes can re-enter the cell cycle 
when stimulated (Engel et al., 2005), and following cardiac damage, approximately 3% 
of pre-existing cardiomyocytes on the periphery of the injury do so in a mouse model 
(Senyo et al., 2013). Nevertheless, the response is insufficient to replace damaged 
myocardium (Ali et al., 2014). Thus, other studies have made efforts to produce an 
alternative source of cardiomyocytes from endogenous or induced cardiac progenitor 
cells (Chong et al., 2011; Domian et al., 2009; Laugwitz et al., 2005; Smart et al., 2011).  
In the neonatal mice models of MI via coronary ligation and apical resection, the primary 
source of neomyocytes are derived from pre-existing cardiomyocytes (Haubner et al., 
2012). Attempts to replenish cardiac lesions by stimulating endogenous cardiomyocyte 
cell cycle re-entry or stem cell differentiation in adult mammals have been unsuccessful 
so far, but still maintain therapeutic promise (Garbern and Lee, 2013). Some studies 
implicate a pool of resident cardiac stem cells capable of producing a limited 
cardiomyocyte population, however, the consensus of these studies is that progenitor 
populations are insufficient to replace the huge cardiomyocyte loss that occurs following 
MI (Hsieh et al., 2007; Malliaras et al., 2013). One study estimated that c-kit (a receptor 
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tyrosine kinase) positive endogenous resident cardiac progenitor cells contribute to 
0.03% or less of the total cardiomyocyte population following cardiac damage and thus 
questioned the physiological relevance of such a small population (Garbern and Lee, 
2013; van Berlo et al., 2014). On the contrary, other studies reported that resident c-kit 
positive cells are essential for MI recovery, improve cardiac function and therefore hold 
therapeutic potential (Ellison et al., 2013; Hsieh et al., 2007; Loffredo et al., 2011; Senyo 
et al., 2013). The generation of new cardiomyocytes from a population other than pre-
existing cardiomyocytes is still a hotly debated topic and an active area of research. 
1.4.4.2 Zebrafish cardiomyocyte proliferation 
Pre-existing cardiomyocytes are the primary source for cardiac neomyogenesis in 
zebrafish following cardiac injury (Gupta et al., 2013; Jopling et al., 2010; Kikuchi et al., 
2010; Schnabel et al., 2011). In contrast to pathological cardiomyocyte hypertrophy 
occurring in the adult mammalian heart under stress, the zebrafish heart can undergo 
homeostatic growth to modify its size via cardiomyocyte proliferation throughout their 
lifetime (Itou et al., 2012a; Wills et al., 2008). The trigger for cardiomyocytes to re-enter 
the cell cycle may shed light on the proliferative capacity of adult zebrafish 
cardiomyocytes following cardiac damage. Cardiomyocyte mitogenic potential 
correlates with nuclei numbers and DNA content: neonatal mammals, urodele 
amphibians and teleost fish all maintain the ability to regenerate their heart, and all 
possess a majority of mononuclear diploid cardiomyocytes. In contrast, the adult 
mammalian heart is made up binucleated and polyploid cardiomyocytes. (Kikuchi and 
Poss, 2012). Zebrafish cardiomyocytes remain mononuclear and diploid throughout 
their lifespan and retain their regenerative capacity (Figure 8) (Itou et al., 2012a). 
 60 
 
 
  
Figure 8 Cardiomyocyte nuclear content and proliferative capacity 
Diagram illustrating human (upper row), mouse (middle) and zebrafish 
(bottom) cardiomyocytes nuclear content at birth and adulthood. Shortly 
after birth neonatal mammalian cardiomyocytes undergo an incomplete 
round of mitosis and arrest in a polyploid (human) or binucleated (mouse) 
state; this coincides with the time at which cardiomyocyte proliferative 
capacity is lost. Zebrafish cardiomyocytes remain in a mononuclear and 
diploid throughout their lifetime and cardiomyocytes retain proliferative 
potential. Blue arrows indicate regenerative capacity. Image modified from 
Kikuchi and Poss (2012) 
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Seven days after cardiac damage induced by cryoinjury, zebrafish enter the regenerative 
phase (Figure 7). Global cardiomyocyte proliferation is observed with increased 
myocardial proliferation at the injured area border and cardiomyocytes invade and 
replenish lost myocardium (Manuel Gonzalez-Rosa et al., 2011). The regenerative phase 
completes within 60 to 130 days (Figure 7) (Chablais and Jazwinska, 2012; Manuel 
Gonzalez-Rosa et al., 2011). Cardiomyocytes dedifferentiate and disassemble 
sarcomeric structures before dividing. This process is strongly associated with the 
expression of embryonic markers (Jopling et al., 2010; Kikuchi et al., 2010). The viable 
cardiomyocytes proximal to the damaged area re-express nkx2.5 and hand2 within 4 
days of ventricular amputation (Lepilina et al., 2006). Further studies showed that at 7 
days post-injury Fgf signalling induces gata4 expression by subepicardial 
cardiomyocytes at the periphery of the injury within the compact layer. This 
cardiomyocyte population is thought to be the primary source of cells contributing to 
the regenerating neomyocardium (Kikuchi et al., 2010), although evidence exists for a 
significant contribution to new cardiac tissue by peripheral cardiomyocytes in the 
trabecular myocardium (Manuel Gonzalez-Rosa et al., 2011). NF-kappaB signalling was 
also demonstrated to initiate cardiomyocyte gata5 expression upon injury (Karra et al., 
2015). Cardiomyocytes localized at the epicardial edge of the injury proliferate 
extensively to provide new myocardium and migrate into the injured region leading to 
initial compact myocardium recovery (Gupta et al., 2013; Jopling et al., 2010). After this 
process, the scar is encased and the wound is described as “closed”. Subsequently the 
scar tissue is gradually removed and replaced with new myocardium (Gupta et al., 2013; 
Gupta and Poss, 2012; Manuel Gonzalez-Rosa et al., 2011).  
Paracrine factors have been implicated in stimulating cardiomyocyte replication after 
cardiac damage in the zebrafish heart. Retinoic acid produced by the epicardium and 
endocardium signals to underlying healthy myocardium and is able to induce 
cardiomyocyte proliferation (Figure 9) (Kikuchi et al., 2011b). This is in contrast to the 
retinoic acid response observed in zebrafish during cardiac development, whereby 
retinoic acid was shown to restrict atrial cardiomyocyte addition from the second heart 
field and limit organ growth (Waxman et al., 2008). Leucocyte-derived TGFβ also 
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initiates zebrafish cardiomyocyte proliferation (Figure 9) (Chablais and Jazwinska, 2012), 
whereas the same signal drives pathological hypertrophy in adult mammalian hearts 
(Rosenkranz, 2004). It is also reported that PDGF signalling can influence the 
cardiomyocyte cell cycle, although it is uncertain whether this results from the secretion 
of mitogenic factors by PDGF-stimulated epicardium or if Pdgf can directly signal to 
cardiomyocytes (Kim et al., 2010). The epicardium also secrets Cxcl12a that signals 
through the cardiomyocyte receptor, Cxcr4, and induces migration and proliferation of 
the cells in close proximity to the lesion (Itou et al., 2012b). 
Although the scar tissue is ultimately resorbed, extracellular matrix deposition and 
cardiomyocyte proliferation occur simultaneously (Kikuchi et al., 2010; Kikuchi and Poss, 
2012). The newly generated myocardium does not recapitulate the initial architecture 
of the original healthy cardiac tissue, the compact layer is thicker in comparison with 
uninjured control hearts (Manuel Gonzalez-Rosa et al., 2011). Furthermore, it was 
reported that the regenerated myocardium presents altered contraction dynamics 
compared with uninjured myocardium. Despite the slight hypertrophic phenotype of the 
compact layer and asynchronous contraction after regeneration, cardiac function is fully 
restored (Manuel Gonzalez-Rosa et al., 2011). 
 Revascularisation 
1.4.5.1 Mammalian angiogenesis 
Part of the myocardium at risk is salvaged, and adverse remodelling and heart failure 
reduced when vascular supply to the ischemic tissue is enhanced in MI patients (Harada 
et al., 1996; Pearlman et al., 1995; Yanagisawa-Miwa et al., 1992). Although angiogenic 
signals are triggered early at the onset of MI, the lesion remains poorly vascularised in 
the mammalian heart (Dimmeler et al., 2005; Harrison et al., 2015). Hypoxia and 
mechanical stress induce the expression of VEGFA, a key mitogen essential for 
revascularisation (Heil and Schaper, 2004; Lee et al., 2000). VEGFA is primarily produced 
by hypoxic cardiomyocytes, endothelial cells and leucocytes recruited to the infarct 
(Berse et al., 1992; Taichman et al., 1997). Endothelial cells detect VEGFA via VEGFR2 
(KDR), stimulating their proliferation and migration (discussed in further detail in section 
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1.5.5.2). The VEGFB isoform of VEGF has also been found to stimulate coronary artery 
growth post MI through a VEGFR1-NRP1 signalling axis in rats; however, this has not 
been replicated in other species (Kupatt and Hinkel, 2014; Lahteenvuo et al., 2009).  
Despite the triggering of endogenous signalling in response to hypoxia, the blood supply 
to the infarcted area is insufficient; thus, stimulating revascularisation has been 
identified as a potential therapeutic target for the treatment of acute MI (Haider et al., 
2009; Hao et al., 2007; Henry et al., 2003). Zangi et al. (2013) used modified RNA 
encoding VEGF in MI mice models and observed improved cardiac function in parallel 
with increased myocardial capillary density. The study also highlighted a previously 
uncharacterised epicardial response to VEGF that could also play a role in heart repair. 
However, attempts to increase revascularisation using VEGF, FGF or other angiogenic 
factors have not ameliorated cardiac dysfunction in MI patients (Haider et al., 2009; 
Henry et al., 2003; Losordo and Dimmeler, 2004). Although the delivery of endothelial 
or bone marrow-derived progenitor cells to the infarct area brings acute benefits, these 
effects are short-lived (Lunde et al., 2006; Schachinger et al., 2006). Additionally, VEGFA 
signalling, if not tightly regulated, can potentially result in the generation of leaky vessels 
and inhibition of vessel maturation because of interference with the PDGF pathway and 
mural cell recruitment (Cochain et al., 2013; Schwarz et al., 2000). One study by Hao et 
al. (2007) demonstrated that controlled VEGF and PDGF deliveries facilitated 
revascularisation following MI in rat and, ultimately, led to improved cardiac function 
1.4.5.2 Zebrafish angiogenesis 
In the injured adult zebrafish heart, new vessels are formed via angiogenesis (Zhao et 
al., 2014); however, until recently, the molecular mechanisms and characterisation of 
the revascularisation process after MI were largely undefined. Marin-Juez and 
colleagues (2016) reported that vessels are observed invading the cardiac lesion as early 
as 15 hours after cardiac damage and inhibition of the initial vascular response severely 
impedes the entire regenerative process. Therefore, the early-onset angiogenic 
response is essential for the regeneration of the zebrafish heart. Vegfaa signalling was 
shown to mediate early revascularisation (Figure 9) using a dominant negative Vegfaa 
mutant fish that presented reduced infarct vessel density, inefficient cardiomyocyte 
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proliferation, and permanent scar formation and failed to regenerate (Marin-Juez et al., 
2016). Because neovascularisation precedes vegfaa upregulation (this occurs at 24 hour 
post injury); the authors hypothesised that endothelial cells responded to the local 
release of extracellular matrix-bound Vegfaa made available by proteolytic activity, as 
previously described by Ferrara et al (2010), but this requires further investigation.  
Additionally, maturation of new coronary vessels via mural cell recruitment is central to 
the revascularisation of the cardiac lesion. Pericyte coverage maintains integrity and 
provides structural support for the newly formed vessels. Pdgfbb signalling is essential 
for endothelial cell proliferation and, upregulation of mural cell markers such as acta2 
by pericytes mediate angiogenesis following injury (Kim et al., 2010). The authors noted 
an upregulation of EMT markers such as snail and twist1b after apical resection 
reminiscent of arteriogenesis, which is partly regulated by FGF and PDGF signalling 
(Figure 9) (De Smet et al., 2014; Wiens et al., 2010). Inhibition of the Pdgfbb signalling 
pathway has deleterious effects on coronary vasculature formation and zebrafish heart 
regeneration. Whether Pdgf effects on revascularisation are mediated directly or 
indirectly via endothelial cells is unclear, but it was confirmed that Pdgf receptor β 
(Pdgfrβ) activity is required for vascular development in the lesion during regeneration 
(Figure 9)  (Kim et al., 2010). Lepilina and colleagues (2006) demonstrated the 
importance of Fgf signalling for the regulation of vessel formation during zebrafish heart 
regeneration. Dominant negative Fgfr2 zebrafish mutants were unable to regenerate 
their heart after apical resection due to their inability to revascularise the injury site. 
These studies strongly suggest that epicardial transdifferentiation is largely regulated by 
Pdgf and Fgf signalling during zebrafish heart regeneration (discussed in greater detail 
in section 1.4.6). 
. 
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Figure 9 Signalling pathways and cellular mechanisms in zebrafish heart regeneration. 
Retinoic acid (RA) produced in the epicardium and endocardium stimulate 
cardiomyocyte (CM) proliferation additional to Tgfβ production by fibroblasts and 
leucocytes. Tgfβ also coordinates fibrosis and remodelling of the lesion in conjunction 
with tenascin-c and fibronectin synthesised by fibroblasts. Angiogenesis is promoted 
by several paracrine factors, Vegfaa is produced by hypoxic cardiomyocytes. It is 
hypothesized that hypoxic infiltrating leucocytes and local release of ECM bound 
Vegfaa provide additional Vegf sources. Pdgfbb and Fgf17b (derived from 
cardiomyocytes) signalling through epicardial cell Pdgfrβ and Fgfr2, respectively, 
facilitate neovessel maturation.    
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 Epicardial response in zebrafish heart regeneration  
The epicardium is a mesothelial epithelial monolayer surrounding the heart. It is made 
of a quiescent cell population that provides basal cytokine secretion for the homeostasis 
of the underlying myocardium (Wills et al., 2008). However, following cardiac damage, 
the epicardium becomes “activated”, proliferates and facilitates cardiac repair. This is 
highlighted by the expression of epicardial embryonic transcription factors; such as, 
wilms tumour 1 (wt1), T-box 18 (tbx18) and retinoic acid synthase enzyme retinaldehyde 
dehydrogenase 2 (raldh2) which are otherwise silenced shortly after cardiac maturation 
(Takeichi et al., 2013; Zhou and Pu, 2011). Injury-activated embryonic epicardial gene 
profile expression is conserved in adult mammals after MI (Limana et al., 2010; van Wijk 
et al., 2012; Zhou et al., 2011a), and in regenerative models such as the zebrafish and 
neonatal mouse (Kikuchi et al., 2011b; Lepilina et al., 2006; Manuel Gonzalez-Rosa et 
al., 2011; Porrello et al., 2011b). This suggests that the upregulation of epicardial 
developmental genes in response to cardiac damage is conserved across species. 
In zebrafish, the epicardium responds to cardiac damage by proliferating extensively 
around the injured area (Manuel Gonzalez-Rosa et al., 2011; Schnabel et al., 2011). 
Organ wide epicardial activation occurs very rapidly after cardiac damage. It is evident 
as early as 3 hours after injury in zebrafish (Kikuchi et al., 2011b), within 24 hours in 
adult mammals (von Gise et al., 2011), then soon becomes restricted to the injured area. 
The epicardial activation is highly responsive, such that even after sham operation, 
raldh2 expression is detected in the epicardium, though wt1 and tbx18 expression are 
not induced in these conditions, suggesting partial activation after sham operation (Itou 
et al., 2014). A recent study investigated the importance of the epicardium after cardiac 
injury using genetic ablation of the epicardial cell population, showing that hearts devoid 
of epicardium do not regenerate (Wang et al., 2015).  
The role of the epicardium is central to cardiac repair and has been extensively studied. 
In zebrafish, it provides structural support via the secretion of fibronectin and thus 
supports myocardial proliferation and migration (Wang et al., 2013a). This is in line with 
the role of fibronectin during cardiogenesis when the timely migration of myocardial 
precursors relies on epithelial integrity (Trinh and Stainier, 2004), but contrasts with the 
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pathological association of ECM deposition in cardiac fibrosis following adult 
mammalian MI (Brooks et al., 2010; Knowlton et al., 1992; Willems et al., 1996).  
Figure 10 Epicardial-derived cells (EPDC) in the embryonic and injured mammalian heart 
(A) Flow chart describing proepicardial (PEO) progenitor cell fates and functions following 
epicardial epithelial to mesenchymal transition (EMT) in embryonic development. (B) Flow 
chart diagram of adult heart epicardial response to myocardial infarction (MI) and EPDC 
fate and functions. EPDC transdifferentiate to fibroblasts and smooth muscle cells (SMC) 
and secrete cytokines. It remains unclear whether EPDCs adopt an endothelial cell (EC) or 
cardiomyocyte (CM) fate. Dashed lines and red boxed highlight outcomes that remain 
unclear at present. Image adapted from (Smits and Riley, 2014) 
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1.4.6.1 Epicardial derived paracrine signalling 
An increasing body of evidence supports the epicardium as a central signal transducer 
for paracrine and autocrine signalling that orchestrates cellular events required to 
achieve zebrafish heart regeneration. Treatment of infarcted hearts with conditioned 
medium supplemented with epicardial secreted factors improves cardiac function and 
enhances coronary vasculature density (Zhou et al., 2011a). In the following paragraphs, 
I will highlight some of the epicardium-derived cytokines playing a conserved role across 
species in the response to cardiac damage as well as cytokines with promising 
therapeutic potential that were characterised in model systems.  
The epicardium secretes retinoic acid (RA) both during development and following 
cardiac damage. Retinoic acid transduces signals via retinoic acid receptors (RARs) that 
form heterodimers, translocate to the nucleus and mediate transcription factor 
activities to regulate gene expression. In the adult mammalian heart, shortly after MI, 
the epicardium re-expresses embryonic-associated RA synthesising enzyme RALDH2 
(also referred to as Aldh1a2 in the zebrafish) and the production of RA inhibitors is 
reduced (Bilbija et al., 2012; Zhou and Pu, 2011). Raldh2 is expressed by the zebrafish 
epicardium following cardiac damage, indicating conserved epicardial RA production 
between species. Additionally, Raldh2 is expressed by the endocardium, which is not 
observed in the mammalian heart after MI (Kikuchi et al., 2011b; Limana et al., 2010). In 
the zebrafish heart, epicardial expression of radlh2 accumulates near the injury site and 
enhances cardiomyocyte proliferation (Kikuchi et al., 2011b).  In contrast to its beneficial 
effects in zebrafish, RA encourages pathological inflammatory cell infiltration (Huang et 
al., 2012) and consequently mediates the fibroblast synthetic profile and ECM 
deposition in mammals (Figure 10)(Bilbija et al., 2012).  
In the mouse, FGF2 (also referred to as basic FGF (bFGF)) and FGF9 are secreted by 
epicardial cells after MI and mediate autocrine and paracrine signalling (Zhou et al., 
2011a). In line with its role in zebrafish, FGF signalling helps cardiac recovery in 
mammals. Mice lacking FGF2 exhibit increased infarct size caused by the lack of scar 
tissue formation and fibroblast proliferation that compromise cardiac function; this is 
compounded by limited angiogenesis (Virag et al., 2007). The reverse was observed in 
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FGF2 overexpressing mice, whereby greater fibroblast proliferation caused excessive 
scar deposition, and vascular density and increased cardiomyocyte hypertrophy, 
ultimately improving cardiac function (Virag et al., 2007). In the zebrafish, Fgf17b, 
derived from cardiomyocytes, signals through Fgfr2 in the epicardium to mediate 
epicardial EMT (Figure 9) (further described in section 1.4.6.2). In addition, Pdgf is 
essential for epicardial cell proliferation and neovascularisation, and is essential for the 
epicardial response to cardiac damage in zebrafish (Kim et al., 2010; Lien et al., 2006). 
1.4.6.2 Epithelial to mesenchymal transition 
Epithelial to mesenchymal transition (EMT) is the process whereby epithelial cells 
transdifferentiate to a mesenchymal phenotype and acquire a migratory profile. EMT 
has been described in several physiological and pathological processes and is particularly 
associated with cancer metastasis (Chaffer et al., 2016), during which epithelial cells 
delaminate from the epithelial layer, and migrate to other organ tissues (Figure 11). 
During mammalian cardiac development, epicardial cells undergo epicardial EMT in 
response to PDGF; they migrate into the underlying myocardium and transdifferentiate 
into vascular smooth muscle cells, cardiac fibroblasts and pericytes (Figure 10) (further 
discussed in section 1.1.1.4) (Lu et al., 2001). The re-expression of embryonic epicardial 
markers after cardiac injury in the adult heart has led to the hypothesis that the 
epicardium recapitulates developmental events such as EMT to facilitate 
revascularisation and fibrosis (Zhou et al., 2011a). This concept has been convincingly 
demonstrated by several other studies that have used lineage tracing to identify 
epicardial cell fate in the regenerating adult zebrafish heart (Aguiar and Brunt, 2015; 
Kikuchi et al., 2011a; Kim et al., 2010; Lepilina et al., 2006; Manuel Gonzalez-Rosa et al., 
2012). A subpopulation of these epicardial cells undergo epithelial-to-mesenchymal 
transition and migrate into the damaged myocardium to provide vascular smooth 
muscle cells (Lepilina et al., 2006) and myofibroblasts (Chablais and Jazwinska, 2012) 
(Figure 11).  
Myocardium-derived Fgf17b is reported to signal through epicardial Fgfr2 and Fgfr4 to 
initiate epicardial EMT and promote revascularisation of the injured area. Inhibition of 
Fgf signalling via dominant negative Fgfr transgenic fish resulted in reduced migration 
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of activated tbx18-positive epicardial cells into the injury area, implicating a role for Fgf 
induced epicardial migration. Kim et al. (2010) demonstrated that Pdgfbb, via Pdgfrβ, 
mediates a similar epicardial response during zebrafish heart regeneration. In primary 
epicardial cultures the authors showed that Pdgfbb enhances proliferation and 
stimulates epicardial tight junction disassembly, two key features observed in epicardial 
EMT during regeneration indicating a loss of epithelial identity. Inhibition of Pdgfbb 
signalling perturbs epicardial expression of EMT markers following injury and abrogates 
heart regeneration. This study also elucidated that Pdgf signalling was transduced, at 
least in part, by Rho-associated protein kinases in primary epicardial cultures.  
Wt1 expression by activated epicardium targets the upregulation of snai1 (encoding 
transcription factor Snail) and twist, which in turn, promotes a migratory phenotype 
essential for EMT (Martinez-Estrada et al., 2010). Wt1b, and not its wt1a ohnolog, is 
specifically expressed by epicardial cells after injury in the zebrafish (Aguiar and Brunt, 
2015; Schnabel et al., 2011). However, not the entire epicardial cell population express 
wt1b after cardiac damage presumably indicating that only a subpopulation of epicardial 
cells undergo EMT (Manuel Gonzalez-Rosa et al., 2011; Peralta et al., 2014). 
1.4.6.3 Endocardial response to injury  
During zebrafish cardiac repair, endocardial expression of Raldh2 is observed within 3 
hours of cardiac injury and is restricted to the injury site by 24 hours. The endocardium 
undergoes endothelial to mesenchymal transition (endoMT) which induces 
morphological changes, endothelial delamination from the endocardium and 
transdifferentiate to contribute fibroblast mural cells in the injury site proliferation 
(Kikuchi et al., 2011b). Although different to the zebrafish response, the mammalian 
heart is also known to elicit an endocardium response after MI. Endocardium-derived 
FGF-2 is implicated in cardiomyocyte proliferation and growth. It is expressed by the 
endocardium for up to 14 days post MI in the mammalian heart (Zhao et al., 2011) 
supporting a role for the endocardium in cardiac repair. Few studies have addressed the 
endocardial response to cardiac damage and regeneration, but clear evidence exists for 
a damage-induced response that likely helps recovery. 
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Figure 11 Epicardial epithelial to mesenchymal transition (EMT) 
Schematic representation of epicardial EMT. Epicardial cells (green) express embryonic genes 
(listed to the right) that induce a mesenchymal profile and trigger delamination from the 
epicardium, giving rise to migratory epicardial derived cells (EPDCs) (light blue). EPDCs 
translocate to the myocardium and transdifferentiate into fibroblasts (dark blue) to synthesise 
extracellular matrix and pericytes/smooth muscle cells (pink cells) to support coronary 
vasculature maturation. The precise signal pathways that drive EPDC fate are 
undercharacterised. Image modified from Braitsch and Yutzey (2013) 
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1.5 Neuropilin as a potential contributor to zebrafish cardiac 
regeneration  
It is evident that several cell types and signals co-ordinate zebrafish heart regeneration, 
however, there remain many candidate signalling pathways to be characterised. The co-
receptor, neuropilin (NRP), has been reported to modulate signalling of a number of 
extracellular ligands, namely VEGF, PDGF, FGF and TGFβ (Evans et al., 2011; Glinka and 
Prud'homme, 2008; Liu et al., 2005; Pellet-Many et al., 2011; Soker et al., 1998). These 
signalling pathways have also been demonstrated to be essential regulators of zebrafish 
heart regeneration (Chablais and Jazwinska, 2012; Kim et al., 2010; Lepilina et al., 2006; 
Marin-Juez et al., 2016). However, the role of neuropilins in zebrafish heart regeneration 
has not been characterised to date.  
 Neuropilin structure  
Neuropilins (NRPs) are type 1 transmembrane glycoprotein receptors. In humans, two 
NRP isoforms exist, NRP1 and NRP2, which share 44% protein sequence similarity ( 
Table 1). The zebrafish karyotype contains 25 pairs of chromosomes; and the zebrafish 
genome encodes four neuropilins, nrp1a, nrp1b, nrp2a and nrp2b due to evolutionary 
teleost fish genome duplication (Amores et al., 1998; Phillips et al., 2006; Postlethwait 
et al., 1998). Zebrafish Nrp1a and Nrp1b ohnologs are the zebrafish orthologs for human 
NRP1 (hNRP1) and share 65% and 51% protein sequence similarity with hNRP1, 
respectively ( 
Table 1). A similar level of sequence similarity is observed between human NRP2 and 
zebrafish orthologs, Nrp2a and Nrp2b (57% and 59%, respectively) ( 
Table 1) (Bovenkamp et al., 2004).  
NRP1 was originally identified in 1987 via an antibody screen in the developing xenopus 
brain and termed the A5 antigen (Takagi et al., 1987). Subsequently, its basic structural 
features were characterised (Fujisawa et al., 1989) and was named neuropilin, because 
the A5 antigen was found localised in the xenopus ‘neuropile’, a dense neuronal 
structure (Fujisawa et al., 1995; Takagi et al., 1991).  NRP2 was later characterised in 
 73 
 
1997 and identified as a NRP1 isoform because of structural similarities (Chen et al., 
1997). Although both were initially reported in neuronal development, they have since 
been described as regulators of various additional physiological and pathological 
processes.  
Table 1 Full-length NRP amino acid sequence similarity (%) 
Protein % 
homology 
zf Nrp1a zf Nrp1b Zf Nrp 2a zf Nrp2b hNRP1  hNRP2 
zf Nrp1a 
(923 aa) 
100 54.9 43.9 43.6 65.8 45.9 
zf Nrp1b  
(959 aa) 
54.9 100 47.3 47.1 51.5 41.6 
zf Nrp2a  
(927 aa) 
43.9 47.3 100 74.0 43.7 56.6 
zf Nrp2b  
(920 aa) 
43.6 47.1 74.0 100 43.4 59.3 
hNRP1  
(923 aa) 
65.8 51.5 43.7 43.4 100 44.2 
hNRP2  
(926 aa) 
45.9 41.6 56.6 59.3 44.2 100 
h – human, zf – zebrafish, aa – amino acid 
The neuropilins derive from two structurally conserved genes that encode the 923 
amino acid (aa)-long NRP1 and the 926 aa-long NRP2 proteins, both with an approximate 
molecular mass of 130 kDa (Chen et al., 1997). The NRPs consist of a large extracellular 
domain (ectodomain), anchored to the cell by a single pass transmembrane domain and 
contain a small intracellular cytoplasmic domain (Figure 12). The ectodomain is formed 
by 5 protein homology domains: two CUB repeats (a1/a2) , two FA58C domains (b1/b2) 
and a MAM domain (c) (Takagi et al., 1991). The protein domain arrangement is 
conserved between species; they contain the identical ectodomain organisation (a1/a2, 
b1/b2, MAM). 
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The CUB domains share significant similarity with complement factor C1s/C1r, Uegf (sea 
urchin fibropellins) and Bone Morphogenetic Protein 1 (BMP1) proteins (Bork and 
Beckmann, 1993). Each of the CUB domains contain approximately 100 aa residues 
arranged in an anti-parallel β-barrel structure and require calcium to mediate 
electrostatic protein-protein interactions (Gaboriaud et al., 2011). NRP1 and NRP2 CUB 
domains are required for class 3 semaphorin binding to modulate axonal guidance 
(described in greater detail in section 1.5.5.1) (Gu et al., 2002). 
The FA58C domains (b1/b2) are 150 aa regions that share structural similarity to the C-
termini anion-binding structures of blood coagulation factors V and VIII. The b1 domain 
is essential for both semaphorin and VEGF binding (Appleton et al., 2007). The b2 
domain further enhances NRP affinity for VEGF (Appleton et al., 2007; Gu et al., 2002).  
The MAM (c) domain has homology to mephrin (a cell-surface glycoprotein), A5 antigen 
(the former name of NRP) and receptor tyrosine protein phosphatase μ and κ. The MAM 
domain has been previously implicated in neuropilin receptor oligomerisation and the 
formation of signal complexes to mediate semaphorin signal transduction to plexin-A1 
(Nakamura et al., 1998; Takahashi et al., 1997). However, a recent study elucidated that 
the MAM domain alone is insufficient for receptor multimerisation and proposed that 
the MAM domain’s function is to modify neuropilin domain positioning and optimise 
protein/protein interactions in signal complexes (Yelland and Djordjevic, 2016).  
The cytoplasmic carboxyl (C)-terminal domain of neuropilins is made of 44 amino acid 
residues for NRP1 and 43 for NRP2, and does not possess any known enzymatic activity; 
thus, neuropilin complex formation with other receptors has been considered to be the 
primary mechanism for neuropilin signal transduction. This theory is supported by 
studies that showed no downstream signalling in response to VEGF stimulation of cells 
expressing NRPs but devoid of VEGFRs (Gluzman-Poltorak et al., 2000; Soker et al., 
1998). The C-terminus ends with the protein sequence serine-glutamic acid (glutamate)-
alanine (S-E-A); this motif interacts with PDZ (post synaptic density protein (PSD95), 
Drosophila disc large tumor suppressor (DlgA), and zonula occuldens-1 protein) 
homology domain-containing intracellular proteins. Further studies have demonstrated 
that the neuropilin C-terminus mediates interactions with a variety of cytosolic proteins, 
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best described as scaffold adaptor proteins, including synectin (also known as GIPC and 
neuropilin-interacting protein-1) (Cai and Reed, 1999). Synectin regulates the 
endocytosis of membrane receptors via myosin VI recruitment to form non-coated 
vesicles (Naccache et al., 2006). This mechanisms is thought to facilitate receptor signal 
transduction as VEGFRs propagate signalling most efficiently from intracellular vesicles 
(Lanahan et al., 2010). Furthermore, the PDZ domain has been implicated in VEGFR2 
complex formation, as deletion of the SEA C-terminal sequence of NRP1 impairs VEGFR2 
multimerisation (Prahst et al., 2008). The C-terminus can regulate receptor trafficking 
via rab proteins to facilitate endocytosis and has been linked to the turnover of focal 
adhesion components to aid cell motility (Seerapu et al., 2013). The NRP1 C-terminus is 
required for cytokine stimulation of tyrosine phosphorylation of the integrin adaptor 
molecule p130Cas phosphorylation that participates in the formation of a signalling 
platform to enhance cell motility, cytoskeletal organisation, cell survival and 
proliferation (Cai and Reed, 1999; Evans et al., 2011; Lanahan et al., 2010; Pellet-Many 
et al., 2011).  
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Figure 12 Neuropilin structure 
Representative diagram depicting basic neuropilin structure. The ectodomain 
consists of the semaphorin-interacting a1 and a2 domains (CUB domains) 
(purple), VEGF-binding (and other heparin binding growth factors) b1 and b2 
(FA58C) (green) and the MAM domain (pink) implicated in optimising receptor 
binding. The receptor has a single-pass transmembrane domain (grey) and a 
small cytosolic C-terminal domain (red) that mediates signal transduction with 
cytosolic proteins and regulates receptor trafficking. aa – amino acids 
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 Neuropilin 1 
1.5.2.1 Human NRP1 
Full-length NRP1 is a 120 kilo base pair (kb)-spanning gene located on chromosome 
10p12 and encoding a 17 exons/16 introns gene transcribed into a 7kb mRNA (Rossignol 
et al., 2000). Several variants are differentially spliced to generate either a shorter 
transmembrane NRP1 lacking exon 16 (Tao et al., 2003) or a soluble NRP1 (sNRP1) 
species (Figure 13). sNRP1 is encoded by a 2.2-2.5kb-long mRNA sequence and 
translated to a 90kDa protein containing the CUB (a1/a2) and coagulation factor 
domains (b1/b2) (Figure 13) (Gagnon et al., 2000). Several sNRP1 exist as a 551- 704 
amino acid peptide; termed s12NRP1, s11NRP1, sIIINRP1 and sIVNRP1 referring the exons 
they contain. The soluble species retain the structural features required for ligand 
interaction but lack the MAM, intracellular and transmembrane domains and 
additionally encode a unique GIK (glycine-isoleucine-lysine) aa sequence (Figure 13). 
s12NRP1 has been demonstrated to act as VEGF165 antagonist/decoy for VEGF in vitro 
(Figure 14) (Gagnon et al., 2000). Although the endogenous physiological sNRP splice 
variant roles are still uncharacterised, soluble NRP species may alter NRP activity to be 
antagonistic as a monomer, but an agonist when dimerised, aiding delivery of ligands 
(Figure 14) (Yamada et al., 2001). Another two isoforms, sIIINRP1 (551aa) and sIVNRP1 
(609 aa) were later identified. They contain a similar structure (a1/2, b1/2) and are 
endogenously expressed in normal and cancerous tissue in humans (Cackowski et al., 
2004). Soluble and full-length neuropilins are differentially expressed: full length NRP1 
is found mostly in neuronal tissue and vessels, whereas, sNRP1 is not detected in 
endothelial cells (Rossignol et al., 2000). 
Moreover full-length neuropilin is subject to posttranslational modifications that vary in 
different tissues; O-linked chondroitin sulphate addition at ser612 and N-linked 
glycosylation (CS-GAG) (Figure 13) are proposed to modify migratory capacity but 
further studies are required to elucidate the role of the modification (Frankel et al., 
2008; Pellet-Many et al., 2011; Shintani et al., 2006). Ser612 is encoded by some sNRP1 
isoforms, and not all undergo posttranslational modification by CS-GAG addition. 
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Figure 13 Neuropilin isoform homology 
Illustrations representing neuropilin gene organization and protein structures. NRPs are encoded by a 17 exon gene (black rectangles). Both full-length NRP1 (923 amino 
acids (aa)) and NRP2 (926 - 931 aa) proteins contain a large ectodomain; two CUB (a1 and a2) domains (pink); two Factor V/VIII homology (b1 and b2) domains (green); a 
linker region; a MAM (c) domain (yellow); a single transmembrane domain (TM) (red); and a 43-44 aa cytoplasmic (Cyt) domain containing a C-terminal PDZ-binding domain 
motif (PDZ BD) (blue), with the sequence, SEA. The ectodomain mediates semaphorin and VEGF ligand interactions and optimises oligomerisation (indicated). NRP1 is subject 
to posttranslational O-linked CS-GAG modification (CS GAG) at Ser612 (red arrows). Soluble NRP1 (sNRP1) is truncated between the second Factor V/VIII and the MAM 
domain and ends with the three amino acids GIK. NRP2 exists as two main isoforms (NRP2a and NRP2b) that have identical ectodomains, but share only 11% 
transmembrane/C-terminal homology. NRP2b lacks the SEA PDZ-motif binding domain. A soluble NRP2 (sNRP2) is truncated at aa 548 (blue arrow) with an additional 9 aa 
(VGCSWRLPL). Sizes of NRPs and splice variants are indicated to the right. Amino acid homology between full-length NRPs is indicated as %values. Image modified from 
Pellet-Many et al. (2008) 
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1.5.2.2 Zebrafish NRP1 
Evolutionary teleost genome duplication gave rise to two zebrafish nrp1 genes, nrp1a, 
and its ohnolog, nrp1b. The zebrafish nrp1a gene is located in linkage group 24 
(chromosome 23), and encodes a 4 kb-long mRNA translated into a 923 aa protein of 
125kDa (Bovenkamp et al., 2004). The nrp1b genes is located in linkage group 2 
(chromosome 8) and contains a 4.5 kb-long mRNA encoding for a 959 aa protein of 
intracellular
extracellular
sNRP
Sequestered 
VEGF
Delivered  
VEGF
KDR
Key: NRP FA58C (b) 
homology  domain
NRP CUB (a) 
homology  domain
Figure 14 Soluble neuropilin mechanisms 
Representative image of soluble neuropilin (sNRP) 
sequestration and delivery of vascular endothelial growth 
factor (VEGF) to receptors. When monomeric (left), sNRP acts 
a VEGF signalling antagonist.   When sNRP is dimeric (right) it 
is thought to deliver VEGF to KDR (VEGFR2) rather than act as 
a decoy. 
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approximately 145kDa (Bovenkamp et al., 2004). A soluble Nrp1b (Nrp1b(s)) is 
endogenously expressed in the zebrafish. This isoform is 871 aa-long and translated into 
a 135kDa protein comprising the entire ectodomain, but lacking TM and C-terminus. It 
is therefore comparatively larger than the endogenous human sNRP1 isoforms that 
contain exclusively a1/a2, b1/b2 (Yu et al., 2004). 
 Neuropilin-2 
1.5.3.1 Human NRP2 
NRP2 is a 17 exons/16 introns gene located on chromosome 2q34, spanning over 112 
kb and encoding a 926-931 aa-long protein. Two distinct isoforms, NRP2a and NRP2b, 
with identical ectodomains, are expressed in humans, however, their C-terminus and 
transmembrane domain exhibit only 11% protein sequence similarity (Figure 13) 
(Rossignol et al., 2000). NRP2a contains the SEA C-terminal sequence, whereas NRP2b is 
devoid of the PDZ-binding motif (Figure 13). Two NRP2a isoforms exist, NRP2a(17) and 
NRP2a(22) in humans, and four in mice (with the addition of NRP2a(0) and NRP2a(5)), which 
are alternative splice variants resulting from the addition of 0, 5, 17 or 22 amino acids 
after amino acid 809 (between the MAM and transmembrane domain). The differential 
functions and roles of these isoforms caused by these insertions are undefined. Two 
endogenous isoforms of NRP2b also exist in humans. Similarly to NRP2a, insertions of 
either zero or 5 residues are added after amino acid 808, to generate NRP2b(0) or 
NRP2a(5), respectively (Rossignol et al., 2000).  
Despite their identical extracellular domains, divergent roles for the different C-termini 
have evolved and their tissue expression varies. NRP2b is the isoform predominantly 
expressed in skeletal muscle, whereas NRP2a is seen in lungs, small intestine and 
kidneys, and both are present in the brain and heart (Rossignol et al., 2000). Lastly, a 
soluble NRP2 species, generated by alternative splicing, also exists. It is a 555 aa-long 
protein (62kDa) containing the a1/a2, b1 and a truncated b2 domain with a 9 aa 
insertion, and thus termed (s9NPR2) (Figure 13) (Rossignol et al., 2000). 
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1.5.3.2 Zebrafish NRP2 
The zebrafish nrp2a gene is located in linkage group 1 (chromosome 6) and encodes a 
5.3 kb-long mRNA translated into a 927 aa-long protein (Bovenkamp et al., 2004). The 
nrp2b gene is located in linkage group 9 (chromosome 5) encodes a 4.8 kb gene and is 
translated into a 920 aa-long protein. The molecular weights of Nrp2a and Nrp2b have 
not yet been characterised in the zebrafish. Similarities to the Nrp1a and Nrp1b protein 
sequence would predict a molecular weight for Nrp2 of approximately 130kDa, 
however, post-translational modifications may alter molecular size. The zebrafish 
neuropilin 2 ohnologs both encode two small soluble splice variants, nrp2a express 
nrp2a1 (1423bp, 309aa) and nrp2a2 (437 bp, 84 aa). nrp2b1 (759bp, 101 aa) and nrp2b2 
(704bp,188 aa) are splice variants (Bovenkamp et al., 2004), but their physiological role 
is unclear.    
 Neuropilins in development  
1.5.4.1 Mammalian NRPs in development  
Mammalian and zebrafish neuropilins have important roles in neuronal and vascular 
embryonic development. NRP1 null-mutant mice die in utero between embryonic day 
(E) 12 and E13.5 due to severe vascular and neuronal defects (Gerhardt et al., 2004; 
Kawasaki et al., 1999; Kitsukawa et al., 1997). Abnormal directionality of cranial and 
spinal efferent nerve fibres is also observed in NRP1 mutant mice (Kawasaki et al., 1999). 
NRP1 is also critical for vasculogenesis: null mutants display persistent truncus arteriosus 
of the great vessels due to septation defects, reduced vessel networks in the brain, and 
agenesis of great vessels such as the dorsal aorta (Kitsukawa et al., 1997; Kitsukawa et 
al., 1995). The NRP1-null mice vascular phenotype is recapitulated in transgenic mice 
that lack NRP1 specifically in endothelial cells; these mice die in utero around mid-to-
late gestation (Gu et al., 2003). Conversely, excess neuropilin expression during 
development results in embryonic lethality with excess capillary growth, increased 
vascular permeability, haemorrhaging in the head and neck and a malformed heart, in 
addition to anarchic sprouting and defasciculation of nerves (Kitsukawa et al., 1995).  
Doubly deficient NRP1/NRP2 knockout mice exhibit earlier embryonic mortality than the 
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single NRP1 knock out (E8 versus E12-13.5) and have a more severe vascular phenotype 
with large avascular areas in the yolk sacs, and head and trunk regions, and a lack of 
connections between blood vessel sprouts. (Takashima et al., 2002). 
1.5.4.2 Zebrafish Nrps in development 
In zebrafish, morpholino (MO) knockdown (KD) of neuropilins results in developmental 
defects. nrp1 KD impairs angiogenesis of the intersegmental vessels (ISV) (analogous to 
mammalian capillary sprouting) (Lee et al., 2002) and leads to embryonic lethality 
(Jensen et al., 2015). Arteriovenous malformations, notably of the dorsal aorta and ISV 
are observed in zebrafish embryos injected with MO targeting nrp1a, nrp1b or nrp2a 
(Martyn and Schulte-Merker, 2004). In contrast, nrp2b morpholino knockdown causes 
more restricted impairment of vessel development, with effects on the caudinal vein 
and artery and cardiac oedema (Martyn and Schulte-Merker, 2004). Morpholino 
knockdown of nrp1a or nrp2b also results in axonal guidance defects in the developing 
zebrafish embryo (Wolman et al., 2004).  
The zebrafish neuropilins display differential expression patterns during embryogenesis 
(see Table 2).  However, they are predominantly localised to neuronal and vascular 
organs and tissues, with the addition of fin bud and mandibular expression. Taken 
together with higher vertebrate neuropilin expression patterns, the roles of neuropilins 
are largely conserved among species during development and provide evidence for 
retention of similar functions between species.   
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Table 2 nrp expression patterns in developing zebrafish embryo 
Neuropilin 
isoform 
Neuronal expression Cardiovascular 
expression 
Other localised 
expression 
Morpholino 
knockdown phenotype 
Reference 
 
nrp1a 
Vagus and spinal motorneurons, 
hypochord 
Retina, telecephalon, hypothalamus, 
hindbrain, otic sensory epithelium, 
epiphysis 
Lateral plate mesoderm, migrating 
cranial neural crest cells (nccs) 
Heart 
Intersegmental vessels, tail 
angioblasts, dorsal aorta, 
posterior cardinal vein, 
caudal vein plexus 
Gut, pronephros, 
mandibular 
Pharangeal arches  
Pectoral fin buds 
Arteriovenous 
malformations. 
Intersegmental vessel 
sprouting irregularities 
Bovenkamp (2004) 
Yu (2004) 
Lee (2002) 
Schulte-Merker (2004) 
 
nrp1b 
Hind brain 
Anterior neural tube, cranial ganglia, 
dorsal neural tube, lateral plate 
mesoderm 
Dorsal aorta 
Endothelial cells, 
angioblasts 
Melanophores 
Ventral fin 
Arteriovenous 
malformations. 
Intersegmental vessel 
sprouting irregularities 
Bovenkamp (2004) 
Yu (2004) 
Schulte-Merker (2004) 
 
nrpb2a 
Migrating cranial nccs, ventral 
cerebellum, anterior hindbrain, 
anterior neural tube, hypothalamus, 
epiphysis 
Caudal vessels  
Cardinal vein 
Pharangeal arches, 
pectoral fin buds 
Arteriovenous 
malformations. 
Intersegmental vessel 
sprouting irregularities 
Bovenkamp (2004) 
Yu (2004) 
Schulte-Merker (2004) 
 
nrp2b 
Migrating cranial nccs, mid- and 
hindbrain, lateral plate mesoderm, 
telecephalon, olfactory axonal 
trajectory, hypothalamus 
Caudal vessel, heart Melanaphores, 
mandibular,  
Gut endoderm, 
pharangeal arches 
Posterior cardinal vein 
Cardiac oedema 
Reduced circulation  
Caudal artery shunting 
Bovenkamp (2004) 
Yu (2004) 
Schulte-Merker (2004) 
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 Neuropilins ligands and physiological functions 
NRPs were initially characterised as co-receptors for semaphorins that mediate axonal 
guidance and were later implicated in limb and heart development (He and Tessier-
Lavigne, 1997; Kitsukawa et al., 1997; Kitsukawa et al., 1995). NRPs interact with several 
ligands, notably class 3 semaphorins and VEGF family members to regulate neuronal cell 
guidance and angiogenesis respectively (Soker et al., 1998; Takahashi et al., 1999; 
Takahashi et al., 1998). NRPs are increasingly implicated in signalling of additional 
heparin-binding extracellular ligands (West et al., 2005) in various physiological 
processes, such as during inflammation (Glinka and Prud'homme, 2008; Tordjman et al., 
2002), cancer metastasis (Adham et al., 2014; Evans et al., 2011; Grandclement et al., 
2011) and smooth muscle cell migration (Pellet-Many et al., 2011). This section will 
briefly summarise neuropilin ligands and functions currently characterised.   
1.5.5.1 Semaphorins 
Semaphorins are a large family of 20 proteins, categorised into 5 classes and expressed 
as both membrane bound and soluble forms that regulate cell-cell contacts and axonal 
growth cone guidance via plexin receptors. The class 3 semaphorins (SEMA3) are 
secreted soluble peptides and require neuropilins as an obligate co-receptor to signal 
through type A plexins. Neuropilin co-receptors bind class 3 semaphorins via the a1/a2 
and b1 ectodomains. These domains are essential for semaphorin signalling and 
presumably required for positioning, oligomerisation or optimal binding to their 
respective plexin receptor (Kitsukawa et al., 1997). The plexin-semaphorin-neuropilin 
signalling axis has been well characterised, in particular in the context of axonal guidance 
and patterning during development, but has been more recently identified to play roles 
in the vascular development of the aortic arch and outflow tract, lymphatic system, 
pulmonary veins and also in immune responses (Bouvrée et al., 2012; Plein et al., 2015; 
Suzuki et al., 2008; Worzfeld and Offermanns, 2014).  
Different subsets of class 3 semaphorins preferentially bind to different neuropilin 
isoforms. SEMA3A signalling via NRP1-interaction was originally identified to cause 
neuronal growth cone collapse, and led to SEMA3A being initially named collapsin-1 (Luo 
et al., 1993). NRP1 is also able to bind SEMA3 classes B-F, although these interactions 
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have not been extensively characterised. NRP2 binding to SEMA3B, C and F is also 
implicated in axonal, vascular and immune cell physiology in mammals (Worzfeld and 
Offermanns, 2014).  
NRP-semaphorin-plexin holoreceptors mediate intracellular signal cascades via the 
relief of plexin auto-inhibition, leading to the stimulation of Rho GTPase activity and thus 
causing neuron collapse (Negishi et al., 2005; Oinuma et al., 2004). The exact 
mechanisms by which NRP modulates semaphorin signalling remain  poorly 
characterised; however, it is known that NRP1 and 2 can form complexes with plexin 
receptors independently of ligand availability (Rohm et al., 2000; Tamagnone et al., 
1999). It has also been shown that the NRP1 C-terminus domain is dispensable for plexin 
receptor signalling (Nakamura et al., 1998).    
Similar to mammals, zebrafish semaphorins regulate neuronal and vascular 
development. Semaphorin 3a1 affects the migration of angioblasts and the formation of 
the dorsal aorta (Shoji et al., 2003), and motor neuron patterning (Feldner et al., 2005). 
Additionally Nrp1a and 2b exert opposite modulation of axonal guidance in response to 
semaphorins: repulsion (Nrp1a mediated) or attraction (Nrp2b mediated) (Wolman et 
al., 2004).  
1.5.5.2 Vascular endothelial growth factor 
Vascular endothelial growth factors (VEGFs) are potent angiogenic glycoproteins that 
form dimers of approximately 40kDa (Leung et al., 1989). In mammals, 5 members of 
the VEGF families are known (VEGF-A, -B, -C, -D, and placental growth factor (PlGF)), and 
alternatively spliced variants give rise to several isoforms of these molecules. VEGFs 
signal through VEGF receptors (VEGFR) which are receptor tyrosine kinases (RTK). Three 
main VEGFRs have been identified: VEGFR1 (FLT-1(FMS-like tyrosine kinase)) and 
VEGFR2 (FLK-1 (Foetal Liver Kinase 1)/KDR (kinase insert domain-containing receptor)) 
regulate vasculogenesis (formation of blood vessels from haematopoietic stem cells) 
and angiogenesis (formation of new blood vessels from pre-existing vessels); VEGFR3 
(FLT-4) is involved in lymphangiogenesis (Soker et al., 1998). VEGFR interaction with VEGF 
dimers initiates VEGFR homo- or heterodimer complex formation that stimulates its 
intracellular tyrosine kinase domain activity and auto(trans)phosphorylation. 
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Phosphorylated tyrosine residues associate with intracellular proteins containing the SH1 
(Src homology 1) domain to mediate downstream signal cascades such as ERK (extracellular 
signal-regulated kinases/MAPK (mitogen-activated protein kinase)) activation. 
VEGFR2 (or KDR) is the VEGFR predominantly expressed in blood vessels. VEGFR1/2 bind 
with high affinity to VEGFA, B and PlGF. VEGFR3 is expressed in venous, lymphatic and 
capillary endothelia, as well as neuronal progenitors during development; it 
preferentially binds to VEGFC and D and can form homodimers or heterodimers with 
KDR (Dixelius et al., 2003). VEGFC signalling through VEGFR3 homodimers stimulates the 
ERK1/2 cascade, whereas VEGFR2/3 heterodimer interaction with VEGFC triggers Akt 
(RAC-alpha serine/threonine-protein kinase/PKB (protein kinase B)) signalling (Deng et 
al., 2015). The Akt signal axis is required for lymphangiogenesis, via the formation of a 
VEFGR3-VEGFC-NRP1 complex in cardinal vein lymphatic progenitors (Deng et al., 2015). 
VEGFC has also been shown to bind to NRP2 with high affinity and to participate in the 
formation of a VEFGR3-VEGFC-NRP2 complex (Xu et al., 2010). This complex plays a role 
in lymphangiogenesis and is associated with poor prognosis in cancer due to enhanced 
metastatic potential (Grandclement et al., 2011; Kawakami et al., 2002). Moreover, 
recent evidence uncovered a role for the VEGFC/NRP2 axis in autophagy and endocytic 
trafficking, improving cancer survival and triggering metastatic profile (Dutta et al., 
2016; Stanton et al., 2013)  
VEGFR1 is thought to act as an endogenous negative regulator of VEGFR2 signalling (Cao, 
2009). Heterodimers formed with VEGFR1 do not stimulate ERK-induced calcium influx 
in endothelial cells (Cudmore et al., 2012), possibly because of weak VEGFR1 kinase 
activity (Ito et al., 1998). It is therefore proposed that VEGFR1 (FLT-1) acts as a decoy, 
sequestering VEGF away from VEGFR2 and therefore limiting signalling via the latter 
(Seetharam et al., 1995; Waltenberger et al., 1994). NRPs are unable to bind VEGF121 in 
the absence of VEGFRs; the interaction of NRPs with VEGFRs is necessary to induce 
conformational changes for efficient VEGF121 binding (Fuh et al., 2000; Gluzman-
Poltorak et al., 2001).  
NRPs act as a co-receptor that promotes VEGF-induced intracellular signal transduction 
by enhancing VEGFR affinity to its ligands. It does so by forming signal complexes, thus 
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bridging VEGF to VEGFRs and regulating intracellular vesicle trafficking (Figure 15). 
VEGFA signalling is central to embryonic development. In mice, haploinsufficiency leads 
to early embryonic lethality due to a lack of vascular and hematopoietic systems 
(Carmeliet et al., 1996). Neuropilin knockout mice models recapitulate some of the 
phenotypes observed in VEGFA mutant mice and highlight the critical influence of NRPs 
on VEGF signalling. The b1 domain is critical for NRP1 and 2 binding to VEGF and the b2 
domain optimises binding, although it is dispensable for NRP1 binding (Gu et al., 2002). 
More precisely, NRP1 b1 domain binds to the VEGFA heparin-sulfate binding domain C-
terminus (Pan et al., 2007). 
The NRP C-terminus domain interacts with synectin which, in turn, interacts with myosin 
VI to mediate endocytosis of the VEGFR/NRP1/VEGF complex and is essential for VEGFR-
mediated ERK activation and intracellular trafficking (Figure 15) (Lanahan et al., 2010). 
In contrast, NRP1 can also negatively regulate VEGFR2 signalling. When NRP1 interacts 
with VEGFR2 expressed by a neighbouring cell (binding in trans), VEGFR internalisation 
is blocked which results in reduced angiogenic signalling (Koch et al., 2014). NRP1 is 
required for VEGFA165-mediated p38MAPK (p38 mitogen-activated protein kinase) 
activation for the induction of angiogenic sprouting and pericyte coverage (Kawamura 
et al., 2008). VEGF signalling in endothelial cells upregulates NRP1 expression via the 
VEGFR2 signalling pathway to enhance angiogenic EC proliferation (Oh et al., 2002). This 
upregulation of both VEGFR2 and NRP1 is relied upon by several physiological systems 
to facilitate vessel growth. For example, in regenerating livers following hepatectomy, 
hepatic endothelial cells redistribute VEGFR2 and NRP1 from perinuclear space to the 
membrane (Braet et al., 2004). Additionally, TNFα targets VEGFR2 and NRP1 in a similar 
manner to mediate the angiogenic properties of TNFα during inflammation (Giraudo et 
al., 1998).  
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Figure 15 NRP trafficking of VEGFR2 
Diagrammatic representation of NRP1 regulation of VEGFR trafficking. 
Upon ligand binding, receptor complex formation and trans- 
autophosphorylation (at the intracellular domains, red), the KDR receptor 
is internalised (black dotted arrow) to propagate signal (black arrow). NRP1 
interacts with synectin via its C-terminal domain SEA (PDZ-recruiting) 
sequence. Synectin binds with myosin VI that mediate endocytic vesicle 
trafficking along cytoskeletal actin filaments.   
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As mentioned in the previous paragraphs, several VEGF-NRP1 pathways are implicated 
in angiogenesis, however NRP1 can also acts as a co-receptor to promote angiogenesis 
via VEGF-independent mechanisms. NRP1 can modulate angiogenesis by interacting 
with other molecules, such as hepatocyte growth factor (Sulpice et al., 2008), 
transforming growth factor (Hirota et al., 2015) and notch (Aspalter et al., 2015). 
Furthermore, NRP1 was shown to contribute to angiogenic sprouting by promoting tip 
cell formation via SMAD/ALK1/5 signalling inhibition (Aspalter et al., 2015). 
VEGF signalling via NRP to regulate vessel growth is conserved in the zebrafish (Lee et 
al., 2002). In zebrafish, Vegfba signals through Nrp1 isoforms and is essential for vascular 
and neuronal development (Jensen et al., 2015). Vegfba knock down is embryonic lethal 
in the developing zebrafish due to cerebral vascular defects (Jensen et al., 2015), in 
contrast to mice where vegfb knockouts are viable but with only mild vascular defects 
(Bellomo et al., 2000). Interestingly, Vegfbb cannot compensate for vegfba morpholino 
knock down, however hypoxia-induced Vegfaa expression can rescue deleterious effects 
of Vegfba morpholino-mediated knockdown. These data provide some evidence for a 
more prominent role for Vegfb and Nrp1 signalling axis in developmental angiogenesis 
(as opposed to VEGFA driven angiogenesis during mammalian development) (Jensen et 
al., 2015).  
1.5.5.3 Fibroblast growth factor 
Fibroblast growth factors (FGFs) represent a large family of polypeptides, 22 fgf genes 
have been described in the human genome, and 10 fgf genes have been identified in the 
zebrafish (Bottcher and Niehrs, 2005; Griffin et al., 1995). All FGFs exhibit high affinity 
for heparin and mediate cellular responses via binding and activation of FGF tyrosine 
kinase receptors (FGFRs). FGF form dimers bridged by heparin sulphate proteoglycans 
(HSP). HSP stabilise the ligands and facilitate receptor dimerisation to mediate trans-
autophosphorylation of intracellular tyrosine residues upon ligand interaction. 
Phosphorylated tyrosine residues interact with SH2 homology-containing intracellular 
proteins to relay signals. Two key signal cascades initiated by FGFs, are the 
phospholipase C and Ras/MAP (mitogen-activates protein) kinase (MAPK) pathways, 
 
 90 
 
which stimulate protein kinase C (PKC), and ERK activity (Presta et al., 2005; Sternberg 
and Alberola-Ila, 1998), respectively. FGF signalling modulates a vast range of cellular 
and physiological processes during development, disease and homeostasis including cell 
migration, angiogenesis, proliferation, differentiation and cell fate specification (Thisse 
and Thisse, 2005). 
It was reported that NRP1 does not bind the exon 7- lacking VEGF121 isoform devoid of 
the heparin-binding domain, thus it was hypothesised that a heparin-like moiety is 
encoded by NRP that permits VEGF isoforms, containing heparin binding motifs, to 
interact (Ashikari-Hada et al., 2005; Pan et al., 2007). Additional proteins and growth 
factors encode heparin-binding motifs in their structure, such as fibroblast growth factor 
(FGF). Indeed, some FGF species have been reported to interact with neuropilin (FGF-1, 
-2 and -4), although, the physiological relevance and endogenous occurrence of these 
interactions remain largely unknown. FGF-2/NRP1 interactions enhance proliferation of 
HUVECs in vitro (West et al., 2005), although there are conflicting reports on signalling 
changes in response to FGF-2 in HUVEC (Guttmann-Raviv et al., 2007). Furthermore, FGF 
can regulate NRP1 availability; FGF signalling increases neuropilin expression in vascular 
smooth muscle cells to enhance VEGF/KDR-induced cell motility (Liu et al., 2005). FGF 
signalling via NRPs is not well characterised; further studies both in vitro and in animal 
models are needed to understand in which physiological or pathological context it is 
relevant. 
1.5.5.4 Platelet derived growth factor 
Platelet derived growth factor (PDGF) is a glycoprotein of approximately 14 kDa that 
forms dimers via a disulphide link to produce a 30 kDa peptide (Deuel et al., 1981). Five 
PDGFs exist, PDGF-A, –B, -C, -D and –AB, that signal through the two types of 180kDa 
PDGF receptor (PDGFR) tyrosine kinases, PDGFRα and PDGFRβ. The receptors are 
capable of forming homo- or hetero-dimers and specific PDGFRs combinations bind 
specific PDGF dimers. Upon ligand binding the PDGFR intracellular tyrosine kinase 
domain is activated, initiating trans-autophosphorylation and downstream signals that 
mediate cell division, motility, angiogenesis, wound-healing, inflammatory cell 
migration, proliferation and epithelial-to-mesenchymal transition (Pierce et al., 1991).  
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Platelet–derived growth factor is able to bind to NRP (Ball et al., 2007; Holmes and 
Zachary, 2005; Keck et al., 1989). PDGF-B and PDGFRβ null mice die shortly after birth 
due to severe cardiovascular abnormalities, haemorrhages, glomerular and renal 
dysfunction and breathing difficulty, thus presenting some common developmental 
defects of NRP1-null and VEGF-null mice (see 1.5.2 and 1.5.5.2) (Leveen et al., 1994; 
Lindblom et al., 2003). NRP1/PDGF interaction is important for vascular smooth muscle 
cell migration in response to PDGF-AA and –BB (Pellet-Many et al., 2011). NRP1 
regulates PDGF-B-induced chemotaxis in hepatic stellate cells that transdifferentiate to 
myofibroblasts and contribute to the pathobiology of liver fibrosis(Cao et al., 2010a). 
These studies also confirmed NRP1/PDGFRβ co-localisation, suggesting complex 
formation, and that NRP1 overexpression enhanced cell migration via Rac1.  
In line with its role in the potentiation of angiogenesis in mammals, Pdgf signalling via 
Pdgfrβ is essential for zebrafish ISV formation during development (Wiens et al., 2010). 
The authors observed impaired ISV development following both PDGFRβ morpholino 
knockdown and dominant negative receptor (lacking the intracellular kinase domains) 
expression. As observed in mammals, PDGFRα initiates PI3K activity in the mesoderm 
during gastrulation in zebrafish (Klinghoffer et al., 2002; Montero et al., 2003). 
Furthermore PDGFRα mediates endodermal myocardial fusion during cardiac 
morphogenesis in both mammals and zebrafish (Bloomekatz et al., 2016). Additionally, 
during zebrafish heart regeneration, Pdgf signalling is required for maturation of the 
neovasculature within in the lesion (Kim et al., 2010). Further studies are required to 
delineate the roles of Pdgfs and their receptors in zebrafish development and disease 
models; however, current reports provide compelling evidence for evolutionary 
conservation of physiological events stimulated by PDGF signalling in the zebrafish and 
higher vertebrates.   
1.5.5.5 Transforming growth factor  
The transforming growth factor beta (TGFβ) family of dimeric secreted polypeptides 
encodes 33 members in humans including TGFβ 1,2,3, activin, nodal and bone 
morphogenic proteins (Huminiecki et al., 2009). The ligands signal via binding and 
activation of TGFβ receptors (TGFβRs). TGFβRs represent a class of transmembrane 
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receptor kinases that phosphorylate serine and threonine residues. Upon ligand binding, 
TGFβRs receptors form a heterocomplex of two type I and two type II receptors to 
initiate downstream signal cascades. There are 7 type I and 5 type II TGFβ receptors 
(Massague, 2012). The type II receptors (activators) phosphorylate the type I receptors 
(signal-propagators) at the intracellular domain and permit SMAD effector protein 
interaction (Wrana et al., 1994). Type I receptors phosphorylate SMAD proteins that 
transduce the signal, primarily through nuclear translocation, with co-SMAD (SMAD4) 
to mediate gene regulation (Huse et al., 2001; Wrana et al., 1994). TGFβ 1,2 and 3 signal 
exclusively via type I receptor TβRI (ALK5) and type II receptor, TβRII (Moustakas and 
Heldin, 2009).   
TGFβ signalling mediates a diverse range of physiological and pathophysiological 
functions, including morphogenesis, inflammation, fibrosis, angiogenesis, tumour 
metastasis and EMT (Derynck and Akhurst, 2007; Leask, 2007; Moustakas and Heldin, 
2009; Scherz et al., 2008). TGFβ signalling drives the expression of EMT genes, such as 
snail and twist, via smad2/3 translocation to the nucleus, thereby enhancing 
dedifferentiation and transdifferentiation implicated in cancer metastasis (Kang et al., 
2003; Xu et al., 2009). A central role in inflammation and fibrosis is governed by TGFβ 
(Frangogiannis, 2006) as it induces the transdifferentiation of myofibroblasts into a 
more synthetic phenotype thus increasing connective tissue deposition (Cao et al., 
2010b; Leask, 2007; Lijnen et al., 2003). 
NRPs involvement in the TGFβ signalling pathway has been well characterised. TGF is 
maintained in a latent inactive form whereby it is bound to latency associated peptide 
(LAP) and requires proteolytic activity or interactions with other proteins like integrins 
to release the active signal peptide. NRP1 can bind and activate LAP-bound latent TGFβ 
by mechanisms not yet fully understood, as well as active TGFβ and interact with TGFβRs 
(Glinka and Prud'homme, 2008). NRPs initiate signal complex formation to enhance 
TGFβ signal transduction and serve as TGFβ co-receptors (Glinka et al., 2011). NRP 
involvement in the TGFβ signal pathways has been described in cancer epithelial to 
mesenchymal transition (EMT) in vivo. NRP2 promotes TGFβ1-mediated EMT in 
colorectal cancer cells and is associated with a worse prognosis because of enhanced 
 93 
 
metastatic potential (Grandclement et al., 2011; Kawakami et al., 2002). NRP1 and NRP2 
modulate regulatory T (Treg) cell TGFβ signalling to promote SMAD3 signal transduction 
and enhance Treg suppression of immune response (Glinka and Prud'homme, 2008). 
The NRP1/TGFβ axis can also mediate an alternative cerebral angiogenesis, 
circumventing VEGFR2-mediated angiogenesis via ERK1/2, to generate neovessels in a 
VEGFR2-independent manner (Hirota et al., 2015).  
The zebrafish tgfβ receptors and smad genes underwent genome duplication 
(Postlethwait et al., 1998; Wu and Hill, 2009). The duplicated TGF signalling genes show 
overlapping and distinct expression patterns during development (Dick et al., 2000; 
Pogoda and Meyer, 2002), indicating additional functional roles for the genes, though 
these are currently poorly defined (Huminiecki et al., 2009). During zebrafish 
development TGFβ/SMAD3 signalling has been linked to spinal cord development 
(Casari et al., 2014) and left-right symmetry (Chocron et al., 2007; Sun et al., 2006). 
1.6 Hypothesis  
Although some cellular processes and mechanisms underlying zebrafish heart 
regeneration have been elucidated, in general these remain poorly characterised. Vegf, 
Fgf, Pdgf and Tgfβ, and are all cytokines implicated in zebrafish cardiac repair, and are 
all known neuropilin ligands. Additionally, cardiac damage switches on the re-expression 
of embryonic genes in the regenerating zebrafish heart, and, it is also known that 
neuropilins are expressed in the cardiovascular system during zebrafish embryonic 
development. It is also evident that the physiological roles of neuropilins extend beyond 
that of vascular and neuronal development, and, several biological processes occurring 
in zebrafish heart regeneration could involve neuropilins. For example, Neuropilins 
could be required for PDGF- and FGF- induced EMT of the epicardium, TGFβ/smad3 
signalling that regulate fibrotic and inflammatory responses, as well as for VEGF-
stimulated revascularisation of the injured area. Thus, I hypothesised that neuropilins 
are upregulated during and required for zebrafish heart regeneration. 
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1.7  Aims  
Using the cryoinjury model of cardiac damage in zebrafish, I intended to carry out the 
following studies:  
 Characterise the temporal expression of zebrafish neuropilin isoforms in the 
heart following cardiac damage using RT-qPCR. 
 Investigate the spatiotemporal expression of neuropilins at time points 
coinciding with the inflammatory, reparative and regenerative stages of 
zebrafish heart regeneration. 
 Identify the cell types expressing neuropilins during cardiac regeneration.  
 Examine the role(s) Nrp1 may have in response to cardiac damage using a mutant 
fish lacking a functional nrp1a gene.  
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2  Materials and Methods  
2.1 Animals 
 Husbandry  
Procedures were performed in line with the Animals (Scientific Procedures) Act 1986 
under project licence 70/7700. Zebrafish were raised at a density of 5 fish per litre in 
mixed sex populations, with a light-cycle (14 hours light + 10 hours of dark), water 
temperature (27-29oC) and diet regulated by the Central University College London fish 
facility. 
 Animal details 
Adult zebrafish between 6-18 months of age were used for experiments (see Table 3). 
Wild type ABxTupLF (AB X Tupfel Long Fin) and nrp1asa1485/sa1485 fish were used for in 
vitro culture, histological samples, RNA and protein expression analysis. Additionally, the 
following transgenic fish were used for histological preparations;  Tg(fli1a:GFP) and 
Tg(kdrl:mCherry) (Chi et al., 2008) to identify endocardial cells, Tg(wt1b:GFP) (Perner et 
al., 2007) to detect activated epicardial cells and Tg(cmlc2:GFP) (Huang et al., 2003) to 
identify viable cardiomyocytes. TraNac zebrafish (gift from Paul Frankel, University 
College London) were crossed to produce embryos used for whole-mount in situ data. 
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Table 3 Details of zebrafish used in the study 
Line name Short name 
Component 
identified 
Obtained from ZFIN ID allele 
AB X Tupfel Long  Fin ABxTupLF 
Wild Type 
Max-Planck, Tübingen, 
Germany 
ZDB-GENO-990623-2 dt2 
nrp1asa1485/sa1485 nrp1asa1485/sa1485 
N/A 
Zebrafish Mutation Project, 
Sanger Centre, Cambridge , 
UK 
ZDB-ALT-120411-534 sa1485 
Wilms’ Tumour 1b: enhanced green 
fluorescent protein 
Tg(wt1b:GFP) Active epicardial cells 
Fritz Lipmann Institute, Jena, 
Germany 
ZDB-TGCONSTRCT-071127-
1 
li1 
Cardiac myosin light chain: 
enhanced green fluorescent protein 
Tg(cmlc2:GFP) Viable cardiomyocytes 
Institute of Molecular and Cell 
Biology, Taipei, Taiwan 
ZDB-TGCONSTRCT-140716-
2 
mss5 
Friend leukaemia integration 1a: 
enhanced green fluorescent protein 
Tg(fli1a:GFP) 
Endothelial cells 
C.A.R.E.G institute, Ottawa, 
USA 
ZDB-TGCONSTRCT-070117-
94 
is10 
Kinase insert domain receptor 
like:mCherry 
Tg(kdrl:mCherry) Endothelial cells 
Max-Planck, Tübingen, 
Germany 
ZDB-ALT-081212-4 s896 
Transparent (mpv17) x nacre 
(mitfa) 
TraNac 
Pigment mutation fish –
transparent appearance 
Cancer Research UK, London 
Research Institute, UK 
ZDB-GENE-040426-1168 
and ZDB-GENE-990910-11 
Mpv17b18 and 
mitfab692 
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 Zebrafish breeding 
Zebrafish aged 3 months and above were used for breeding to generate new transgenic 
lines and maintain stocks. One male and one female fish of selected genotypes were 
placed into a 500 ml tank containing system water and fed with live brine shrimp for 10 
minutes. Following feed, fish were transferred to a new 500 ml tank containing system 
water and breeding base insert (designed to separate eggs from fish) and left overnight. 
The following morning, fish were returned to tanks on system racks and eggs laid 
collected by removing insert and pouring tank water through a narrow-holed sieve to 
retain eggs. Collected eggs were transferred to petri dishes containing 0.01% methyl 
blue (in aquarium water) and stored in a 28oC incubator. After 24 hours, unfertilised 
eggs were identified and removed using a plastic Pasteur pipette. Fertilised eggs, 
selected for fluorescence where appropriate, were transferred to a fresh petri dish 
containing system water with methyl blue and stored in a 28oC incubator. At 4 days post 
fertilisation (dpf) zebrafish embryos (now fry at this stage) were returned to the UCL 
zebrafish facility and raised to adults according to establishment protocol.  
 Cryoinjury 
Fish were anaesthetized in 0.02% (w/v) MS-222 (tricaine) (Sigma-Aldrich, A-5040) and 
transferred to a dampened sponge, ventral side up, under a microscope (Nikon, 
SMZ1500) and halogen fibre optic light (Schott, KL1500). Fine forceps were used to 
remove scales at the chest cavity and a small incision was made into the silvery 
pericardial sac to expose the ventricle (Figure 16A and B). The incised region was then 
dabbed dry of excess liquid and blood. A copper probe (0.75 mm Ø), cooled in liquid 
nitrogen, was gently pressed onto the tip of the ventricle for 5 seconds (Figure 16C). A 
Pasteur pipette containing system fish water was used to thaw and remove probe from 
the ventricle. Fish were returned to tanks containing system water supplemented with 
10 µM lidocaine analgesic (Sigma-Aldrich, L5647) and a pasteur pipette was used to 
direct water towards the gills to improve recovery rate. Fish were left in lidocaine-
containing water for 1 hour before placing them back to the general water system. Sham 
operations were performed as above, with the absence of probe application. 
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 Fin clip 
Fish were anaesthetized in 0.02% (w/v) MS-222 (tricaine) (Sigma-Aldrich, A-5040) then 
transferred to a petri dish. A small segment of the caudal fin was excised with a surgical 
scalpel and sterile forceps were used to transfer the fin sample to a clean Eppendorf 
tube, then residual aquarium water was removed. Fish were placed in 500 ml tanks 
containing aquarium system water to recover from anaesthesia and returned to a 
segmented grid tank (DC-96 R&D aquatics, #103) connected to aquarium system water 
for future identification. Genomic DNA was extracted from fin clips using the Phire 
Animal Tissue Direct PCR Kit (Thermo Scientific, F140WH) dilution protocol. Fin-clips 
were incubated in digestion solution (20 µl dilution buffer, 0.5 µl DNARelease), briefly 
vortexed, then digested at room temperature for 5 minutes before terminating the 
digestion at 98 °C for 2 minutes. Supernatant containing genomic DNA was transferred 
to a new Eppendorf and stored at -20oC until required for genotyping. 
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A B
C D
Figure 16 Cryoinjury procedure 
Zebrafish are anaesthetised and placed into a dampened sponge and the heart location is 
identified by visibility of the heartbeat. The scales are removed from dissection area and 
(A) an incision is made to expose silvery pericardial sac. (B) Removal of the pericardial 
tissue exposes the ventricle at the surface of the thoracic region, excess blood and liquid 
is then dabbed dry. (C) A copper filament probe (0.75 mm Ø) cooled in liquid nitrogen is 
applied to the ventricle for 5 seconds and thawed with system water to aid removal. (D) 
The incision area is monitored briefly for successful injury and fish is returned to system 
water, supplemented with analgesic, for recovery.  
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2.2 Tissue collection 
 Heart collection 
Operated fish hearts were collected at 1, 3, 7, 14, 30, 60 or 160 days post cryoinjury 
(dpci) for all protocols except in vitro epicardial culture whereby hearts were collected 
at 5 dpci. Fish were euthanised in tricaine (0.04% w/v). Gills were monitored for 
movement, the caudal fin pressed between fingers to initiate pinch reflex and reactions 
to vibration assessed. After cessation of all three responses, an incision was made 
between the gills to sever vessels and confirm death. The pectoral was cavity opened 
and heart excised with forceps at the bulbus arteriosus.  
 RNA preservation  
The atrium and the bulbus arteriosus were removed from hearts, and the remaining 
ventricles were rinsed briefly in PBS and stored at -20oC in RNAlater® stabilization 
reagent (Qiagen, Crawley, UK) until RNA extraction procedures. 
 Protein preservation 
The atrium and the bulbus arteriosus were removed from hearts, and the remaining 
ventricles were rinsed briefly in PBS, placed in 1.5 ml Eppendorf tubes and snap frozen 
in liquid nitrogen. Samples were stored at -80oC until processing for protein extraction. 
 Histology preparation 
When possible, the entire heart (atrium, ventricle and bulbus arteriosus) was kept intact 
and placed in PBS/0.1 M KCl for 5 minutes to arrest heart in diastole before fixing with 
4% (w/v) Paraformaldehyde (PFA) overnight at 4oC. After fixation, hearts were rinsed 
several times in PBS. Samples were then dehydrated in biopsy cassettes (ProMarc 
Cellpath, J0109-10A) by immersion in a series of increasing ethanol concentrations (70, 
80, 90 and 95%) to 100%, water-free alcohol using an automated tissue processor (Leica, 
TP1050). Samples were embedded in paraffin wax using a Tissue-Tek®TEC™ (Sakura) 
embedding station and mounted to cassette lids. Samples were cut in serial sections at 
10 µm using microtome (Shandon finesse 325, Leica), mounted to slides and left to dry 
at room temperature (RT) overnight. Samples intended for Acid Fuchsin Orange G 
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(AFOG) staining and immunolabelling were mounted onto Superfrost® Plus 
(ThermoScientific, 630-0950) slides then stored at room temperature, those intended 
for in situ hybridisation were mounted onto Superfrost® ultra plus (ThermosScientific, 
631-0099) slides and stored at -80oC.  
 In vitro assay  
The atrium and the bulbus arteriosus were removed from hearts, and the remaining 
ventricles were rinsed several times in HDMEM (DMEM (Dulbecco's Modified Eagle's 
medium), 23 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 15 
mM NaCl) to remove residual blood, then stored temporarily in a petri dish at room 
temperature before promptly mounting to gel. 
 Embryo harvest 
Zebrafish embryos that have a double mutation in the transparent and nacre genes 
(TraNac) were collected at 24, 48 and 72 hours post-fertilisation (hpf) into 1.5 ml 
Eppendorf tubes and then fixed in 4% PFA overnight at 4oC. The following day embryos 
were rinsed with five 5-minute PBS washes and then transferred to 100% methanol for 
storage at -20oC.  
2.3 PCR 
 Principle of PCR 
Polymerase chain reaction (PCR) is a molecular biology technique used to exponentially 
amplify DNA sequences. It relies on thermal cycling, with repeated heating and cooling 
of the reaction for DNA denaturation and replication, respectively. PCR generates a large 
quantity of a specific genetic sequence used as the starting point for many molecular 
biology protocols such as genotyping, cloning, virus synthesis and probe design. 
To amplify a specific region of a gene, online databases, such as ncbi primer blast, can 
be used to design small 20-25 base pairs (bp) oligonucleotides (primers) that 
complement the gene of interest sequence within parameters required for the protocol. 
Often PCR requires amplicon products of less than 200 bp. The primers will be designed 
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to bind to the gene of interest on the template DNA in either the 3’-5’ direction on the 
leading strand (forward primer) or in the 5’-3’ direction on the lagging strand (reverse 
primer). The primers are often designed to anneal at high temperatures to increase 
specificity and reduce primer dimer formation.  
Taq DNA polymerase was initially isolated from a thermophilic bacterium, Thermus 
aquaticus, that lives in geothermally heated bodies of water such as hot springs. The 
bacterium’s enzymatic activities occur at temperatures exceeding 42°C (the 
temperature at which most mammalian proteins denature). It was consequently used 
to avoid the need of enzyme addition at each cycle and allowed the automated upgrade 
of the original PCR setting. The annealed primer provides a free 3’ hydroxyl group from 
which DNA polymerases catalyse a hydrolysis reaction between the 5’ phosphate group 
of the subsequent deoxynucleotide (dNTP) to form a covalent bond. These hydrolysis 
reactions repeat and the DNA polymerase synthesises a complementary strand of DNA 
from the template sequence, a process described as elongation (Figure 17). The taq 
polymerase can function at 72°C, incorporating up to 100 complementary 
oligonucleotides per second.  
Often, commercially available taq polymerases are provided in an inactive form, 
whereby specific antibodies block non-specific amplification by the enzyme during 
reaction set up. An initial activation incubation at 95°C routinely precedes PCR reactions 
to denature the enzyme and activate taq polymerases.  Following enzyme activation, 
the PCR reaction consists of a repeated series of temperatures, which mediate one of 
three PCR key stages; denaturation, annealing and extension (Figure 17). Denaturation 
is the initial stage, often at 95°C, to disrupt hydrogen bonds between anti-parallel double 
strands of DNA (dsDNA) molecules producing accessible DNA templates for primers to 
anneal to and simultaneously prevent DNA polymerase activity. Following denaturation, 
the temperature is lowered to approximately Tm-5°C (Tm, Melting temperature: 
Temperature at which half of the primers are annealed to the template DNA). Primers 
start to form bonds with the complementary target sequence, this is the second key 
stage: annealing. Finally, the extension step is carried out at 68-72°C, depending on the 
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polymerase used in the reaction. Taq polymerase binds to incomplete regions of double 
stranded DNA (at the primer-bound region) and synthesises a new strand of DNA, 
complementary to the template strand.  
After one PCR thermal cycle, a new fragment of double stranded DNA stemming from 
both the forward and reverse primers is produced, therefore one copy of DNA template 
yields two copies of the desired DNA sequence. The cycle is repeated and the two newly 
synthesised double strands of DNA serve as the new template for the subsequent cycle. 
As there are now more templates available, more products are produced; 2 strands of 
double stranded DNA (dsDNA) will both be amplified and produce 4 new dsDNA PCR 
amplicons after a second cycle. An additional round of PCR will produce 8 amplicons 
from the initial 4 at the third cycle, 8 copies become 16 on the fourth cycle and so on. 
The process amplifies gene products exponentially, efficiently yielding millions to billions 
of copies of the target fragments of DNA.    
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Figure 17 Polymerase Chain Reaction Schematic 
Schematic representation of PCR thermal cycle DNA amplification. Template double 
stranded DNA (dsDNA) (green) from sample is denatured at high temperatures (95oC), 
the temperature is cooled (~60oC) to permit primers (red) to anneal its complementary 
sequence. Taq polymerases use primers as the origin to synthesise a new 
complementary strand of DNA from existing template (blue). Completion of 
denaturation, annealing and extension forms one thermal cycle and yields two strands 
of dsDNA (amplicons) from the original template. The second thermal cycle produces 
4 amplicons from the original 2. This process is repeated over several cycles to yield 
millions to billions of identical amplicons.    
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 Genotyping  
2.3.2.1 Principle of Sanger sequencing 
Sanger sequencing is commonly used to carry out genotyping and applies PCR principles 
to amplify a specific region of the gene of interest, however, it employs additional 
parameters to delineate the sequence of an unknown DNA template. The reaction 
mixture includes a small concentration of dideoxynucleotides (ddNTPs) that do not 
contain the 3’ hydroxyl group required for the hydrolysis reaction catalysed by DNA 
polymerase during elongation. During sequencing, at an unpredictable point during the 
PCR, a ddNTP is incorporated during elongation at its 5’ phosphate group, the absence 
of the 3’ hydroxyl group for the next nucleotide results in the elongation termination. 
The ddNTPs are labelled to be identified. The early sequencing method relied on 
radiolabelled ddNTPs; four separate PCR reactions would be carried out for the same 
gene, containing a single radiolabelled ddNTPs, one per nucleotide base (A, T, C and G) 
along with the unlabelled other dNTPs (Sanger et al., 1977). More recently, ddNTPs have 
been used where each base is labelled with a different fluorophore, and sequencing is 
now performed in a single reaction (Smith et al., 1986). The PCR reaction yields several 
amplicons of differing lengths depending on at which point the complementary ddNTPs 
was incorporated. The PCR reaction can then be ran in an acrylamide gel thereby 
separating the amplicons by size. The unknown sequence can be determined by reading 
the fluorescence of the different amplicons in ascending order of size. As PCR produces 
millions of replicates of a single product, sufficient copies of each possible fragment are 
generated to produce a detectable signal for hundreds of bases.  
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Figure 18 Sanger Sequencing 
Schematic representation of Sanger sequencing. A PCR reaction is carried out with template 
DNA of unknown sequence. The PCR reaction contains both deoxyribonucleotides (dNTPs) and 
a low concentration of fluorescently labelled dideoxyribonucleotides (ddNTPs) that terminate 
elongation. Amplicon fragments of all possible lengths are generated in the PCR, each 
incorporating a fluorescent ddNTP. The PCR products are run in a polyacrylamide gel to 
separate amplicon fragments by size. A fluorescent detector records the light emitted by 
amplicons in sequential sizes and deduces which fluorescently labelled nucleotide is present. 
A chromatogram is produced indicating fluorescence and corresponding nucleotide to 
delineate the DNA sequence.   
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2.3.2.2 Experimental details 
Genomic DNA (gDNA) from fin clip samples was diluted 1 in 10 with molecular grade 
water (HyClone™, SH30538.02). PCR reactions were carried out to amplify the portion 
of the nrp1a gene where nrp1asa1485 nonsense mutation occurs. Maxima Hot Start Green 
PCR Master Mix (Thermo scientific, EP0601) 50 µl reactions were performed as per 
manufacturer’s instructions containing 0.5 µM primers (forward (Fwd) 
TCCAGCAGCGGAGTCATCAAG, reverse (Rev) CCAGGGAATCCGTCCCAAAC (5’-3’)) and 2 µl 
diluted gDNA. 20 µl aliquots of PCR products were analysed with agarose gel 
electrophoresis to confirm presence of a single PCR product. The remaining PCR 
reactions were purified with Zymo DNA clean and concentrator™ spin columns and DNA 
eluted in 12 µl molecular grade water and concentration and purity determined with 
NanoDrop 8000 spectrophotometer (Thermo Scientific). PCR products were sent for 
Sanger sequencing (Source bioscience services) at 2 ng/µl concentration, along with the 
forward primer of the PCR reaction. Sequencing data were analysed with Sequencher 
5.3 software aligned to predicted sequence of mutation.    
 RT-qPCR 
2.3.3.1 Principle of absolute RT-qPCR 
Quantitative reverse transcription PCR (RT-qPCR) relies on the logarithmic generation of 
double stranded DNA fragments following each thermo cycle of PCR. The technique 
employs the use of a fluorescent signal (either a fluorescent/quencher signal reaction or 
non-specific double stranded DNA binding fluorophore) that correlates with the amount 
of DNA amplicons generated after each cycle. For the purposes of this study, the non-
specific dsDNA-binding fluorophore SYBR® green was used. Upon interaction, the DNA-
dye-complex absorbs blue light (λmax = 497 nm) and emits green light (λmax = 520 nm). 
The fluorescence emitted correlates with the amount of DNA amplicons produced 
during the PCR reaction. 
Several variations of RT-qPCR exist, all require template DNA generated by reverse 
transcription of sample messenger RNA (mRNA) to produce complementary DNA 
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(cDNA). Most commonly used is the relative qPCR that simultaneously measures 
amplification of a reference gene along with the gene of interest and calculates a ratio 
between the two. Sample treatments are compared as differences between ratios of 
target gene with the reference gene (often described as a fold-change in expression).  
For the purpose of my project, I used absolute qPCR. Absolute qPCR compares target 
gene expression with a combination of at least three reference genes which are used to 
produce a normalisation factor. Known numbers of amplicons (standards) are used to 
extrapolate the number of amplicons within the unknown samples, thus giving an 
indication of the level of gene expression. Whereas a two-fold change could mean from 
10 to 20 copies, or 100,000 to 200,000 copies, absolute qPCR provides a quantitative 
value of amplicon copy numbers. Variability of qPCR is far greater at low copy numbers 
(e.g. 10-100 copies) than at high copy numbers. Knowing the level of expression gives 
some indication to the likely physiological relevance in gene expression changes.  
qPCR standards are produced by amplifying the single gene product via PCR, they are 
then purified and quantified. Because the DNA sequence of the amplicon is known, the 
copy numbers per µl of that amplicon can be calculated from nanodrop concentration 
measurements. The PCR product is diluted to set concentrations from 1x107 to 1x101 
copies per µl via serial dilutions. The standards are run to produce a standard curve by 
plotting the known copy numbers (x-axis) against the cycle threshold (ct) values (y-axis). 
Using standards also gives a simple way of directly checking the efficiency of the assay 
from the regression line of Cq vs. log standard concentration (Eff = 10-1/slope). The ct 
values of the experimental samples are aligned to the standard curve to extrapolate the 
copy number of the amplicon in the PCR reaction.  Several reference genes are amplified 
following the same principle to gauge which are the most stable amongst all samples 
regardless of treatment, and a normalisation factor is generated by geNorm software 
using a minimum of three reference genes. The previously extrapolated experimental 
(unknown) sample copy numbers per reaction are multiplied by the normalisation factor 
to finally produce a “Normalised copy numbers per reaction” for genes of interest. 
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2.3.3.2 cDNA synthesis 
All primers and standards were designed and purchased from qStandard services. Five 
ventricles were pooled from corresponding time points and treatments for RNA 
extraction.  Ventricles were homogenised in 600 µl RLT buffer (Qiagen, 74106) in 1.4 mm 
ceramic bead-containing tubes (Peqlab precellys ceramic kit, 91-PCS-CKM) and 
mechanically disrupted in minilys® Tissue homogeniser (Bertin instruments). A further 
homogenisation step was carried out by passing homogenates through QIAshredder 
spin columns (Qiagen, 79654). Total RNA was extracted using RNeasy Mini Kit (Qiagen, 
74104) spin columns. Spin column nucleic acid purification is based on silica gel 
membranes embedded within tubes. Nucleic acids are precipitated in ethanol and 
chelating reagents and cations within spin column buffers promote nucleic acid 
negatively charged backbones to bind silica columns. Residual homogenate components 
are then washed and removed from the membranes in a series of ethanol and salt 
washes via centrifugation, resulting in only precipitated nucleic acids bound to the silica 
gel membranes. Nucleic acids are then resuspended in a solvent, such as water, and 
collected in a final spin. RNA extraction for my studies were eluted from columns in a 
final volume of 30 µl. The quantity and purity of RNA were evaluated using a NanoDrop 
8000 spectrophotometer (Thermo Scientific) and RNA integrity was assessed with a 
Bioanalyzer (Agilent). 500 ng of total RNA was treated with DNase to remove genomic 
DNA and cDNA synthesis was performed using QuantiTect® Reverse Transcription Kit 
(Qiagen) as per manufacturer’s instructions. cDNA was stored at -20°C and diluted 10-
fold with yeast transfer RNA (tRNA) (10 µg/ml) (Sigma, R8759) for subsequent PCR 
reactions. 
2.3.3.3 qPCR  
Absolute RT-qPCR reactions were performed by qStandard services using a Rotor-Gene 
PCR thermocycler (Qiagen).  10 μl reactions contained 0.5 M primers (Table 4), 5 µl 
Brilliant III (Agilent) and 1 µl diluted cDNA. All incubations included an initial 
denaturation step at 95°C for 5 minutes, followed by 40 two-step thermocycles of 95°C 
denaturation for 10 seconds, followed by combined annealing and extension at 57°C for 
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7 seconds. Product specificity was confirmed by running the amplified products on an 
agarose gel and thereafter during every qPCR run by melting curve analysis. qPCR 
standards were prepared by amplification of 10-fold diluted zebrafish ventricle cDNA; 
the single PCR amplicon was then isolated by agarose gel electrophoresis (E-gel® 
SizeSelect™ Gels, Life Technologies Ltd, Paisley, UK) and purified with microCLEAN 
(Microzone Ltd, 2MCL-1) purification kit. Quantity and purity of the DNA were evaluated 
using a NanoDrop 8000 spectrophotometer (Thermo Scientific). For all runs, a set of 10-
fold serial dilutions of each internal standard (101 – 107 copies/µl) was used to generate 
a standard curve. All qPCR assays were linear within this concentration range with 
correlation coefficients (r2) >0.95. Normalisation factors were calculated using the 
geNorm software by combining the values obtained for the three following reference 
genes: gapdh, Rpl13a and eef1a1a (see Table 4 for details) whose gene expression 
stayed constant regardless of time points or treatments in the zebrafish ventricles. 
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  Gene Name 
Accession 
Number 
Primer Sequence  5’-3’ 
Melting 
temperature 
Product 
length 
rpl13a 
Ribosomal protein L 13A 
NM_212784 Fwd gtctgaaacccacacgcaaat                                             
Rev cgttcttttcagcctgcttagt  
52 
53 
171 
eef1a1a Eukaryotic translation 
elongation factor 1a 
NM_200009 Fwd ctcctctgggtcgttttgct                                                       
Rev tatgtgtctctggagttggca 
54 
52 
169 
gapdh Glyceraldehyde 3-
phosphate dehydrogenase 
NM_001115114 Fwd ttcctgagctcaatggcaagc                                               
Rev agacggactgtcagatccaca 
54 
54 
85 
nrp1a 
Neuropilin 1a 
NM_001040326 
& NM_181497 
Fwd ctccaacaaaccctaccaggt                                                
Rev tcggtgatgtccaccatgatttc  
54 
55 
184 
nrp1b 
Neuropilin 1b 
AY493415 Fwd gaccaaaagcagatggagggaa                    
Rev catcttctgtattctctggatctttgc 
55 
57 
176 
nrp2a 
Neuropilin 2a 
NM_212965 Fwd gattctgacttcagctgggttatg                       
Rev cgatgtacaggtagtttcccaaa 
56 
53 
109 
nrp2b 
Neuropilin 2b 
NM_212966 Fwd cagcattgagcttgagcagt                           
Rev tcaggtcttcgctcagtcat 
52 
52 
72 
kdrl kinase insert domain 
receptor like 
NM_131472 Fwd ccttgagacgcagatgaatcc                                             
Rev ctgcgttatccaccctggtc  
54 
56 
140 
flt1 
fms-related tyrosine kinase 
1 
NM_001014829 
& 
NM_001257153 
Fwd aactcacagaccagtgaacaaga                                                       
Rev ttagccttctgtgggtatgtcca 
53 
55 156 
vegfaa Vascular endothelial growth 
factor Aa 
NM_001190933 Fwd ccatctgtctgctgtaaaggct                                               
Rev gatgatgtctaccagcagctctc 
55 
57 
130 
vegfc Vascular endothelial growth 
factor c 
NM_205734 Fwd tgccatgcaggagcattcaga                                               
Rev gcctcctccgaccttgtttc  
54 
56 
180 
tgfb1a Transforming growth factor 
beta 1a 
NM_212965 Fwd gctggctctcatttgacgtg                     
Rev ctctgcttgtctagccctga 
54 
54 
157 
pdgfra Platelet-derived growth 
factor receptor alpha 
NM_131459 Fwd tgataatctctacacaacgctgagt 
Rev ctcatagacatcactggacgcat 
54 
55 
178 
pdgfrb Platelet-derived growth 
Factor receptor beta 
NM_001190933 Fwd gctatcacaacaggactggttc                       
Rev ctctgtgcgaaagtctggga 
55 
54 
177 
pdgfab Platelet derived growth 
factor alpha b 
NM_001076757 Fwd tgataatctctacacaacgctgagt                          
Rev caggggtctgaggtcaaagtc 
55 
51 
124 
bcar1 Breast cancer anti-estrogen 
resistance protein 1 
NM_001135133 Fwd gcactaccaacaaacggtatatgac                                               
Rev tggttctgattctccaggctct 
56 
55 
132 
Table 4 qPCR primer details for housekeeper and neuropilin genes 
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2.4 Histology 
 Immunofluorescence 
2.4.1.1 Principle of immunofluorescence 
Immunofluorescence is a common laboratory technique relying on the use of antibodies 
to detect proteins in cells and tissues. Several antibodies can be used simultaneously to 
identify multiple molecules of interest within a sample, therefore allowing the detection 
of proteins localised to the same region (colocalised) of the cell or tissue. In the case of 
indirect immunofluorescence, the antibody specific for the antigen (the primary 
antibody) is unlabelled, and a second anti-immunoglobulin antibody (the secondary 
antibody), conjugated to a fluorophore, recognises the constant portion of the first 
antibody. If co-labelling is desired; primary antibodies generated in distinct species are 
applied to the same sample. Indirect immunofluorescence grants greater sensitivity 
than direct immunofluorescence (whereby the fluorophore is bound to the primary 
antibody) as multiple secondary antibodies can bind each primary antibody, resulting in 
an amplified signal. Moreover, it allows more flexibility with the choice of colour 
combinations and is relatively less expensive. 
Fluorescent microscopes, fitted with lasers to excite the desired fluorophores and filters 
for emitted light, are used to localise the molecule of interest. Sequential images of a 
sample region are obtained for the different fluorophores and combined to produce a 
final image overlay. When proteins of interest colocalise, the colour in the overlay 
changes, e.g. if red and green staining are used, colocalisation will be indicated by a 
yellow stain.  
2.4.1.2 Experimental details 
Slides were placed in an oven at 60oC for 10 minutes to soften paraffin wax, and then 
incubated twice in xylene for 10 minutes. Xylene is a strong organic solvent allowing the 
solubilisation of the paraffin. Sections were then rehydrated through graded washes of 
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ethanol in water, ending in a final rinse in pure water (100%, 95%, 90%, 70%, 30% and 2 
times ddH2O for 5 minutes each). Formaldehyde forms methylene crosslinks between 
proteins and is commonly used to fix tissues for histological preparations. The 
crosslinked proteins can mask epitope recognition by the primary antibodies, therefore 
two methods are commonly used to remove these bridges: heat-induced epitope 
retrieval (HIER) and proteolytic-induced epitope retrieval (PIER). I used HIER for all 
histology procedures in this project: sections were submersed in boiling citrate buffer 
(10 mM sodium citrate dehydrate, 5.4 mM HCl) with occasional boiling of samples in 
microwave for 10 minutes. Slides were then left to re-temper to room temperature for 
10 minutes, washed 3 times in ddH2O and once with Phosphate Buffer Saline Tween 
(PBST) (0.1% tween®20). Samples were permeabilised in PBS Triton X-100 (0.5% Triton 
X-100) for 15 minutes and washed again three times in PBST. Sections were blocked for 
1 hour at room temperature in blocking solution (5% Bovine Serum Albumin (BSA)/10% 
donkey serum/PBST). Primary antibodies (details can be found in Table 5) were diluted 
50-fold (100-fold for IgG controls as stock solutions are twice as concentrated) in 
blocking solution and incubated on samples overnight at 4oC in humidifying chamber. 
The following day, slides were washed three times in PBST, incubated with two 
fluorescent secondary antibodies (anti-rabbit Alexa 488 (Life Technologies Ltd, A11034) 
and anti-mouse Alexa 555 (Life Technologies Ltd, A31570)) diluted 1 in 500 in blocking 
solution in light-insulated humidifying chamber for 1 hour at room temperature. Slides 
were then washed 3 times with PBST and incubated in 1% (w/v) Sudan black in ethanol 
for 15 minutes at room temperature to quench background fluorescence and finally 
rapidly rinsed 8 times with PBS. Slides were mounted with ProLong® Gold Antifade 
reagent with DAPI mounting medium (Life Technologies Ltd, P36931) and left overnight 
at room temperature in light-incubated conditions to set. Z-stack images were captured 
on a Leica TCS SPE1 confocal microscope system and processed using ImageJ software 
(Schneider et al., 2012). 
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Antibody name 
Structure 
labelled 
Catalogue 
number 
Company 
raised 
in 
Neuropilin-1 
antibody 
[EPR3113] 
Neuropilin-1 (c-
terminus) 
GTX62190 Genetex rabbit 
Mouse/Rat 
Neuropilin-2 
Antibody 
Neuropilin-2 AF567 
R&D 
systems™ 
Biotechne® 
goat 
WT1 Antibody (6F-
H2) 
Wilms Tumor 1 NB110-60011 
Novus 
Biologicals® 
mouse 
Monoclonal 
Mouse anti-GFP 
antibody 
Green 
fluorescent 
protein 
11814460001 Roche mouse 
Monoclonal Anti-
Tropomyosin 
antibody 
Tropomyosin T2780 Sigma mouse 
mCherry Antibody 
(1C51) 
mCherry NBP1-96752 
Novus 
Biologicals® 
mouse 
L-plastin 
Lymphocyte 
cytosolic 
protein 
In house 
antibody 
Gift from 
imperial 
College 
London 
rabbit 
mlck Mural cells 018M4800 Sigma Mouse 
aldh2 
Retinoic acid 
dehydrogenase 
GTX124302 Gentex Rabbit 
Mouse IgG N/A 026502 Invitrogen Mouse 
Goat IgG N/A Sc-2028 Santa Cruz Goat 
Rabbit IgG N/A 20009-1-200 
Alpha 
diagnostics 
Rabbit 
Alexa anti mouse-
555 
Mouse IgG A31570 
Life 
Technologies 
Donkey 
Alexa anti goat-
488 
Goat IgG A11055 
Life 
Technologies 
Donkey 
Phalloidin FITC actin 8953S Cell Signalling Donkey 
Alexa anti rabbit-
488 
Rabbit IgG 018M4800 Sigma Donkey 
Table 5 Immunofluorescence antibody details 
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 Acid Fuchsin Orange G 
2.4.2.1 Principle of AFOG staining 
Acid Fuchsin Orange G (AFOG) is a histological chemical stain that identifies the three 
following main tissue components: nuclei, cytoplasm and extracellular matrix. 
Incubation with phosphomolybdic acid is incorporated into the staining procedure to 
allow the dyes to interact with acidophilic macromolecules such as collagen. The 
different interactions of the AFOG dyes results in tissue components being labelled in 
distinct colours (described in Table 6). 
Table 6 Acid Fuchsin Orange G staining key 
Tissue component Colour 
Muscle and cytoplasm Orange 
Collagen Blue 
Fibrin Red 
Basement membrane Pale blue 
Vessels Lively red 
Nuclei Black/dark brown 
Erythrocytes  Yellow/brown 
2.4.2.2 Experimental details 
Slides were placed in the oven at 60oC for 10 minutes to soften paraffin wax, and then 
incubated in xylene for 10 minutes, twice, to remove the paraffin. Sections were then 
rehydrated through graded ethanol in water, ending in pure water (100%, 95%, 90%, 
70%, 30% and 2 times ddH2O for 5 minutes each). Samples were then fixed in Bouin’s 
fixative (Thermo Scientific, 57211) for 2 hours at 60oC followed by overnight incubation 
at room temperature. The following day, slides were rinsed for 10 minutes under a 
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stream of tap water. Nuclei were stained with Weigert’s iron haematoxylin (Amresco, 
0701; Sigma F2877) and differentiated with three rinses in 1% hydrochloric acid (v/v) in 
100% ethanol. Sections were treated for 5 minutes with 1% phosphomolybdic acid (w/v) 
in ddH2O (Sigma-Aldrich, P7390). Slides were then incubated in AFOG staining solution 
(5g Methyl Blue (Sigma, 95290), 10g Orange G (Sigma, 0-3756), 15g acid fuchsin (Acros 
organics, 227900250) per litre ddH2O, pH 1.09) for 10 minutes and briefly rinsed in 
ddH2O 5 times. Slides were rapidly dehydrated in a series of increasing ethanols 
solutions (70%, 80%, 95%, and 100%) to xylene and DPX-mounted with glass coverslips 
for imaging in NanoZoomer automated slide scanner (Hamamatsu). 
 In situ hybridisation 
2.4.3.1 Principle of in situ hybridisation 
In situ hybridisation (ISH) is used to detect nucleic acid localisation within a sample, most 
commonly ribonucleic acids (RNA), and provides a specific detection technique to 
analyse gene expression patterns. In this project, in situ probes were designed to detect 
mRNA of specific genes. All or part of the target gene sequence intended for detection 
is amplified from cDNA to produce a sequence complementary to the mRNA expressed 
in vivo. The gene sequence is inserted into a vector and transformed into bacteria for 
amplification. After recovery of the recombined plasmid via DNA purification, an RNA 
polymerase reaction incorporating UTP ribonucleotides conjugated to digoxigenin (DIG) 
is performed to synthesise DIG-labelled RNA probes. The gene sequence can be 
synthesised to encode the 5’-3’ and 3’-5’ target gene sequence. The 5’-3’ sequence will 
have the same sequence as the mRNA, termed the sense probe and will not bind to 
sample mRNA, this is often used as a blocking reagent or negative control. The 3’-5’ 
sequence will have the complementary sequence to endogenous mRNA and will be able 
to bind in situ, this is known as the anti-sense probe and is used for specific gene 
detection. The anti-sense DIG-labelled probe hybridises with complementary mRNA 
expressed in the sample and an anti-DIG antibody conjugated to an enzyme (most 
commonly a peroxidase or alkaline phosphatase) or fluorescent reporter is used to 
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detect the hybridised probe. In the case of enzymatic detection, the signal is amplified 
using a reaction to produce a visible precipitate (Figure 19).  
2.4.3.2 Dig-labelled RNA probe generation 
cDNA derived from adult zebrafish heart samples were used as template to generate 
digoxigenin-labelled probes (see Table 7). cDNA diluted 10 fold was used for 50 µl 
Maxima Green Hot Start PCR reaction to amplify the probe sequence. The amplification 
of a single PCR product was confirmed by agarose gel electrophoresis, purified with 
Zymo DNA clean and concentrator™ spin columns (Zymo research, D4003) and the DNA 
concentration determined with a NanoDrop 8000 spectrophotometer (Thermo 
Scientific). Purified PCR products were ligated into 50 ng of pGEMT® vector (Promega, 
A3600) at a ratio of 3:1, insert: vector, using instant sticky ends ligase master mix (New 
England Biolabs, M0370L) as per manufacturer’s instructions. The ligation reaction was 
used to transform One Shot® Top 10 competent E.coli. Successfully transformed 
AP
Target 
mRNA
DIG – labelled Anti-
sense RNA probe
Dark blue 
precipitant 
DIG- labelled Sense 
RNA probe
Alkaline 
phosphatase-
conjugated anti-DIG 
antibodies
5’ 3’
5’ 3’
3’ 5’
Figure 19 In situ hybridisation 
Representative illustration of in situ hybridisation. Target mRNA expressed in the 
sample is bound by complementary digoxigenin (DIG)-labelled anti-sense RNA 
probes. Antibodies specific for DIG bind the RNA probes. Alkaline phosphatases 
conjugated to the antibody produce visible precipitate in the sample and mRNA 
localisation can be observed.  
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bacteria were identified through blue white screening and orientation of amplicon 
confirmed from mini prep plasmid isolation (Qiagen, 27104) and Source Bioscience 
Sanger Sequencing. Confirmed plasmids were isolated from bacteria via the midi prep 
procedure as per manufacturer’s instructions (Qiagen, 12145) and plasmid 
concentration determined with NanoDrop 8000 spectrophotometer (Thermo Scientific). 
1 µg of plasmid DNA was linearised by restriction digest; digestion was repeated twice, 
one reaction at either of the pGEMT® multiple cloning sites (for digest details see Table 
7). The linear plasmid was purified in 30 µl molecular grade water with Zymo DNA clean 
and concentrator™ spin columns. Linearised plasmids were used to provide template for 
subsequent RNA polymerase reactions; one to generate a sense probe and the other 
reaction performed from the opposing pGEMT® RNA promoter (SP6 or T7) (see Table 7) 
to generate the anti-sense probe. 20µl reactions (containing 2 µl DIG-labelled RNA 
(roche, 11277073910), 11.5 µl linear plasmid, 2 µl 0.1 M DTT, 2 µl 10X RNA polymerase 
transcription buffer (NEB, B9012S), 0.5 µl RNasin® (Promega, N2111), 1 µl molecular 
grade water) were carried out to generate in situ probes. Probes were purified from 
reaction with Zymo RNA clean and concentrator™ spin columns, 30 µl probe was eluted 
in molecular grade water, concentration determined with NanoDrop 8000 
spectrophotometer (Thermo Scientific), then aliquoted and stored -80oC.  
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Figure 20 In situ probe synthesis 
Schematic representation of nrp1a riboprobe synthesis. For the purpose of 
generating digoxigenin (DIG)-labelled RNA probes (riboprobes) for this study, regions 
of neuropilin genes were amplified from zebrafish cDNA in a taq polymerase PCR 
that leave 3’-A overhangs on products. Amplicons were ligated to pGEM®T-easy 
vector to the complementary 3’ T overhangs of the open plasmid. Two restriction 
enzyme digest reactions were then carried out, one at either multiple cloning site 
(MCS) of the vector. Probes were synthesised with the appropriate RNA polymerase 
(SP6 or T7) in a reaction containing DIG-labelled UTP nucleotides to generate sense 
or anti-sense encoding probes.  
Figure 21 pGEM®T easy vector map 
pGEM®T- Easy is a commercially available open vector. The vector has 3´-T overhangs 
at either end that provide a complementary base for taq polymerase PCR products 
containing 3’-A overhangs. pGEM®T- Easy also encode several restriction enzyme 
recognition sequences in succession in the multiple cloning site (MCS) preceded by 
either the T7 or SP6 RNA polymerase promoters. 
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Table 7: In situ RNA probe details 
Gene 
Primer sequence 
Fwd 5’-3’ 
Rev 5’-3’ 
Probe 
length 
Anti-
Sense 
Enzyme 
Anti-Sense 
RNA 
Polymerase 
Sense 
Enzyme 
Sense RNA 
polymerase 
nrp1a 
TACAGTGCCGCCTACTACAC 
CACGCTTCCGAGTACGAGTT 
993 SalI T7 NCOI SP6 
nrp1b 
CAAAACCATGACACGCCAGA 
TGCCCTCACAGTTCACGATTT 
997 NCOI SP6 SalI T7 
nrp2a 
AGACCAGCACGACACAGAAA 
GTGAGGGGTTTGGTGTGGTC 
813 
 
SalI T7 SacII SP6 
nrp2b 
ACCACCATTCCTGACACTGC 
GTGAGGGGTTTGGTGTGGTC 
715 PstI T7 SacII SP6 
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2.4.3.3 Paraffin-embedded slides in situ hybridisation 
Slides were placed in the oven at 60oC for 10 minutes to soften paraffin wax, and then 
incubated in xylene for 10 minutes, twice, to remove the paraffin. Sections were then 
rehydrated through graded washes of ethanol in diethyl pyrocarbonate–treated double 
distilled water (DEPC-H2O)(100%, 95%, 90%, 70%, and 30%), transferred to PBS for 5 
minutes and then fixed with 4% PFA at RT for 10 minutes. Slides were washed 2 times 
for 5 minutes in PBS and digested with proteinase K (10 μg/ml in PBS) at 37oC for 10 
minutes. Enzymatic activity was stopped with a 10 minute incubation in glycine/PBS (2 
mg/ml) and slides were further washed with PBS for 5 minutes and again fixed with 4% 
PFA for 5 minutes at RT. Sections were subsequently washed twice in PBS for 5 minutes 
and acetylated for 10 minutes with 0.25% acetic anhydride in 0.1 M triethanolamine 
(DEPC-treated) as an initial blocking step (to minimise non-specific binding of the 
negatively-charged probe to the positively charged glass slides). Slides were washed 
with PBS, then DEPC-H2O for 5 minutes and 2 Frame-Seal™ Slide Chambers (Bio-Rad, 
SLF0601) borders were applied to the slides to enclose tissue sections. Hyb+ solution 
(50% deionised formamide, 10% dextran sulphate, 1X Denhardt’s, 5X Saline-Sodium 
Citrate (SSC), 1 mg/ml yeast tRNA, 0.1% Tween®20) was placed into chambers and slides 
incubated at 67oC for 2 hours in humidifying chamber (chamber humidifying solution 
5XSCC/50% formamide in DEPC-H2O). Hyb+ was replaced with 100 μl hyb+ containing 
either anti-sense (AS) or sense (S) digoxigenin-labelled probe (0.5 μg probe/ml) and 
incubated overnight at 67oC in humidifying chamber. 
Slides were washed at 67oC in graded salt solutions (5X SSC/50% formamide, 2X SSC/50% 
formamide, 2X SSC and 0.2X SSC) for 30 minutes per wash. Slides were then washed 
with malate buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5, 0.1% Tween®20) (MAB) 
3 times, and sections blocked with 100 μl blocking solution (MAB/ 2% Boehringer 
blocking reagent/10% sheep serum) at RT for 2 hours. Blocking solution was replaced 
with 100 μl alkaline phosphatase-conjugated anti-DIG antibody (roche, 11 093 274 910) 
containing blocking solution (1:3000 dilution) and incubated overnight at 4oC in 
humidifying chamber (ddH2O was used for chamber humidifying solution).  
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The following day, slides were washed with MAB 6 times for 15 minutes per wash, then 
equilibrated with 3 washes for 5 minutes in staining buffer (100 mM Tris pH 9.5, 50 mM 
MgCl2, 100 mM NaCl, 0.1% Tween®20). Gene detection by alkaline phosphatase/ nitro-
blue tetrazolium (NBT)/ 5-bromo-4-chloro-3'-indolyphosphate (BCIP) reaction 
(containing 5% polyvinyl alcohol) was carried out at 37oC in dark until dark purple 
precipitant was visible under stereomicroscope (Leica S8 APO). Upon substrate 
development, slides were washed in PBS, fixed with 4% PFA for 20 minutes at RT, 
washed a further 2 times in PBS before rapid dehydration in graded ethanols (70%, 80%, 
95%, and 100%) to xylene for mounting with DPX and glass coverslips for imaging. 
2.4.3.4 Whole-mount in situ hybridisation 
Zebrafish embryos were dechorionated in 100% methanol, and rehydrated in graded 
methanols, then permeabilised with proteinase K (10 μg/ml) at RT for 20 minutes and 
further fixed in 4% (w/v) paraformaldehyde. Hybridisation buffer (50% formamide, 5X 
Saline-Sodium Citrate buffer (SSC), heparin (50 μg/ml), torula yeast tRNA (5 mg/ml), 
0.1% Tween®20) was used to block embryos at 67oC for one hour. Probes were diluted 
to 0.5μg probe/ml in the same hybridisation buffer and denatured at 80oC for 3 minutes. 
Equilibrated embryos were then incubated in probe-containing hybridisation solution at 
67oC overnight. Similarly, detection was performed using alkaline phosphatase-
conjugated anti-DIG antibodies (Roche Life Science). Visualization was done using 
alkaline phosphatase substrate BM purple (Roche Life Science) in the dark at room 
temperature until a dark purple precipitant developed. Embryos were then post fixed 
with 4% (w/v) paraformaldehyde overnight at 4oC and stored in 80% glycerol/PBS for 
imaging. 
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2.5 Zebrafish primary in vitro epicardial culture 
 Assay 
Thrombin-induced fibrinogen conversion to fibrin was performed in DMEM (gibco, 
21063029) as described in (Kim et al.) (2012) to produce fibrin gel matrix. Gel matrix was 
set in either 24-well plates or 4-chamber slides (Lab-Tek II Chamber Slide System, 
154526). The apices from dissected cryoinjured and sham-operated zebrafish hearts 
were placed in HDMEM (DMEM, 23 mM HEPES and 15 mM NaCl). Apices were rinsed 
several times with HDMEM at room temperature to remove residual blood. One apex 
per well/chamber was placed firmly on set fibrin gel matrices, ensuring epicardial 
surface contact with the gel. Excess DMEM was removed from heart tissue using a 10 µl 
pipette tip and left to adhere for 1 hour in a 28oC tissue culture incubator. 1 ml of DMEM 
(supplemented with 0.5% FBS, 0.05% Normocin™ (Invivogen, ant-nr-1), penicillin (100 
I.U./ml) and streptomycin (100 µg/ml) antibiotics (Sigma, P0781)) was added to the well 
or chamber and heart tissue cultured in a 28°C incubator (5% CO2 and 100% humidity). 
Medium was changed every 2-3 days and cells were cultured for 7 days before 
harvesting epicardial outgrowths for protein extracts and immunofluorescence imaging.  
 Immunofluorescence 
After 7 days culture, epicardial outgrowths were visible in all treatment groups. Medium 
was removed from slide chambers and rinsed twice with ice cold PBS. Cells were then 
fixed in 4% PFA at room temperature for 15 minutes and washed twice with PBST (0.1% 
Tween®20). Cells were permeabilised with PBS/triton X-100 (0.1% triton x-100) at room 
temperature for 10 minutes and further washed with PBST twice. Samples were blocked 
in blocking solution (1% BSA/10% donkey/PBST) at room temperature for 1 hour and 
incubated overnight at 4oC with primary antibody diluted 1 in 200 (1 in 400 for IgG 
controls) (see Table 5 for antibody details) in blocking solution. The following day, 
samples were washed three times in PBST and incubated for one hour at room 
temperature with fluorescent secondary antibody (anti-rabbit Alexa 488 and Alexa 
Fluor® 546 conjugated phalloidin (Thermo Scientific, A11034 and A22283) in blocking 
solution (both 1 in 500) and insulated from light. Chambers were washed a further three 
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times in PBST to remove unbound excess antibodies. Boundaries were removed, heart 
tissue discarded and slides mounted with ProLong® Gold Antifade reagent with DAPI 
mounting medium (Life Technologies Ltd, P36931). Slides were left to set overnight at 
room temperature in light-insulated conditions and z-stack images captured on Leica 
TCS SPE1 confocal microscope system. Images were processed using ImageJ software 
(Schneider et al., 2012).  
2.6 Rat epicardial culture and assays 
Cultured rat epicardial cells described in (Wada et al.) (2003) were used to study 
epicardial cell signalling. Cells were grown in DMEM (Life Technologies Ltd, 41965-039) 
supplemented with 10% FBS, penicillin (100 I.U./ml) and streptomycin (100 µg/ml) 
antibiotics (Sigma, P0781). For signalling studies, cells were seeded to 6-well culture 
plates, when ~70% confluent, cells were infected with adenovirus encoding rat short 
hairpin RNA (shRNA) targeting either NRP1 or a control Scrambled (Scr), as described in  
Pellet-Many et al. (2015) at a multiple of infection (MOI) of 100. After 48 hours infection, 
cells were serum-starved for 16 hours and stimulated with various growth factors at 
concentrations and durations specified in Figure legends, before harvesting for western 
blotting analysis. 
2.7  Western blotting 
 Principle of Western blotting 
Western blotting is a common semi-quantitative molecular biology technique used to 
compare regulation of protein synthesis, post-translational modification and signalling. 
Homogenates of tissues or lysates of cells are made by mechanical disruption in a 
detergent containing solution to break cell membranes and release intracellular and 
membrane proteins. The proteins are often denatured to their primary peptide 
structure using a reducing agent (most commonly used Tris(2-carboxyethyl)phosphine 
(TCEP), dithiothreitol (DTT) or beta-mercaptoethanol) to remove disulphide bonds and 
heated to break secondary structures such as hydrogen bonds within the protein. The 
 125 
 
samples are coated with an anionic surfactant, sodium dodecyl sulfate (SDS), to ensure 
all proteins have a negative charge. The proteins are then loaded into a polyacrylamide 
gel immersed in a conductive solution. An electric current is run through the gel and 
induces the migration of the negatively charged proteins towards the anode; this 
process is referred to as polyacrylamide gel electrophoresis (PAGE). The gel consists of 
a series of cross-linked polymers forming nanopores. The pore size is determined by the 
acrylamide concentration, a higher acryclamide concentration increases crosslinks and 
narrows the pore size. The denatured proteins are able to migrate through the polymer 
crosslinks, however, the rate of migration is restricted by their size (larger proteins 
migrate at a slower rate than the smaller proteins) and therefore gel electrophoresis 
allows the separation of proteins by size. A protein ladder with proteins of a known 
molecular weight and labelled with coloured dye is run alongside the samples as a 
reference, allowing the direct visualisation of the achieved separation. 
Once the gel has run, proteins are transferred to a nitrocellulose or polyvinylidene 
fluoride membrane (PDVF), polymers with adhesive properties for proteins. This 
transfer process is also mediated in a chamber with an electric field driving the 
movement of proteins out of the gel and onto the membrane. The protein lysates are 
now immobilised on a stable platform that can be used to detect proteins of interest. 
A primary antibody is used to target the protein or post-translational modification of 
interest, and a secondary antibody conjugated to horseradish peroxidase (HRP) enzyme 
is used to detect the primary antibody. In the final chemiluminescence reaction, HRP 
catalyses the oxidation of luminol into a reagent that emits light upon decay. Western 
blotting is often described as a semi-quantitative technique, with the amount of protein 
originally present in the lysate proportional to the amount of peroxidase enzyme bound 
to protein on the membrane, and so, to the amount of light generated and area and 
intensity of the band present on the film. 
 Lysate preparation 
Proteins were extracted from samples with lysis buffer (consisting of RIPA buffer (Sigma, 
R0278) supplemented with proteinase inhibitor (cOmplete mini, Roche Diagnostics, 
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04693116001), phosphatase inhibitor cocktails (Sigma-Aldrich, P5726 and P2850), and 
TCEP (sigma, 646547)). For Western blot loading, lysates were mixed with 4x lithium 
dodecyl sulfate (LDS) loading buffer (Novex, NP0007) and radioimmunoprecipitation 
assay (RIPA) buffer, to obtain loading samples of equal volumes and protein content. All 
samples were then boiled for 3 minutes at 98oC to denature proteins before loading to 
gels.  
2.7.2.1  Zebrafish ventricles 
Zebrafish heart lysates were obtained by homogenizing 3 ventricles of identical 
treatment and time points in 100 µl lysis buffer in 1.4 mm ceramic bead-containing tubes 
(Peqlab precellys, 91-PCS-CK14) using a MINILYS benchtop homogeniser (Bertin 
instruments). Homogenates were collected in 1.5 ml Eppendorf tubes and cellular debris 
separated by centrifugation at maximum speed for 15 minutes at 4oC in a tabletop 
centrifuge. Homogenate supernatants were transferred to fresh Eppendorf tubes for 
subsequent use in Western blotting experiments. Protein lysate concentrations were 
determined with DC™ protein assay (Bio-Rad) to calculate the homogenate volume 
required for 1 g protein/µl of sample to load to gels.  
2.7.2.2  Rat epicardial cells 
Following serum free or growth factor treatment of adenovirus infected rat epicardial 
cells, 6-well plates containing cells were placed on ice and washed with cold PBS twice, 
then all residual medium and liquid removed from wells with vacuum aspirator. 50 µl 
lysis buffer was added to each well and cell contents obtained by mechanical disruption 
with cell scrapper. The lysates were transferred to 1.5 ml Eppendorf tubes and vortexed. 
Cellular debris was pelleted from samples by centrifugation at maximum speed for 15 
minutes at 4oC in a tabletop centrifuge and the liquid homogenate was transferred to a 
fresh Eppendorf tube and stored at -20oC before subsequent use in Western blotting 
experiments. 
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2.7.2.3 Zebrafish in vitro epicardial cells  
Culture medium was removed from wells, explants were rinsed twice with ice cold PBS 
and residual liquid and medium were removed via vacuum aspiration. 15 µl lysis buffer 
was placed directly onto heart tissue (to ensure coverage of epicardial outgrowth), then 
the heart tissue promptly removed to allow lysis of underlying epicardial cell outgrowth. 
Lysates were collected to 1.5 ml Eppendorf tubes and care taken to minimise fibrin gel 
incorporation to lysate extract. Lysate from 3 outgrowths were pooled for cryoinjured 
samples and from 4 outgrowths for sham operated hearts. Cellular debris was pelleted 
from samples by centrifugation at maximum speed for 15 minutes at 4oC in a tabletop 
centrifuge and the liquid homogenate was transferred to a fresh Eppendorf tube and 
stored at -20oC before subsequent use in Western blotting experiments. 
 Western protocol 
Lysate protein contents were separated by electrophoresis on 4–12% Bis-Tris 
polyacrylamide gels (novex, NP0322) in NuPage® SDS MOPS running buffer solution 
(Thermo scientific, NP0001) at 200 volts for 1 hour. Proteins were then electro-
transferred onto PVDF membranes (Thermo scientific, LC2002) at 35 volts for 1.5 hours 
at room temperature in 20% methanol/2X transfer buffer (Thermo scientific, NP0006). 
Protein loading and transfer quality were briefly assessed with Ponceau S staining of the 
membrane. The membranes were then rinsed several times with distilled water and 
blocked with 5% (w/v) non-fat dried milk in PBS containing 0.1% Tween®20 (PBST) for 
one hour at room temperature on rocking platform. Membranes were incubated with 
primary antibodies (for details see Table 8) diluted 1000 fold in 5% milk/PBST overnight 
at 4oC. The following day, membranes were further washed five times in PBST, incubated 
for 1 hour with horseradish peroxidase-labelled secondary antibody (Alfa diagnostic, 
20320) in 5% milk/PBST (1 in 10,000 dilution) at room temperature for one hour. 
Proteins were detected using the ECL Plus™ Western blotting detection system and 
Hyperfilm ECL (both Amersham Biosciences). 
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2.8 Statistics 
All statistical analysis were calculated with graphpad prism 6 software; using either 
unpaired t-test, one-way anova or two-way anova (specified in the Figure legend). Data 
compared for statistical analysis with a P value <0.05 were considered statistically 
significant. Graphs present data as means ± standard error of the mean (S.E.M), unless 
stated otherwise and were generated using graphpad prism 6.  
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Table 8 Western blotting antibody details 
Antibody name Structure labelled Catalogue number Company  raised in 
Neuropilin-1 antibody 
[EPR3113] 
Neuropilin-1 (c-terminus) GTX62190 Genetex rabbit 
Mouse/Rat Neuropilin-2 
Antibody 
Neuropilin-2 AF567 R&D systems™ Biotechne® goat 
Mouse/Rat Neuropilin-1 
Antibody 
Neuropilin-1 AF566 R&D systems™ Biotechne® goat 
GAPDH Antibody (V-18) 
Glyceraldehyde 3-
phosphate 
dehydrogenase 
sc-20357 Santa Cruz goat 
Phospho-p44/42 MAPK 
(Erk1/2) (Thr202/Tyr204) 
Phosphorylated 
threonine 202 and 
tyrosine 204 Erk 
9101L Cell Signalling Technology rabbit 
p44/42 MAPK (Erk1/2) Erk 9102L Cell Signalling Technology rabbit 
HSP90 Heat shock protein 90 4874 Cell Signalling Technology rabbit 
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3 Results chapter 1: Characterisation of neuropilin 
expression in adult zebrafish heart regeneration 
Zebrafish have the remarkable capacity to regenerate their heart following injury and 
several investigations have set out to uncover the cellular and molecular mechanisms 
orchestrating this repair process. It has been reported that Pdgf, Tgfβ, Vegf and Fgf 
signalling are essential for zebrafish heart regeneration (Chablais and Jazwinska, 2012; 
Kim et al., 2010; Lepilina et al., 2006; Marin-Juez et al., 2016). These cytokines are also 
known ligands for neuropilin (NRP) co-receptors (Glinka and Prud'homme, 2008; Pellet-
Many et al., 2011; West et al., 2005); however, the role of Nrps in zebrafish heart 
regeneration has not been characterised. Therefore, I investigated the expression, 
localisation and function of Nrps in zebrafish heart regeneration. This first chapter 
focuses on the gene expression of nrp isoforms in the cryoinjured zebrafish heart. 
3.1 Establishing the zebrafish cryoinjury model of cardiac damage  
In order to investigate the zebrafish heart regenerative response, I used the cryoinjury 
(also known as cryocauterisation) model of cardiac damage to induce cardiac damage. 
A platinum-filament probe cooled in liquid nitrogen is pressed against the ventricle apex, 
resulting in thermal shock-induced injury and the death of cardiac tissue in the targeted 
region (Figure 22B). I analysed the reproducibility of the cryoinjury model in my hands 
using transgenic zebrafish that encode green fluorescent protein (GFP) downstream of 
the cardiac myosin light chain 2 (cmlc2) promoter (termed Tg(cmlc2:GFP)). In this model, 
viable cardiomyocytes express GFP (Figure 22C and D). Within 24 hours of surgery, the 
green fluorescence is significantly reduced in cryoinjured hearts (see Figure 22E), 
implicatining that cryoinjury results in loss of cardiomyocyte viability as a result of 
thermal shock.   
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Figure 22 Loss of GFP signal in the cryoinjury lesion 
Whole-mount images at 1 day post sham surgery (A and C) and 1 day post 
cryoinjury (dpci) (B and D) in transgenic cardiac myosin light chain 2:GFP 
(Tg(cmlc2:GFP)) zebrafish hearts, expressing GFP under a cardiomyocyte-
specific promoter. Panels A and B show bright field images of the 
corresponding fluorescence images below (C and D). The cryoinjured 
region is highlighted by black and white dotted lines and arrows (B and C). 
Note the swollen and discoloured appearance (B) and absence of green 
fluorescence (D) in the injured ventricle region. A – atrium, ba – bulbus 
arteriosus, V – ventricle, IA – Injured area, scale bars 1 mm. (E) 
Quantification of GFP signal expressed as a percentage (%) of total 
ventricle area in sham (white bar) and cryoinjured (black bar) hearts n = 5 
hearts p = 0.0008 (***p<0.005). 
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 Heart regeneration after cryoinjury 
The zebrafish heart is reported to fully regenerate up to 20% of the ventricle within 60 
days after resection (Poss et al., 2002), or up to 25% ventricular mass after cryoinjury 
within 130 days (Gonzalez-Rosa and Mercader, 2012). There are numerous cryoinjury 
procedures reported using probes of varying size and material (Chablais et al., 2011; 
Gonzalez-Rosa and Mercader, 2012; Schnabel et al., 2011) introducing potential 
variability of injuries between reports. I set out to analyse the size and consistency of 
ventricular damage induced by the surgeries I performed and align injury features to 
those previously characterised in the literature.  
 Regeneration 
Using Acid Fuchsin Orange G (AFOG) staining of serial sections to quantify injury size of 
hearts at 1 day post cryoinjury (dpci) (Figure 23B and H), I was able to achieve 25.2% 
(±5.6 % S.E.M., n = 5)  ventricular damage. This is a similar injury size to the level of 
damage achieved by the authors who established and taught us the technique 
(Gonzalez-Rosa and Mercader, 2012). I monitored the regeneration of zebrafish hearts 
after injury and compared them with previously published data. The size of the injury 
(as a percentage of total ventricle size) was reduced at each consecutive time point, 
confirming regeneration occurs in the surgeries I perform. However, in my hands, from 
30 dpci, regeneration slowed down and reached a plateau with an injury size 
comparable to the 60 dpci time-point (1.8% ± 0.98% S.E.M., n = 4 versus 2.2% ± 0.88% 
S.E.M., n = 8).  
Moreover, a small scar deposit was observed in half of all 60 dpci samples, suggesting 
complete regeneration was not consistently accomplished in all surgeries within 60 
days. This is consistent with other reports that state almost complete regeneration is 
achieved by 130 dpci using this approach (Gonzalez-Rosa and Mercader, 2012; Manuel 
Gonzalez-Rosa et al., 2011).  
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 Scar composition 
The composition of the injury was comparable to that reported by Manuel Gonzalez-
Rosa  and colleagues (2011). At 1 dpci, compared to the sham-operated hearts (Figure 
23A), the injured region appears inflamed, and contains blood clots, yet retains 
myocardial trabeculations (Figure 23B). Also consistent with this study, fibrosis is 
evident in the injured area by 3 dpci and the epicardial layer is thickened (Figure 23C). I 
also analysed the outline and composition of the injury at 7 dpci. The expanded 
epicardial layer covering the entire injured region remains at 7 dpci, encasing more 
extensive fibrotic deposits consisting of a fibrin cap (red staining) with a collagen core 
(blue staining) on the luminal region of the injury (Figure 23D). At 14 dpci the scar 
composition is largely similar to that observed at 7 dpci, however, the overall injury is 
smaller due to the regenerating compact layer of cardiomyocytes infiltrating the outer 
boundaries of the injury (Figure 23E). At 30 dpci, as the heart undergoes the later stages 
of regeneration, healthier tissue is evident and the compact layer of the myocardium 
has fully recovered (Figure 23F), an observation noted by Gonzalez-Rosa et. al. (2011). 
Notably, the fibrin deposits of the scar tissue are cleared, leaving collagen deposits 
within the trabeculated region of the ventricle where damage was sustained (Figure 
23F). When complete regeneration is evident, no blue collagen staining remains in the 
ventricle (Figure 23G). The progress of heart regeneration and the reduction in the 
damaged ventricular area are shown in Figure 23H.   
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Figure 23 Recovery of Zebrafish heart following cryoinjury regeneration 
(A-G) Acid Fuchsin Orange G (AFOG) staining of adult zebrafish hearts 1, 3, 7, 14, 30 and 60 dpci and sham surgery. Healthy cardiac 
muscle tissue is stained orange/brown, cytosolic components orange/yellow, fibrin red and collagen blue. The injury appears as an 
interruption of consistent orange colouring within the ventricle and demarcated with black dotted lines. The initial injury size 
observed at 1 day post cryoinjury (dpci) can be seen to reduce in area by 60dpci confirming regeneration occurring. A – Atrium, ba 
– bulbus arteriosus, V – ventricle, scale bar 250 µm (H) Quantification of total area of the ventricle damaged is presented as 
percentage ventricle damaged ± SEM (n ≥ 4) 
 135 
 
 RT-qPCR quality measurements 
3.1.4.1 RNA integrity 
To assess the regulation of nrp isoform gene expression in the regenerating zebrafish 
heart following cryoinjury, absolute RT-qPCR was performed. Total RNA was extracted 
and its purity was initially assessed using a NanoDrop spectrophotometer (Thermo 
Fisher Scientific) by confirmation of a clear 260nm peak (the wavelength at which nucleic 
acids display maximal absorbance). To assure minimal reagent contamination the 
260/280 ratio was also assessed and purity indicated by a value above 1.6. 24 randomly 
selected RNA samples were assessed for integrity by qStandard Ltd. using a Bioanalyzer 
(Agilent). The 18S and 28S ribosomal RNA bands are clearly visible and defined on the 
BA
Figure 24 RNA integrity of zebrafish ventricle RNA extracts 
(A) Zebrafish ventricle total RNA extract electrophoresis recorded on Agilent Bioanalyzer 
of 12 randomly selected samples. Two bands of high intensities are visible and represent 
the populations of 18S and 28S ribosomal RNA. Greater resolution of these bands indicates 
high quality RNA, while degradation of RNA would appear as smears between lower 
resolution bands. Fainter bands lower in the gel represent tRNA and mRNA. (B) 
Electropherogram depicting size distribution ([S]) of total RNA band fluorescent intensities 
([FU]). Below the graph are listed the software-generated calculations of RNA 
concentration and RNA integrity (RIN). Values are calculated combining 18S and 28S 
fluorescent intensity peaks with the software algorithm. RIN values range from 1 to 10; 
the spectrum identifies 1 as degraded RNA and 10 as completely intact RNA. An RIN value 
of 7 or above is deemed suitable RNA for subsequent analytical techniques. n = 24 
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Bioanalyzer electrophoresis gel (Figure 24A). Bioanalyzer software algorithms calculate 
RNA integrity (RIN), incorporating the ratio of ribosomal electrophoresis band thickness 
and provides a number between 1 and 10; where 1 represents completely degraded 
RNA and 10 represents RNA of the highest integrity. Samples randomly selected for 
analysis produced RIN values of ≥9 (Figure 24B). High RIN values (>7) confirm minimal 
degradation during the RNA extraction procedure, and therefore, give confidence that 
the following reverse transcription to produce cDNA for the RT-qPCR will have complete 
and representative levels of mRNA templates. 
3.1.4.2 Absolute qPCR standard curve and melt curve analysis 
The majority of qPCRs were performed by qStandard Ltd., which provide additional 
analytical measurements to ensure qPCR efficiency and reliability. Standard curve 
amplification efficiency and melt curve analysis were systematically assessed for each 
qPCR. Standards containing known copy numbers of the gene of interest are run 
A B
Figure 25 Absolute qPCR post-run analysis 
Representative graphs of absolute qPCR quality measurements assessed following 
the final qPCR cycle. (A) Absolute qPCR standard curve applied to quantify copy 
numbers from samples. The standard curve is required to have an R2 value of 0.95 
or more for reliability. (B) Melt curve analysis is run at the end of the qPCR to ensure 
single peak observed to confirm one target gene PCR product amplified in the 
reaction.     
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simultaneously alongside the samples, allowing the extrapolation of the number of 
copies in the unknown samples. The target gene PCR amplification efficiency can be 
assessed via analysis of the standard curve. PCR at 100% efficiency amplifies all available 
DNA templates in each cycle and results in standard curve samples reaching the qPCR 
threshold at regular intervals. Placing standard curve values at a logarithmic scale 
against cycle threshold (ct) values generates a standard curve with a correlation 
coefficient (R2) of 1.0 in 100% efficient qPCRs. The R2 value ranges from 0 to 1, low R2 
indicates poor PCR efficiency and introduces inaccuracies in measurements, therefore 
only qPCRs with standard curves demonstrating 95% efficiency and R2≥0.95 were 
considered suitable for subsequent quantification. Figure 25A presents a software-
generated standard curve (blue dots) following the completion of a R2≥0.95 qPCR run; 
sample ct values are plotted along the standard curve (red dots) to decipher gene of 
interest copy numbers in the reaction.  
Melt curve analysis was performed for each qPCR reaction; it assesses the fluorescence 
of dissociating double stranded DNA amplicons at increasing temperatures. The 
fluorophore SYBR®green, used in the qPCR reaction, only fluoresces when bound to 
double stranded DNA (dsDNA). At a specific temperature (Tm), half of the amplicons will 
dissociate into single DNA strands and cause a sharp drop in fluorescence (or a peak if a 
graph of the negative first derivative of the melting-curve is plotted). For each gene, 
specific amplification of the single product was assessed. If another non-relevant 
product was generated, this would be evident via analysis of the melting curve (an 
additional peak would be visible). A single peak in the melt curve indicates a single PCR 
product in the reaction, confirming specific amplification of the target gene as 
demonstrated in Figure 25B.  
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Figure 26. nrp gene expression in the cryoinjured zebrafish heart 
Absolute Real Time quantitative PCR (RT-qPCR) analysis of nrp1a (A), nrp1b (B), nrp2a 
(C) and nrp2b (D) at 1, 3, 7, 14, 30 and 60 days following cryoinjury (black bars) or sham 
surgery (white bars). Basal expression of neuropilin isoforms were assessed with 
uninjured hearts (grey bars). Data are represented as means of normalised copy 
numbers per reaction ± S.E.M (error bars) **p<0.01, ***p<0.005, ****p<0.001. n = 4-5 
with each n being a pool of 5 ventricles of identical treatment and time point. 
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 RT- qPCR results 
3.1.5.1 Neuropilin isoforms are upregulated after cryoinjury 
Gene expression of all four neuropilin isoforms (nrp1a, nrp1b, nrp2a, and nrp2b) was 
evaluated in sham and cryoinjured ventricles at 1, 3, 7, 14, 30 and 60 days following 
sham operation and following surgery and cryoinjury, using absolute qPCR. Five 
zebrafish ventricles for each specific treatment and time point following sham operation 
and post-surgery were pooled, homogenised and used for RNA extraction and absolute 
RT-qPCR in order to generate a single value (i.e. n = 1). Gene expression in sham samples 
was assessed with one-way anova (Figure 26, white bars) and no significant changes in 
expression of any of the nrp isoforms was observed at different times following sham-
operation. Also, the levels of nrp isoform expression between sham-operated and non-
injured hearts (Figure 26, grey bars) were similar, indicating minimal effect of sham 
operation on nrp expression. Therefore, any change in gene expression following 
cryoinjury can very likely be attributed specifically to the cryoinjury of the heart.  
A significant increase in expression of nrp1a, nrp1b and nrp2a was observed at earlier 
time points (1 and 3 dpci) following cryoinjury (Figure 26A-C). Nrp1a was significantly 
upregulated at 1 and 3 days post cryoinjury (dpci) (p<0.005 and p<0.001, respectively) 
by approximately 2-fold in comparison to the corresponding sham samples (Figure 26A). 
At 7 and 14 dpci nrp1a gene expression remained elevated but this increase was not 
statistically significant when compared with sham control samples. Finally, by 30 and 60 
dpci, nrp1a expression returned to baseline levels. A significant increase in nrp1b was 
observed at 3 dpci only. It was also upregulated at 1 dpci but statistical significance was 
not reached at this time-point compared with sham control samples. Nrp1b expression 
returned to basal levels from 7 dpci onwards. Nrp2a was expressed at lower levels in the 
heart compared to other neuropilin isoforms, but was significantly upregulated at 1 and 
3 dpci and returned to basal levels from 7 dpci onwards. Out of the four neuropilin 
isoforms, nrp2b had the highest level of basal expression, with baseline copy numbers 
at least ten times higher than for the other three nrp isoforms (Figure 26, grey bars), 
However, nrp2b expression was not significantly altered following cryoinjury compared 
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with sham samples, though some trend to an increase was observed at 3dpci (Figure 
26D).  
3.1.5.2 Vascular genes regulated following cryoinjury 
I investigated the regulation of genes controlling angiogenesis because the 
revascularization of the injured area is an important process required for zebrafish heart 
regeneration (Kim et al., 2010; Marin-Juez et al., 2016). Moreover, neuropilins have an 
essential role in angiogenesis in mammals and zebrafish (Soker et al., 1998; Bovenkamp 
et al., 2004). Furthermore, NRP1 mediates VEGF and PDGF-BB signalling in endothelial 
cells and smooth muscle cells, respectively (Pellet-Many et al., 2011; Soker et al., 1998; 
Wang et al., 2003).  
I could not detect a significant change in expression of Vascular endothelial growth 
factor Aa (vegfaa) after cryoinjury, though a non-significant increase was observed at 
1dpci (Figure 27A). Vegfaa is the zebrafish orthologue of VEGF-A, the most potent 
angiogenic cytokine in mammals. Vascular endothelial growth factor C (vegfc), which 
plays a major role in lymphangiogenesis, was significantly upregulated at 1 and 3 dpci 
(both p<0.001) and returned to  baseline levels thereafter, consistent with previous 
publications (Lien et al., 2006) (Figure 27B). It should be noted that vegfc is expressed in 
the 100s of copy numbers at baseline (grey bar Figure 27B), whereas vegfaa basal 
expression is 10 times higher (Figure 27A).  
The regulation of VEGF receptors (VEGFRs), flt1 (orthologue of Human Vegfr1) and kdrl 
(orthologue of Human Vegfr2), was also assessed. No significant difference between 
sham and corresponding cryoinjury samples was observed for either gene at any time 
point post-cryoinjury (Figure 27C and D).  
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Figure 27 Regulation of genes associated with angiogenesis in the cryoinjured zebrafish 
heart  
Absolute Real Time quantitative PCR (RT-qPCR) of vegfaa (A), vegfc (B), flt1(C), kdrl (D) and 
bcar1 (E) at 1, 3, 7, 14, 30 and 60 days following cryoinjury (black bars) or sham surgery (white 
bars). Basal expression of genes was assessed with uninjured hearts (grey bars). Data are 
represented as means of normalised copy numbers per reaction ± S.E.M (error bars), *p<0.05, 
**p<0.01, ***p<0.005, ****p<0.001. Each n is a pool of 5 ventricles of identical treatment 
and time point. 
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p130Cas is an intracellular adaptor molecule encoded by the bcar1 gene implicated in 
angiogenesis, cytoskeletal dynamics and cell movement and its tyrosine 
phosphorylation is mediated via NRP1 in mammalian endothelial and vascular smooth 
muscle cells (Barrett et al., 2013; Evans et al., 2011; Pellet-Many et al., 2011). Although 
there was a trend for an increase in expression at 3, 7, and 14 dpci, these changes did 
not reach statistical significance (Figure 27E).  
3.1.5.3 Expression of other  cytokine ligands for Nrps and their receptors 
Several cytokines are ligands for Nrps, and have previously been reported to be 
upregulated in response to zebrafish heart injury and implicated in heart regeneration, 
including pdgfab and receptor, pdgfr and transforming growth factor beta (TGFβ). 
Therefore, I investigated the regulation of these genes both to confirm previous data, 
and to identify potential ligands and co-receptors for Nrps in the regenerating heart. 
Kim et al 2010 reported the upregulation of platelet derived growth factor receptor beta 
(pdgfr) but not platelet derived growth factor receptor alpha (pdgfrα) expression 
during zebrafish heart regeneration. Similarly, my results showed that pdgfrα displayed 
only a small non-significant trend for increased expression at 3 dpci (Figure 28A), 
whereas pdgfrβ expression was significantly upregulated at 1, 3 and 7 dpci and returned 
to baseline levels thereafter (Figure 28A). Using inhibitors of PDGFRs, Kim et al also 
reported platelet derived growth factor (PDGF) signalling as an essential regulator of 
epicardial response and revascularisation during zebrafish heart regeneration. My 
results also show a significant upregulation of pdgfab (encoding the PDGFab cytokine) 
at 3 and 7 dpci (Figure 28C), further supporting a role of PDGF signalling in cardiac 
regeneration. These data support the observations by Kim et al., implicating a role for 
PDGF in the early stages of zebrafish cardiac regeneration. 
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A study by Chablais and Jaźwińska (2012) identified transforming growth factor beta 
(TGFβ) signalling as an essential regulator of zebrafish heart regeneration, coordinating 
the inflammatory and fibrotic response and stimulating cardiomyocyte proliferation.  
My qPCR data shows that indeed, tgf1a expression is upregulated early at 3 dpci, 
during the inflammatory phase of repair (Figure 28D), in accordance with their findings. 
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Figure 28 Gene expression of growth factors and receptors previously reported in the 
regenerating zebrafish heart 
Absolute Real Time quantitative PCR (RT-qPCR) analysis of pdgfrα (A), pdgfrβ (B), 
pdgfab(C), tgf1a (D) 1, 3, 7, 14, 30 and 60 days following cryoinjury (black bars) or sham 
surgery (white bars). Basal expression of genes was assessed with uninjured hearts (grey 
bars). Data are represented as means of normalised copy numbers per reaction ± S.E.M 
(error bars), *p<0.05, **p<0.01, ***p<0.005, ****p<0.001, n = 4-5 with each n being a 
pool of 5 ventricles of identical treatment and time point. 
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 In situ hybridisation 
The vast majority of the ventricle mass is composed of cardiomyocytes, however other 
cell types, such as epicardial cells, fibroblasts, endothelial cells and leucocytes, are 
important for the cardiac regenerative response. All these cells express neuropilins, but 
represent relatively, a smaller proportion of the cells in the heart.  qPCR provides 
information of quantitative mRNA expression, but cannot determine which specific cells 
or regions of the heart are expressing the target genes. Moreover, variation in gene 
expression by a smaller cell population may not be detected by qPCR of the entire 
ventricle due to variation from sample to sample. One way to selectively investigate 
gene expression of one particular cell type is to purify a specific cell population via 
fluorescence-activated cell sorting; alternatively, laser capture could isolate specific 
sample regions, for example healthy myocardium versus injured area. I addressed 
differential tissue gene expression using in situ hybridisation, which provides qualitative 
information on mRNA localisation and in which, staining intensities correlate to relative 
expression levels. However, variations in probe efficiencies and development times 
need to be considered when interpreting expression intensities. 
3.2 Positive control riboprobe whole mount in situ hybridisation 
Initially, I optimised the in situ protocol using whole-mount TraNac zebrafish embryos 
to confirm the procedure results in the specific binding of probes to target mRNA. I was 
provided with probes of genes reported to be activated in the epicardial and endocardial 
response to injury (T-box18 (tbx18), retinaldehyde dehydrogenase 2 (raldh2), and Wilm’s 
tumor 1b (wt1b)) as well as the cardiomyocyte marker cmlc2 (kindly donated by Nadia 
Mercader, CNIC, Madrid). All four probes displayed staining patterns in agreement with 
the published literature (Figure 29), confirming the validity and stringency of my 
protocol.  
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3.3 Neuropilin isoform probe validation using whole mount in situ 
hybridisation 
Riboprobes of approximately 1000 bases were designed to specifically bind the mRNA 
of each nrp isoform. Additionally, I synthesized sense probes (negative controls) which 
were tested alongside the anti-sense whole mount in situ hybridisation reaction (Figure 
30 A-D). As expected, sense probes failed to develop a signal, confirming their inability 
to bind mRNA and their use as reliable negative controls.  
Figure 29 Positive riboprobe validation 
In situ hybridisation of TraNac zebrafish 48 hours post fertilisation (hpf) with positive control 
anti-sense riboprobes (kindly donated by Nadia Mercader, CNIC, Madrid) targeted to; (A) cmlc2, 
(B) tbx18, (C) raldh2, (D) wt1b mRNA. Gene detection is comparable to that of the literature (E-
H) and confirms riboprobe reliability and protocol parameter stringency.  v- ventricle a-atrium 
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I confirmed anti-sense riboprobe specificity using whole mount in situ hybridisation in 
TraNac zebrafish embryos 48 hours post fertilisation and compared the expression 
patterns with previous reports. I observed staining consistent with expression patterns 
characterised by Bovenkamp et al. (2004). All neuropilins are expressed in the brain 
(Figure 30E-L); yet additional differential staining is evident between isoforms 
suggesting different targets were bound by the different probes (Figure 30E-L). Nrp1a is 
also expressed in the fin buds, otic vesicles and hind brain in the developing embryo 
(Figure 30E), whereas nrp1b is expressed in the dorsal aorta and intersegmental vessels 
(Figure 30F), nrp2a expression is observed in the hind brain and fin buds (Figure 30G), 
and nrp2b expression is largely restricted to the brain and hind brain (Figure 30H) as well 
Figure 30 nrp riboprobe specificity validation 
In situ hybridisation of TraNac transgenic zebrafish embryos 48 hours post fertilisation 
(hpf) with nrp sense riboprobes (A-D) and nrp anti-sense riboprobes (E-H). A comparison 
to expression patterns reported by Bovenkamp et al (2004) in 48 hpf zebrafish embryos 
are presented in panels I-L (images obtained from (Bovenkamp et al., 2004). n ≥ 8 
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as the heart (Martyn and Schulte-Merker, 2004). These data confirm differential 
expression of neuropilins in the embryo and verify riboprobe specificity.  
3.4 Positive riboprobe localisation in the injured adult zebrafish heart  
I tested the specificity of my positive control riboprobes in paraffin-embedded adult 
zebrafish heart sections. The positive probes are specific for cardiomyocytes (cmlc2), 
activated epicardium (wt1b:GFP) and endocardium (raldh2 and tbx18), and  were used  
to inform on localisation and potential cells types expressing the neuropilin isoforms. 
The cmlc2 riboprobe clearly identifies viable cardiomyocytes, whereas the injured area 
(Figure 31A, A’), the bulbus arteriosus and active proliferating epicardium (Figure 31A’) 
remain devoid of staining. In contrast, raldh2 and tbx18 are developmental genes 
expressed by the endocardium and epicardium in the injured heart (Kikuchi et al., 
2011b; van Wijk et al., 2012). Accordingly, both genes were localised to the epicardium 
and endocardium surrounding the injured region in my samples (Figure 31B,B’,C,C’). 
Wt1b is a marker specific for epicardial cells undergoing EMT. The embryonic wt1b gene 
is re-expressed by a subpopulation of epicardial cells following cardiac damage. wt1b in 
situ staining can be observed near the injury and is indeed restricted to the epicardium 
(Figure 31D.D’).   
3.5 Neuropilin mRNA localisation in the injured zebrafish heart 
Neuropilins are required for cardiogenesis in mice and zebrafish (Bovenkamp et al., 
2004; Kitsukawa et al., 1995; Rossignol et al., 2000), however the localisation of 
neuropilin mRNA in the adult zebrafish heart has not been characterised in either basal 
conditions or during the regenerative response. After cardiac damage, embryonic genes 
are re-expressed by the zebrafish adult heart; therefore, I decided to investigate if 
neuropilins were similarly re-expressed in the heart following patterns observed 
throughout cardiogenesis. I investigated the localisation of the four zebrafish neuropilin 
isoforms in the injured adult heart using in situ hybridisation. 
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Figure 31. Positive riboprobe mRNA detection in the injured zebrafish heart 
Adult zebrafish heart section were probed with positive control anti-sense riboprobes (kindly 
donated by Nadia Mercader, CNIC, Madrid) targeted to; (A) cmlc2, (B) raldh2, (C) tbx18, and (D) 
wt1b, previously characterised in zebrafish heart regeneration. A - atrium, ba - bulbus arteriosus, 
IA - injured area, HM - healthy myocardium, epi - epicardium, endo – endocardium black 
scale bar 500 µm, red scale bar 100 µm n ≥ 3 
 149 
 
 Localisation of nrp1a mRNA in the regenerating zebrafish heart 
Under basal control conditions neuropilin isoforms demonstrate differential expression 
(Figure 32A, F, K and P): nrp1a was expressed modestly within cardiomyocytes and a 
stronger signal was seen at the epicardium (Figure 32A). At 1 dpci, all neuropilin isoforms 
were detected within injured hearts and displayed a similar expression pattern (Figure 
32B, G, L and Q) at the interface between the healthy myocardium and the injured area 
as well as in the epicardium surrounding the injury. Additionally, at 1dpci, nrp1a 
continued to show modest and diffuse expression within the entire myocardium, though 
the intensity of myocardial staining was fainter than at the injury interface. In contrast 
to the 1 dpci time-point, nrp1a expression was predominantly epicardial at 3 and 14 dpci 
(Figure 32B-D). Expression of nrp1a at the interface between injury and healthy 
myocardium persisted, however, at 3dpci, but was undetectable at 14dpci (Figure 32D).  
At 60 dpci, when almost complete regeneration should have occurred, nrp1a mRNA 
expression was very weak (Figure 32E). These data broadly support the qPCR 
measurements that revealed a significant upregulation of nrp1a at 1 and 3 dpci, with 
elevated yet not significant expression persisting until 14 dpci. The markedly 
upregulated expression of nrp1a localised at the epicardium and injury border at 1 and 
3 dpci observed with in situ hybridisation, correlates with the significant gene 
upregulation detected in qPCR at those time points.  Although expression of nrp1a 
mRNA is still evident at 14dpci, because its expression pattern is more restricted to the 
epicardium, this discrete upregulation was not sufficient to result in a significant 
increase of nrp1a gene expression in qPCR using the whole ventricle. 
 Localisation of nrp1b mRNA in the regenerating zebrafish heart 
Following sham surgery, no evident expression of nrp1b mRNA was detected in the adult 
zebrafish heart (Figure 32F). At 1 dpci, nrp1b mRNA is markedly expressed at the 
interface between healthy myocardium and the injured area as well as at the epicardium 
(Figure 32G). This nrp1b mRNA distribution stays similar up to 14 dpci (Figure 32H and 
I). Nevertheless, in contrast to nrp1a and its striking epicardial expression, nrp1b mRNA 
is predominantly expressed at the injury/healthy myocardium interface throughout the 
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regenerative process. Finally, expression of nrp1b in the regenerated heart diminishes 
to basal levels by 60 dpci (Figure 32J) in accordance with the qPCR results.  
 Localisation of nrp2a mRNA in the regenerating zebrafish heart 
According to our absolute qPCR results, nrp2a is the isoform with the lowest expression 
and, indeed, little nrp2a can be seen in the zebrafish heart following sham surgery 
(Figure 32K). However, acute nrp2a mRNA upregulation is observed at 1 and 3 dpci, and 
correlates with qPCR measurements. At 1 dpci, similarly to all neuropilin isoforms, nrp2a 
mRNA is discretely localised at the epicardium and injury/healthy myocardium interface 
(Figure 32L). nrp2a expression redistributes and exclusively localises to the epicardium 
by 3 dpci (Figure 32M). Consistent with qPCR data, nrp2a mRNA detection in the injured 
heart by in situ hybridisation is low at 14 dpci and 60 dpci (Figure 32N and O). The data 
suggests an acute role for nrp2a in the injury-activated epicardium and injury border.   
 Localisation of nrp2b mRNA in the regenerating zebrafish heart 
Sham-operated hearts modestly express nrp2b in the entire ventricle (Figure 32P).  At 1 
dpci, nrp2b mRNA remains localised to the healthy myocardium additionally to 
upregulated expression at the injury/healthy myocardium border and by the epicardium 
surrounding the injury (Figure 32Q). Expression of nrp2b becomes predominantly 
localised within the injured region at 3 dpci (Figure 32R) and from 14 dpci onwards, 
nrp2b expression is comparable to expression in sham-operated hearts (Figure 32S and 
T).  
Nrp2a and nrp2b display differential expression patterns in the regenerating heart; 
while nrp2b expression is evident within the injury, nrp2a is dominantly expressed by 
the epicardium, implicating differential roles for both isoforms in the cardiac response 
to damage.  
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Figure 32 nrp mRNA localisation in the cryoinjured zebrafish heart 
The localisation of nrp isoforms in the adult zebrafish heart were assessed after sham surgery (A,F,K,P) or 1, 3, 14, 
60 days post cryoinjury (dpci) using in situ hybridization. Gene detection is observed as a dark blue stain within 
the section. IA = injured area, HM= healthy myocardium, epi = epicardium, arrows indicate gene expression within 
the epicardium or healthy myocardium to injury border. Scale bar 250µm.  n ≥ 3 
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3.6 Discussion 
 Technique validation 
In this chapter I have demonstrated that I can generate reproducible cryoinjuries in the 
zebrafish heart. The damage causes loss of cardiomyocyte viability in a localised region 
of the ventricle. AFOG staining reveals inflammation 1 day following the injury and scar 
formation of similar composition as reported in the literature during the fibrotic 
response. By 60 dpci almost all injuries are resolved. In some isolated cases, a hint of 
scar was still observed by that time-point. Therefore, I have demonstrated that I am able 
to reproduce the cryoinjury model and trigger similar physiological responses as 
reported in the literature. I am also confident that I can injure the heart in a reliable and 
reproducible manner, affecting around 25-30% of the ventricle with limited variability. 
 Nrp mRNA regulation 
The neuropilin isoforms, nrp1a, nrp1b, and nrp2a were all upregulated during the first 
three days following the injury. Upregulation suggest they all play a positive role in the 
zebrafish heart, and in situ hybridisation showed that these isoforms all localised at the 
injury interface and epicardium in the injured area 1 day following the injury. Despite 
these similar expression patterns, differential expression between these isoforms was 
noted, suggesting distinct roles may be played by different neuropilins in different cell 
types. Thus, nrp1a and nrp2a show marked expression in the activated epicardium, 
whereas expression of nrp1b was predominantly expressed at the injury interface.  
Localisation of the nrp isoform mRNA was persistent at regions of the heart at the injury 
border up to 14 dpci, further supporting a positive role of neuropilins in cells required 
for the regenerative response.  
According to my qPCR analysis, in basal conditions, nrp2b is the most highly expressed 
isoform in the zebrafish heart. This suggest that it might play a role in cardiac 
homeostasis.  Cardiac nrp2b is regulated in the heart during embryogenesis (Bovenkamp 
et al., 2004), but, according to the qPCR data presented here, nrp2b expression was not 
altered after injury. Nevertheless, in situ hybridisation indicated that nrp2b increased 
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markedly at the injury/healthy myocardium interface and within the injured region, 
supporting the conclusion that heart injury induces nrp2b upregulation, and suggesting 
that nrp2b also plays a role in the regenerative response of the zebrafish heart. 
The data in this chapter indicate possibly different roles for neuropilins in the 
regenerating zebrafish heart with evidence suggesting epicardial cells that are activated 
after injury and cells at the injury border require neuropilin activity. A study carried out 
by Chablais and Jaźwińska (2012) categorises the first 4 days following cryoinjury as the 
inflammatory phase, in which TGFβ signalling co-ordinates leucocyte infiltration and 
clearance of cellular debris. It is therefore possible that the increase in neuropilin 
isoform gene expression within this timeframe is associated with a role for neuropilins 
in the inflammatory response after cardiac damage. The expression of nrp isoforms at 
the border regions of the injured area might be consistent with such a notion, since this 
is where inflammatory cells infiltrate the injury. 
qPCR data does not provide information of specific heart area changes in gene 
expression; additionally, use of the entire ventricle for RNA isolation may mask smaller 
populations of expression changes. 
The validity of the conclusion that nrp isoforms are upregulated in response to cryoinjury 
is reinforced by the demonstration in the same mRNA samples of upregulation of several 
other cytokines and their receptors, shown previously to be upregulated early (1-7 dpci) 
after zebrafish heart injury, including pdgfab (encoding the PDGFab cytokine), platelet 
derived growth factor receptor beta (encoding its receptor, Pdgfr), and tgf1a (2012). 
My results also showed significant upregulation of vegfc 1-3 dpci, consistent with 
previous findings (Lien et al., 2006). Therefore, these findings also implicate a role for 
VEGFC in heart regeneration likely linked to lymphatic vessel development in the acute 
response to injury. Stimulating lymphangiogenesis to aid recovery from myocardial 
infarction and has been identified as a therapeutic approach (Henri et al., 2016; Klotz et 
al., 2015). Furthermore, it is known that NRP2 is required for lymphatic vessel 
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development and is a receptor for VEGF-C  (Xu et al., 2010), and, indeed, in my model, 
vegfc follows a similar expression pattern to that of nrp2a (Figure 26C).  
The analysis of gene expression suggests that vegfaa and its receptor kdr, the 
major endothelial ligand and co-receptor for Nrp1, respectively, are not upregulated 
during zebrafish heart regeneration. However, the use of the entire ventricle for qPCR 
may mask small and localised changes of vegfaa expression within the growing vessel in 
the injured area. Both vegfaa and kdr were expressed in high copy numbers, and thus 
localised changes in expression may be masked by performing qPCR of the entire 
ventricle rather than using a specific population of cells, obtained, for example, by 
fluorescence-activated cell sorting of endocardial and endothelial cells using a 
Tg(fli1a:GFP) fish. Marin-Juez et al very recently reported transient upregulation of 
Vegfaa at 1 dpci after cardiac cryoinjury, with a return to baseline expression by 3 dpci, 
and showed an important role for Vegfaa in inducing rapid revascularisation of the 
injured heart (Marin-Juez et al 2016). Though we found no significant upregulation of 
vegfaa following zebrafish cardiac cryoinjury concomitatnt with changes in Nrp1 
expression, our data did show a trend towards increased Vegfaa expression at 1 dpci, 
very similar to the findings of Marin-Juez and co-workers. Thus our findings could be 
consistent with a role for Nrp1 in mediating Vegfaa-driven angiogenesis in the 
regenerating heart. However, recent findings indicate that the role of NRP1 in 
mammalian developmental angiogenesis may be largely independent of VEGF, since 
NRP1 mutations which prevent VEGF-A binding impair post-natal angiogenesis but are 
compatible with normal embryonic development (Fantin et al., 2014). Establishing 
whether Nrp1 mediates angiogenesis in the regenerating heart through binding of Vegfa 
and heterocomplex formation between Nrp1 and Kdr will require studies of binding-
deficient Nrp1a mutants.  
Because of time and money constraints, I did not attempt to reproduce data 
related to FGF expression, which has also been implicated in the zebrafish regenerative 
response to cardiac damage and is also a neuropilin ligand. Although I investigated vegfc 
gene expression, regulation of its receptor, flt4, was not assessed. Due to the zebrafish 
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genome duplication, many genes have two ohnologs. I have investigated the expression 
of all neuropilin orthologs, but did not do so for all genes studied here. For example, 
PDGFAb has a distinct expression profile after cardiac damage in contrast to PDGFAa. 
Further investigation of expression of components of these signalling pathways, 
including in situ hybridisation analysis, would be of interest in future work. 
 qPCR 
The absolute RT-qPCR was carried out by external services that use automated systems 
to minimise human errors, all measurements were run in duplicates, non-template 
controls and reverse transcriptase controls were included for every gene and the 
reactions. Often, RNA quality is not addressed in studies before cDNA synthesis and 
qPCR; however, degraded RNA can result in unreliable, inconsistent and misleading 
qPCR measurements. I selected randomly 24 RNA samples (approximately 30% of the 
total samples used to make cDNA in the qPCR) and evaluated their integrity, and all 
samples had RIN values above 9. Because the method used to extract RNA, the tissue 
and subsequent RNA storage were identical, I assumed that all of the remaining RNA 
samples were of similar integrity. It would have been preferable (but prohibitively 
costly) to assess the integrity of all RNA samples extracted to ensure high quality of all 
samples before qPCR quantification.   
The absolute qPCR method informs of mRNA expression as copy number (rather than 
relative levels of expression), extrapolated from the reaction’s cDNA content. The cDNA 
is generated from a reverse transcription reaction, which is of limited efficiency (only 
around 30% of RNA is reverse transcribed into cDNA) introducing a potential source of 
experimental variability. Gene variation in the high copy number values range are most 
likely to be less variable and translate as physiologically relevant in vivo. In general, qPCR 
cannot inform on whether the mRNA turnover is rapid or to what extent the mRNA is 
translated into protein, nevertheless, there is a correlation between mRNA expression 
and protein level and therefore physiological function associated to changes in gene 
expression.  
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The RNA isolated for the qPCR was derived from the entire ventricle. Cardiomyocytes 
dominate the cell population represented in the ventricle; however other smaller cell 
populations have important roles in the regenerative response. Therefore, expression 
pattern changes after cardiac damage in these smaller cell populations could be masked 
by gene expression by cardiomyocytes. One way to circumvent this, would be to isolate 
specific cell populations from transgenic fish with specific myocardial, epi- or 
endocardial marker by FACS and isolating RNA from purified cell type.  
 In situ hybridisation 
I established the in situ hybridisation protocol to observe gene expression patterns in 
zebrafish heart samples. I confirmed that my technique leads to specific detection of 
target genes. Sense riboprobes did not stain samples, confirming them as a reliable 
negative control. Anti-sense neuropilins riboprobes stained whole mount embryos 
identically to previous reports in the literature confirming their specificity (Bovenkamp 
et al., 2004; Martyn and Schulte-Merker, 2004; Yu et al., 2004). The technique was then 
applied to paraffin embedded heart sections, positive control probes confirmed 
epicardial and endocardial activation, loss of cardiomyocyte viability and technique 
stringency. 
I was provided some control riboprobes from another institute (CMIC, Madrid) and had 
limited information about the target sequence and I was unable to generate the 
negative control sense probes. However, these probes were used in previous 
publications which provided confidence about their specificity and therefore the sense 
probe would have been unlikely to provide any contradictory data. 
The anti-sense riboprobes have different interaction properties depending on the target 
mRNA, therefore the staining intensity observed using the different riboprobes could be 
due to riboprobe binding efficiency, rather than expression levels. The nrp isoform 
staining intensities are not directly comparable between one another due to these 
variations in riboprobe affinity to target, only the localisation of probe detection can be 
compared. 
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Some sham hearts show slight expression of nrps whereas the expression is no longer 
evident at 60 dpci. This could be due to low grade activation of the epicardium during 
sham surgery which does not affect qPCR values on the entire ventricle, but that can be 
detected by ISH. Indeed, it has been reported that there is an epicardial and 
cardiomyocyte activation after even moderate disruption (de Preux Charles et al., 
2016b; Itou et al., 2014). Alternatively, this might reflect downregulation of nrp 
expression at 60dpci relative to control expression. 
 Summary 
In this chapter I have demonstrated: 
 In my hands, the zebrafish cryoinjury procedure results in 25% ventricle damage and 
cardiomyocyte viability loss in the targeted region. 
 Half of all cryoinjured fish fully replenish cardiac tissue and resolve the fibrotic scar 
within 60 days following cryoinjury.  
 nrp1a, nrp1b and nrp2a are significantly upregulated within the first three days of 
cardiac damage, corresponding to the inflammatory phase. 
 nrp2b is the dominant neuropilin isoform in the zebrafish heart.  
 All nrp isoforms mRNA is localised at the injury healthy myocardium border at 1 day post 
cryoinjury (dpci). Thereafter, nrps display differential localisation patterns in the injured 
heart until 14 dpci and return to basal expression levels by 60 dpci.  
 This chapter provides compelling evidence for positive yet distinct roles for neuropilins 
during the early cardiac regenerative response.  
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4 Results chapter 2: Cell-type specific nrp expression in 
zebrafish heart regeneration  
In the previous chapter, I demonstrated that 3 of the 4 zebrafish nrp isoforms are acutely 
upregulated at 1 and 3 days post cryoinjury (dpci). Although nrp2b does not seem to be 
upregulated, it is the most highly expressed nrp isoform in the zebrafish ventricle. In situ 
hybridisation (ISH) revealed that all nrp isoforms are strongly localised to the injury-
healthy myocardium border at 1 dpci, after which, the isoforms are differentially 
localised: 
- nrp1a expression persists in the epicardium until 14 dpci,  
- nrp1b is concentrated predominantly at the injury/healthy myocardium interface, 
-  nrp2a is distinctly epicardial at 3 dpci,  
-  nrp2b is localised within the injury and expressed throughout the myocardium. 
qPCR and ISH strongly suggest positive but distinct roles for the neuropilins in 
regenerating zebrafish hearts. In this chapter, I set out to characterise Nrp protein 
expression and identify Nrp-positive cell types after cardiac damage in the zebrafish.  
4.1 NRP C-terminus sequence similarities 
The zebrafish has recently emerged as a popular vertebrate model to study 
cardiovascular diseases. However, commercially available reagents, notably antibodies, 
that specifically detect zebrafish antigens are limited. Evolutionary genome duplication 
in the zebrafish has resulted in frequent occurrence of duplicate genes, adding further 
complexity, and making it more difficult to distinguish between the protein products of 
ohnologs (a gene duplicate originating from whole genome duplication) of high levels of 
sequence similarity.  
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Figure 33 NRP C-terminus amino acid sequence alignment 
A) Alignment of human NRP1 against zebrafish (zf) Nrp1a and Nrp1b c-terminus protein 
sequence. (B) Alignment of human NRP2 against zebrafish (zf) Nrp2a and Nrp2b C-
terminus protein sequence. Amino acids that differ between the two species but 
classified in the same amino acid group are highlighted in purple. Amino acid differences 
of unrelated molecular properties are highlighted in yellow. (C) Percentage protein 
sequence homology between zebrafish (zf) and human NRP isoforms c-termini were 
calculated using ClustalW sequence alignment software. 
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The NRP 42-44 amino acid C-terminal cytoplasmic domain is highly conserved between 
species and provides a suitable epitope for some commercially available and validated 
NRP antibodies. I compared the amino acid sequences of zebrafish and human NRP C-
termini to predict if human-targeting NRP antibodies were likely to cross-react with 
zebrafish Nrps (Figure 33). Immunogen sequence similarities of 80% and above are 
considered to have high cross-reactivity potential. 
Human NRP1 has 86% and 72.7% C-terminus sequence similarity to zebrafish Nrp1a and 
Nrp1b (respectively) (Figure 33A,C), suggesting that Nrp1a will likely cross react more 
with antibodies targeted to the C-terminus of human NRP1 than will Nrp1b. The 
zebrafish Nrp2 ohnologs have an 82.9% C-terminal amino acid sequence similarity to 
human NRP2 (Figure 33B,C), also supporting the potential cross-reactivity of human 
NRP2 C-terminal targeting antibodies to Nrp2a and Nrp2b. Amino acids that differ 
between the two species often belong to the same amino acid group and therefore 
possess similar chemical properties, suggesting they may retain comparable molecular 
interactions with antibodies (purple highlight Figure 33A and B). 
The zebrafish Nrp1a and Nrp1b ohnologs share 74% C-terminus protein sequence 
similarity, whereas Nrp2a and Nrp2b C-termini have complete sequence homology. This 
is consistent with a previous hypothesis suggesting that the genetic drift that has 
occurred between nrp1a and nrp1b genes is greater than between the nrp2 ohnologs 
(Bovenkamp et al., 2004). Therefore, with respect to antibody specificity, both Nrp2a 
and Nrp2b isoforms are predicted to indistinguishably bind to antibodies that detect 
zebrafish Nrp2 C-termini. However, antibodies targeting the C-terminus of human NRP1 
may not cross-react with both zebrafish Nrp1a and Nrp1b. Moreover, because the Nrp1 
ohnologs have different molecular weights, they can be identified as two separate bands 
when performing immunoblotting.  
There is approximately 50% amino acid sequence similarity between the zebrafish Nrp1 
ohnologs and the human NRP2 C-terminus, a similar level of C-terminus sequence 
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similarity as observed between human NRP1 and human NRP2 (52.7%). This strongly 
suggests that antibodies targeting the C-terminus of human NRP1 will unlikely cross 
react with the C-terminus of zebrafish Nrp2.   
Taken together, the C-terminus amino acid sequence suggests there is a high probability 
that antibodies targeted to human NRP C-terminus will cross react with the 
corresponding zebrafish Nrp ortholog, although it is uncertain which ohnolog will be 
identified and whether the antibodies will non-specifically cross-react with other 
zebrafish proteins. 
4.2 Neuropilin protein regulation in the cryoinjured heart 
qPCR and ISH data confirm regulation of nrp mRNA expression in response to cardiac 
damage. mRNA regulation is correlated to changes in protein levels. I observed an acute 
(1 and 3 dpci) upregulation of nrp mRNA in the zebrafish ventricle after cryoinjury and 
thus predicted this would be accompanied by protein upregulation at similar time 
points. To assess this hypothesis, immunoblotting was performed to measure protein 
expression in lysates from sham-operated versus cryoinjured ventricle at 1,3,7,14 and 
30 days post-surgery.  
GAPDH was used as a loading control for Western Blot as absolute qPCR measurements 
indicate stable GADPH expression regardless of treatment or time point (data not 
shown), suggesting that GADPH protein expression should also remain consistent. 
Several antibodies targeted to human, rat and mouse NRP1 or NRP2 C-termini were 
tested for cross-reactivity with zebrafish NRPs. Unfortunately, NRP2 immunoblots 
showed that NRP2 antibodies bound off-target zebrafish proteins (data not shown). 
However, a NRP1 antibody was validated and could identify two separate bands at 
approximately 130 and 150kDa (Figure 34A). These Nrp1 zebrafish doublets have been 
previously described by Bovenkamp et al., who identified the lower molecular weight 
band as Nrp1a at 125kDa, and the upper higher molecular weight band as Nrp1b at 
145kDa. The variation in Nrp1a and Nrp1b molecular weight, despite protein sequence 
similarity, are probably due to differential post-translational modifications.  Indeed, 
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work from others in our group has shown that NRP1 was post-translationally modified 
by the addition of a single glycosaminoglycan residue (either chondroitin sulphate or 
heparin sulphate) at Serine 612 in vascular smooth muscle cells and some cancer cells 
(Frankel et al., 2008; Pellet-Many et al., 2011). 
Nrp1a and Nrp1b band intensities were measured with the ImageJ software and 
normalised to GAPDH. Quantification of the two Nrp1 bands as a doublet shows a trend 
for NRP1 upregulation at 3 and 7 dpci and reaches statistical significance at 14 dpci in 
comparison to sham control samples (Figure 34B). The quantification of the single Nrp1a 
band hints a trend towards upregulation at 7 dpci, which is not concomitant with the 
timing from my qPCR results showing an earlier upregulation of nrp1a at 1 and 3 dpci 
(Figure 34C). Since translation occurs after transcription, the increased mRNA levels 
most likely precede the increase in protein expression. The quantification of the single 
Nrp1b band shows a significant upregulation at 3 dpci and reverts to basal sham 
expression levels thereafter (Figure 34D). Nrp1 upregulation during the first 14 days 
following cardiac damage is observed both at mRNA levels (qPCR analysis) and protein 
levels (immunoblotting) and thus support a role for Nrp1 role in the early regenerative 
process, concomitant with the inflammatory and reparative phases. At later stages of 
the regenerative response (30 dpci and later), neuropilin levels return to basal level 
expression, similar to sham expression in qPCR, ISH and Western blot analysis, indicating 
that neuropilin’s role is more important during the immediate and early cardiac 
responses following injury.  
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Figure 34 Nrp1 is regulated in cryoinjured zebrafish ventricle 
(A) Adult zebrafish ventricle lysates were obtained 1, 3, 7, 14 and 30 days following sham surgery (Sh) or cryoinjury (CI). 
Lysates were immunoblotted for Nrp1 and Gapdh. Nrp1a bands are visible at approximately 130kDa and Nrp1b at 
approximately 150 kDa (indicated). Quantification of (B) both bands, (C) Nrp1a lower band and (D) Nrp1b upper band 1, 3, 7, 
14 and 30 days following sham surgery (white bars) or cryoinjury (black bars). Data are represented as means of band 
intensities normalised to GAPDH ± S.E.M (error bars) *p<0.05; n = 4 with each n being a pool of 3 ventricles of identical 
treatment and time point. 
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4.3 Neuropilin localisation in the regenerating zebrafish heart 
ISH identified increased nrp expression localised at regions in close proximity to the 
injured area. Therefore, I further investigated which cell types express Nrps in the 
regenerating heart with immunofluorescent staining.   
 Nrp1 expression in the endocardium  
Immunofluorescence staining detecting Nrp1 and GFP in sham-operated Tg(fli1a:GFP) 
zebrafish heart sections was performed (Figure 35A). The endocardium lining the 
ventricle lumen and coronary vessel endothelial cells in the myocardium compact layer 
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Figure 35 Nrp1 colocalises with endothelium and endocardium in sham-operated hearts 
AFOG staining (A and A’) and immunofluorescence images (B-D and B’-D’) of Tg(fli1a:GFP) 
zebrafish heart 7 days post sham surgery. AFOG staining confirms the integrity of cardiac 
tissue and gives reference to the heart structure. fli1a expression by endothelium and 
endocardium are immunolabeled with GFP‐targeted antibody (red) (B and B’) and Nrp1 
expressing regions stained green (C and C’). Overlay of the two colours are displayed with 
DAPI nuclei staining (D and D’). White arrows indicate areas of colocalisation. Dotted boxes 
highlight magnified region. v – ventricle ba- bulbus arteriosus n = 5 
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express fli1a (Figure 35B and B’). Co-staining reveals Nrp1 in the epicardium and 
endocardium (Figure 35C,C’), and Nrp1 colocalisation with GFP-positive coronary vessel 
endothelial cells within the compact myocardial layer and the endocardium of sham-
operated Tg(fli1a:GFP) hearts (Figure 35D,D’). Nrp1 expression that does not colocalise 
with GFP positive cells is seen in the quiescent epicardial monolayer (Figure 35D’). 
Sections from cryoinjured Tg(fli1a:GFP) zebrafish hearts 1 dpci were evaluated with 
immunofluorescence, and corresponding serial sections were stained with AFOG (Figure 
36A,A’) or used for nrp1a and nrp1b anti-sense riboprobe ISH (Figure 36B,B’,C,C’). GFP 
immunofluorescence shows endothelial cells forming new vessels at the edges of the 
injured area (Figure 36D, D’). Nrp1 colocalises with all GFP positive cells of neovessels in 
the injured area suggesting a role for Nrps in early revascularisation after cardiac 
damage (Figure 36E, E’, F, F’). ISH staining of nrp1a and nrp1b shows  mRNA expression 
localised within the injury that could in part reflect Nrp1-positive neovasculature (Figure 
36B’ and C’). 
An endocardial GFP signal was largely absent within the injury core, however viable Nrp1 
endocardium remained evident in healthy cardiac tissue at the injury border (white 
arrows) (Figure 36F’). Furthermore, NRP1 immunofluorescent staining demonstrated 
greater intensity within the viable endocardium at the injury interface (Figure 36E’) and 
recapitulates ISH staining patterns that implicate a neuropilin expression increase at the 
injury border at 1 dpci (Figure 36B’ and C’). The data suggest a requirement for Nrp1 
upregulation in the endocardium proximal to the injury immediately after imsult. The 
endocardium responds within hours of cardiac damage essential for the regenerative 
process (Kikuchi et al., 2011b). 
Nrp1 expression patterns in the injured region were analysed at 7 dpci in Tg(fli1a:GFP) 
zebrafish (Figure 37A, A’). At this point of the regeneration process, revascularisation 
continues to develop in the injured area (Lepilina et al., 2006; Marin-Juez et al., 2016) 
and endocardium activation is established (Kikuchi et al., 2011b). At 7 dpci, endocardial 
cells proximal to the injury exhibited a rounded morphology (Figure 37B,B’) consistent 
with previous characterisation of the endocardial endoMT in response to ventricular 
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amputation (Kikuchi et al., 2011b). Moreover, a subpopulation of endocardial cells were 
observed protruding into the injured area (Figure 37B’ white arrows); these cells are 
likely being activated to form new vessels or provide new endocardium for the 
regenerating cardiac tissue by transiently transdifferentiating into mesenchymal cells. A 
higher vessel density stemming from the epicardium was evident (Figure 37B and B’), 
but the core of the injury remained largely avascular. 
Similar to my observations at 1 dpci, Nrp1 colocalised with all Tg(fli1a:GFP) positive 
cardiac tissue (Figure 37D,D’) at 7dpci, suggesting Nrp1 is required for endocardial 
activation and vessel development in the regenerating zebrafish heart from 1 dpci to 7 
dpci.  Additional staining of Nrp1 was observed at the periphery of the injury in a layer 
of GFP negative cells. The location and appearance of these latter cells suggested that 
they might be of epicardial origin since the epicardium has been previously reported to 
undergo extensive proliferation in response to injury (Kikuchi et al., 2011b; Manuel 
Gonzalez-Rosa et al., 2012; Schnabel et al., 2011). This indicates that distinct cell types 
other than endocardial and endothelial cells express Nrp1 in the regenerating zebrafish 
heart. 
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Figure 36 Nrp1 is expressed by the activated endocardium and neovasculature during 
the inflammatory phase (1 dpci) 
AFOG staining (A and A’), in situ hybridisation (B, B’, C and C’) and immunofluorescence 
of Tg(fli1a:GFP) zebrafish heart 1 day post cryoinjury (dpci). AFOG staining gives 
reference to the heart structure and cryoinjury-location (A and A’). nrp1a and nrp1b 
mRNA detection are observed as dark blue staining (B, B’, C and C’), black arrows indicate 
mRNA expression within the injury and at the injury/healthy myocardium border. GFP 
positive cells highlight fli1a expression by viable endothelium and endocardium labelled 
in red (D and D’) and Nrp1 expressing regions of the heart in green (E and E’). Overlay of 
the two colours are displayed with DAPI nuclear staining (F and F’). White arrows 
indicate areas of colocalisation. Dotted boxes highlight magnified regions. Dashed lines 
define injury interface. v – ventricle ba- bulbus arteriosus IA- injured area HM- healthy 
myocardium n = 3 
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Figure 37 Nrp1 is expressed by the activated endocardium and neovasculature during 
reparative phase 
AFOG staining (A and A’) and immunofluorescence images (B-D and B’-D’) of Tg(fli1a:GFP) 
zebrafish heart 7 days post cryoinjury (dpci). AFOG staining identifies cardiac damage and 
gives reference to the heart structure and cryoinjury-location. fli1a expression by 
endothelium and endocardium are immunolabeled with anti-GFP antibody (red) (B and B’) 
and Nrp1 expressing cells are shown in green (C and C’). Overlay of the two colours are 
displayed with DAPI nuclei staining (D and D’). White arrows indicate areas of colocalisation. 
Dotted boxes highlight magnified region. v – ventricle ba- bulbus arteriosus A – atrium n = 3 
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I studied the expression and colocalisation of Nrp1 using an additional transgenic 
endothelial/endocardial reporter line that express the mCherry fluorophore 
downstream of the kdrl (kinase insert domain receptor like, also known as vascular 
endothelial growth factor receptor-2) promoter in 7 dpci hearts (Figure 38A,A’). ISH was 
used in serial sections to localise nrp1a mRNA expression in these hearts (Figure 
38,B’,C,C’). mCherry positive cells were almost exclusively endocardial with limited 
expression by coronary vessels in the compact myocardium, indicating a lack of coronary 
vessel Kdrl expression in the zebrafish heart (Figure 38D’). Nrp1 colocalised with 
mCherry positive cells throughout the entire endocardium including the endocardium 
within the regenerating injured area (Figure 38E,E’,F ,F’) consistent with the 
Tg(fli1a:GFP)/Nrp1 co-staining data presented (Figure 37). This further strengthens the 
hypothesis that Nrp1 is constitutively expressed by the endocardium in zebrafish hearts 
and that Nrp1 could act as a potential endocardial marker. 
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Figure 38 Nrp1 expression in the endocardium at 7dpci 
AFOG staining (A and A’), in situ hybridisation (ISH) (B, B’, C and C’) and immunofluorescence 
(D-F) of Tg(kdrl:mCherry) zebrafish heart 7 days post cryoinjury (dpci). AFOG staining gives 
reference to cryoinjury location and tissue composition (A and A’). ISH of nrp1a anti-sense 
riboprobe (nrp1a AS) (B and B’) and negative control sense (nrp1a S) riboprobe (C and C’), 
signal is observed as a dark blue stain within the section (B and B’), black arrows indicate 
mRNA expression. kdrl expression by viable endocardium is immunolabeled with anti-
mCherry antibody (red) (D and D’) and Nrp1 expressing cells are labelled green (E and E’). 
Overlays of the two colours are displayed with DAPI nuclei staining (F and F’). White arrows 
indicate areas of colocalisation of Nrp1 and kdrl-mCherry. Dotted boxes highlight magnified 
regions. v – ventricle ba- bulbus arteriosus a – atrium IA- injured area n = 3 
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 Nrp1 expression in the myocardium 
The expression of Nrp1 by cardiomyocytes was assessed in sham-operated and 
cryoinjured adult zebrafish heart sections. Cardiomyocytes form the majority of the 
ventricle mass. Viable cardiomyocytes were identified with tropomyosin and injury 
location was identified where damaged tissue lacked tropomyosin expression (Figure 
39C’ and D’). In sham-operated hearts, Nrp1 expression by cardiomyocytes was limited; 
tropomyosin and Nrp1 staining patterns were mostly discrete from one another (Figure 
40B). Nrp1 expressing cells predominantly encase the trabeculated folds of the 
myocardium, distinctive pattern of the endocardium, or form a monolayer at the 
periphery of the heart, characteristic of the epicardium (Figure 39B).  
Following cardiac damage Nrp1 expression remained largely absent from 
cardiomyocytes; however Nrp1 expression was evident in cardiomyocytes protruding 
into the injured area from the sub-epicardial layer (Figure 39D white arrows). 
 Nrp1 expression in the epicardium 
The epicardium is a quiescent mesothelial cell monolayer that surrounds the entire 
heart. In the zebrafish, after cardiac damage, the epicardium becomes activated, 
proliferates and re-expresses developmental genes such as tbx18, raldh2 and wt1b. The 
activated epicardium produces cytokines to mediate epicardial epithelial-to- 
mesenchymal transition (EMT) (Kikuchi et al.., 2011; Manuel Gonzalez-Rosa et al.., 2012; 
Masters and Riley, 2014), orchestrate inflammatory cell recruitment (Han et al.., 2014) 
and induces cardiomyocyte proliferation (Chen et al.., 2002; Kikuchi et al.., 2011; 
Lepilina et al.., 2006). The mammalian epicardium responds to cardiac damage (Zhou et 
al.., 2011) and, during development expresses NRP1 (Partanen et al.., 1999). In my 
studies, neuropilin ISH and immunofluorescence staining patterns strongly indicated 
epicardial expression of Nrp1. Thus, localisation of neuropilin to the epicardium was 
assessed in sham-operated and cryoinjured Tg(wt1b:GFP) zebrafish, in which GFP 
expression is controlled by the promoter for the activated epicardial marker, wilms’ 
tumor 1b (wt1b). In sham-operated control Tg(wt1b:GFP) zebrafish heart sections 
(Figure 40A,D), GFP signal was absent consistent with the conclusion that epicardial cells 
 172 
 
were not in an activated state, and confirming the quiescence of the epicardium 
following sham surgeries (Figure 40B’ and C’). In sham-operated hearts, as seen 
previously, Nrp1 was expressed by the endocardium and also expressed within the 
quiescent and discrete epicardial monolayer (Figure 40C). 7 days after cardiac damage, 
there was a robust increase in the number of wt1b:GFP positive cells within the 
activated epicardium, all of which also expressed Nrp1. Activated wt1b:GFP positive 
epicardial cells expressed Nrp1 after cardiac damage (Figure 40F white arrows). A subset 
of activated epicardial cells expressed wt1b:GFP (Figure 40F and Figure 41H), as 
previously described (Peralta et al., 2014). 
The localisation of Nrp1 immunofluorescent staining within the epicardium was 
compared to nrp1a AS ISH staining (Figure 41). nrp1 mRNA was strongly expressed at 
the border between healthy myocardium and the injured tissue as well as having an 
epicardial-wide expression at 3 dpci (Figure 41E), similar to protein expression of Nrp1 
observed using immunofluorescent staining at 3 dpci (Figure 41C,G). 
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Figure 39 NRP1 is expressed in migrating sub-epicardial cardiomyocytes 
Immunofluorescence of adult zebrafish heart sections 7 days post sham surgery (A and B) 
or 7 days post cryoinjury (C and D). Viable cardiomyocytes were labelled with tropomyosin 
and stained in red (A’-D’). Nrp1 expressing cells are shown in green (A’’-D’’). Overlay of the 
two colours are displayed with DAPI nuclei staining (A-D). Dotted boxes highlight magnified 
region. White arrows indicate colocalisation. v – ventricle ba- bulbus arteriosus IA – injured 
area HM- healthy myocardium n = 3 
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Figure 40 Nrp1 is expressed by epicardial cells 
AFOG staining (A and D) and Immunofluorescence (B, C, E and F) of Tg(wt1b:GFP) zebrafish 
heart sections 7 days post sham surgery (A-C) or 7 days post cryoinjury (D-F). AFOG staining 
confirms cryoinjury location and gives reference to tissue composition (healthy myocardium 
- orange, collagen – blue, fibrin – red, basement membrane – pale blue). Injury-activated 
epicardial cells were detected with anti-GFP antibody (B’, C’, E’ and F’) (red). Nrp1 expressing 
cells are shown in green (B’’, C’’, E’’ and F’’). Overlay of the two colours are displayed with 
DAPI nuclei staining (B, C, E and F). Dotted boxes highlight magnified region. Dotted lines 
indicate injury border with healthy myocardium. White arrows indicate areas of 
colocalisation. v – ventricle ba- bulbus arteriosus IA – injured area epi= epicardium n = 4 
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Figure 41 nrp1a mRNA localisation is reflected by Nrp1 immunostaining 
AFOG staining (A), nrp1a in situ hybridisation (ISH) (E) and immunofluorescence (B-D and F-
H) of Tg(wt1b:GFP) zebrafish heart 3 days post cryoinjury (dpci). AFOG staining show tissue 
composition and gives reference to injury location (healthy myocardium - orange, collagen – 
blue, fibrin – red, basement membrane – pale blue) (A). ISH of nrp1a anti-sense riboprobe 
(nrp1a AS) shows localisation of nrp1a mRNA observed as a dark blue stain within the section 
(E). Activated epicardium that express wt1b are GFP positive and are probed with anti-GFP 
antibody (red) (B and F) and Nrp1 expressing regions of the heart in green (C and G). Overlay 
of the two colours are displayed with DAPI nuclei staining (E and E’). White arrows indicate 
colocalisation. Dotted boxes highlight magnified regions. v – ventricle ba- bulbus arteriosus A 
- atrium IA- injured area epi- epicardium AS n = 3 
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 Nrp2 expression in the endocardium 
The ISH and qPCR data showed that nrp2a was upregulated at 1 and 3 dpci and that 
mRNA expression was initially localised to the injury borders and epicardium before re-
distributing to become almost exclusively epicardial at 3 dpci. Whereas nrp2b is 
expressed widely by the myocardium, by cells within the injury, at the injury border and 
in the epicardium.  
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Figure 42 Nrp2 expression is limited in endothelium and endocardium 
Immunofluorescence of Tg(flia:GFP) adult zebrafish heart 1 day post cryoinjury (dpci). 
fli1a expression by viable endothelium and endocardium are immunolabeled with anti-
GFP antibody (green) (A’’ and B’’) and Nrp2 expressing regions of the heart in red (A’ and 
B’). Overlay of the two colours are displayed with DAPI nuclei staining (A and B). Dotted 
box highlights magnified region. Dotted line indicates healthy myocardium and injury 
border.IA- injured area HM- healthy myocardium n = 2 
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  NRP2 antibody cross-reactivity to zebrafish  
Nrp2 was difficult to confirm by Western Blot; several NRP2 bands were detected using 
Western blot analysis, thus making antibody specificity questionable. I next tried to 
assess Nrp2 expression using immunofluorescence in Tg(fli1a:GFP) zebrafish heart 
sections. Nrp2 and GFP staining were segregated from each other 1 dpci at the injury 
border (Figure 42B). These data suggest that the ISH staining pattern of nrp2a and nrp2b 
observed at 1 dpci at the border between the injured tissue and the healthy myocardium 
was not due to endocardial expression was instead due to another cell type; 
alternatively, there may be a lag between nrp2 mRNA expression and NRP2 protein 
translation in the endocardium. 
 
 Nrp2 in inflammatory cells after cardiac damage 
At 1 dpci the zebrafish heart is in the inflammatory phase of the regeneration process, 
during which innate immune cells infiltrate the injury and clear cellular debris (Chablais 
and Jazwinska, 2012; Evans et al., 2013). Inflammatory cells express NRP2 (Aung et al., 
2016; Ji et al., 2009; Stepanova et al., 2007), therefore Nrp2 expression by leucocytes 
was investigated using immunofluorescence. The leucocyte marker, L-plastin, was used 
to identify inflammatory cells. Under basal sham-operated conditions, detection of L-
plastin is sparse in the zebrafish heart (Figure 43B). At 1 dpci, a cluster of L-plastin 
positive leucocytes was observed in and around the injured area (Figure 43C’ and D’). 
Co-staining of Nrp2 with L-plastin revealed that, at 1 and 7 dpci, these infiltrating 
leucocytes were Nrp2 positive (Figure 43D and F).  
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Figure 43 Inflammatory cells express Nrp2  
Sham-operated (A and B), 1 dpci (day post cryoinjury) (C and D) and 7 dpci (E and F) adult 
zebrafish hearts sections stained with immunofluorescence. Samples were immunolabeled 
for leukocyte marker L-plastin (red) (A’ - F’) and Nrp2 (green) (A’’ – F’’). Overlay of the two 
colours are displayed with DAPI nuclei staining (A - F). Dotted box highlights magnified region. 
White arrows indicate colocalisation.v – ventricle, ba- bulbus arteriosus, epi – epicardium, IA- 
injured area HM- healthy myocardium n = 2-3 
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 Nrp2 expression in cardiomyocytes  
Nrp2 immunofluorescence staining was observed throughout the entire myocardium. 
This is aligned with the qPCR data that suggests that nrp2b is highly expressed in the 
zebrafish heart under basal conditions and the ISH data showing nrp2b mRNA expression 
in the entire ventricle. Therefore, I investigated Nrp2 expression by cardiomyocytes. 
Immunofluorescent staining confirmed expression of Nrp2 by healthy cardiomyocytes 
in both basal sham conditions and after cryoinjury (Figure 44). Additionally, Nrp2 
colocalised with proliferating and migrating cardiomyocytes that infiltrate and replenish 
the injured area (Figure 44F). Nrp2 immunofluorescent staining also appeared to detect 
sarcomeric structures in cardiomyocytes (Figure 44F). This suggests a homeostatic role 
for Nrp2 in healthy cardiomyocytes consistent with previous studies that report Nrp2 
being expressed in the developing zebrafish heart (Bovenkamp et al., 2004). The bulk of 
Nrp2 protein expression by cardiomyocytes detected via immunofluorescence is likely 
due to nrp2b expression, given the ISH and qPCR data.   
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Figure 44 Nrp2 localises with viable cardiomyocytes 
AFOG staining (A and D) and immunofluorescence (B, C, E and F) of wild type zebrafish hearts 
7 days post sham surgery (A-C) and 7 dpci (days post cryoinjury) (D-F). AFOG staining shows 
tissue composition and gives reference to injury location (healthy myocardium - orange, 
collagen – blue, fibrin – red, basement membrane – pale blue). Immunofluorescence show 
viable cardiomyocytes immunolabeled in red (B’-F’) and Nrp2 expressing regions in green (B’’-
F’’). Overlay of the two colours are displayed with DAPI nuclei staining (B, C, E and F). Dotted 
box highlights magnified region. White arrows indicate colocalisation. HM – Healthy 
myocardium, ba- bulbus arteriosus, a- atrium, IA- injured area, v-ventricle n = 2 (sham), 3 
(cryoinjured) 
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 Nrp2 expression in endo and epithelial –to mesenchymal transition in the 
zebrafish heart  
ISH indicated a striking nrp2a epicardial expression at 3 dpci, whereas nrp2b is 
predominantly present within the injury with some expression in the epicardium. I set 
out to investigate Nrp2 expression in injury-activated epicardium and endocardium. 
Raldh2 is expressed by both the activated epicardium and endocardium following injury 
and contributes to EMT (Kikuchi et al., 2011b). Raldh2 positive cells expressed Nrp2 in 
both the endocardium and epicardium at 7 dpci, supporting a role for Nrp2 in the 
endocardial and epicardial EMT (Figure 45), a physiological process previously identified 
to require NRP2 in another pathophysiological setting (Grandclement et al., 2011). 
These data contrast with  expression of Nrp2 in endothelium and endocardium at 1 dpci 
in Tg(fli1a:GFP) hearts, which showed Nrp2 detection was discrete from GFP positive 
cells (Figure 42). It is possible Nrp2 is expressed in the endocardium and epicardium at 
time points later than 1dpci when epicardial and endocardial activation is established.    
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Figure 45 Activated endocardium and epicardium express Nrp2 
Immunofluorescence image of adult zebrafish heart 7 days post cryoinjury (dpci). Activated 
epicardium and endocardium are labelled with Raldh2 (A’ and B’) (red) and NRP2 expressing 
regions of the heart in green (A’’ and B’’). Overlay of the two colours are displayed with DAPI 
nuclei staining (A and B). Dotted box highlights magnified region. ba- bulbus arteriosus, IA- 
injured area, HM- healthy myocardium n = 2 
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4.4 Discussion  
 Nrp1 regulation 
The Human NRP1 cytoplasmic C-terminus sequence shares high amino acid sequence 
similarity to the zebrafish Nrp1a and Nrp1b C-termini (86% and 72% respectively). 
Immunoblotting for the Nrp1 C-terminus detected two bands in zebrafish hearts: a 
lower molecular weight Nrp1a band and higher molecular weight Nrp1b band. 
Quantified together Nrp1 protein was significantly upregulated in zebrafish ventricle 
lysates at 14 dpci. Whereas individual band analysis showed no statistical difference in 
the regulation of Nrp1a, Nrp1b upregulation was statistically significant at 3 dpci. The 
close proximity of Nrp1a and Nrp1b bands introduced potential for variation in Western 
blot band quantification due to the difficulty in delineating isolated ohnolog signal. 
Furthermore, similar to the qPCR studies, the samples measured for protein analysis 
were derived from the entire ventricle, and thus reflect total heart Nrp1 expression, 
which may mask smaller localised regions of high expression. Additionally, 
immunoblotting is a semi-quantitative technique, meaning that a standard curve is 
needed to interpolate the unknown protein levels in the experimental samples, 
something I was unable to do. Finally, Western Blotting is not a technique of high 
sensitivity able to detect subtle changes. A more sensitive and quantitative technique, 
such as ELISA, could be applied to quantify Nrp1 concentration in the ventricle samples. 
Because the Western blot sample consists of whole ventricle protein lysate of the entire 
ventricle, mainly made up of cardiomyocytes, localised changes of NRPs in the discrete 
endocardium and epicardium might be concealed. This was clearly evident when 
localisation of Nrp1 expression was analysed using immunofluorescent (IF) staining. 
Concordant with qPCR results, Nrp1 protein levels returned to basal expression by 30 
dpci. 
It is not possible to distinguish which Nrp1 isoform is detected via immunofluorescence. 
However, ISH expression patterns correlate with the localisation of Nrp1 observed using 
immunofluorescent staining, and therefore support antibody cross-reactivity to both 
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Nrp1a and Nrp1b. Immunofluorescence imaging demonstrates that, under basal 
conditions, Nrp1 localised to the epicardium, endocardium and fli1a-expressing 
endothelium of coronary vessels in the myocardium compact layer. Whereas, Nrp1 
expression by cardiomyocytes is low. Taken together, this suggests that Nrp1 has a 
constitutive role in the homeostasis of the endocardium, epicardium and coronary 
vasculature in the zebrafish heart, but probably not in cardiomyocytes themselves. 
After cardiac damage, activation of the endocardium in close proximity to the injury 
occurs within 24 hours and is required for zebrafish heart regeneration (Kikuchi et al., 
2011b). All or most fli1a and kdrl expressing endocardium also expressed Nrp1 after 
injury. This was including cells protruding into the cryoinjured region from the border 
between the injury and the healthy myocardium, implicating a role for Nrp1 in the 
endocardial response to cardiac damage. Additionally, early fli1a positive vessels that 
help revascularize the injured area from as early as 1 dpci, were also all positive for Nrp1 
and continued to express Nrp1 in the neovasculature at 7 dpci, indicating that Nrp1 
expression and upregulation is involved in revascularisation of the injured heart. The 
lack of coronary vessel kdrl expression in the zebrafish hearts analysed here (Figure 
38D’), is an unexplained observation, as arterial kdrl expression has been reported in the 
zebrafish heart coronary arteries 24 hours after cryoinjury (Marin-Juez et al.., 2016) and 
other tissues (Kumar et al., 2016). It is possible that, at 7 dpci, fli1a expressing vessels in 
the injured area are not arterial, but may be capillaries, venous or lymphatic vessels and 
thus might not express the mature arterial marker kdrl.   
The epicardium is also known to be essential for regulating the heart regeneration 
process (Lepilina et. al., 2006). After injury the epicardium becomes activated and 
proliferates and interestingly, I noted that Nrp1 was expressed in all epicardial cells after 
cardiac damage. Nrp1 could potentially serve as an epicardial marker in both its 
quiescent and activated states. A subpopulation of wt1b-expressing epicardial cells 
initiate EMT; they trans-differentiate and gain a migratory phenotype required for 
mesenchymal cell contribution to the regenerative process (Peralta et.al., 2014). All 
 184 
 
wt1b-positive epicardial cells undergoing EMT also expressed Nrp1, suggesting Nrp1 is 
required for the trans-differentiation and/or the migration of these cells. 
Cardiomyocytes expressed low levels of Nrp1 after cardiac damage and some sub-
epicardial cardiomyocytes migrating into the injured region expressed Nrp1. Pre-existing 
cardiomyocytes provide the majority of new cardiomyocytes in the regenerating 
zebrafish heart (Jopling et al., 2010), with a subpopulation proposed to be derived from 
epicardial cells and cardiac stem cells  (Ellison et al., 2013; van Wijk et al., 2012). 
However, the accuracy of these lineage tracing studies have been questioned by other 
groups that identified different fates for epicardial cells and limited cardiac progenitor 
populations (Jopling et al., 2010; Manuel Gonzalez-Rosa et al., 2012). Cardiomyocytes in 
close proximity to the injury are stimulated to dedifferentiate, proliferate and invade 
damaged cardiac tissue to replenish the cardiomyocyte population (Itou et al., 2012b; 
Jopling et al., 2010). Proliferating and migrating cardiomyocytes localise to the sub-
epicardial area at the injury (Kikuchi et al., 2010), that results initially in the formation 
of a new compact myocardium, and they then invade the underlying scar tissue to 
regenerate the trabeculated myocardium (Manuel Gonzalez-Rosa et al., 2011). Nrp1 
expression in protruding cardiomyocytes from the sub-epicardial compact layer could 
indicate a role for Nrp1 in migrating cardiomyocytes that repopulate the damaged area 
or the subpopulation of epicardial cells implicated in contributing to new 
cardiomyocytes.  
Though basal Nrp1 expression by cardiomyocytes was low in comparison to the more 
prominent Nrp1 expression by the endocardium and epicardium, increased Nrp1 
staining in injured hearts suggests its potential role for the migration of cardiomyocytes 
from the sub-epicardial layer into the injured area following cardiac damage.  These data 
also support my Western blot and qPCR observations that show trends for NRP 
upregulation but do not reach significance.  
Thus, in the injured heart, Nrp1 likely plays a role in several cell types critical for the 
regenerative process. A common characteristic shared by the endocardium, epicardium, 
sub-epicardial cardiomyocytes and vessels during regeneration is that they are all 
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required to gain a migratory phenotype to elicit their regenerative function. Nrp1 has 
previously been implicated in cell migration in various cell types (Banerjee et al., 2006; 
Evans et al., 2011; Frankel et al., 2008; Pellet-Many et al., 2011; Seerapu et al., 2013; 
Soker et al., 1998) and therefore could also play a role in response to migratory cues in 
the regenerating zebrafish heart.  
Unfortunately, due to antibody incompatibility, Nrp1 colocalisation with the marker of 
active endocardium, Raldh2, was not possible; nevertheless, the data presented in this 
chapter strongly indicates Nrp1 as playing a role in these cells (Figure 37 and Figure 38). 
Nrp1 is clustered at the border between the healthy myocardium and the injury, a region 
that contains both activated endocardial cells and inflammatory cells. Previous studies 
support a role for Nrp1 in the immune response (Aung et al., 2016; Ji et al., 2009; 
Tordjman et al., 2002). However, I was unable to assess the expression of Nrp1 by 
leukocytes because the L-plastin and Nrp1 antibodies were both raised in rabbits, 
therefore it is possible that Nrp1 may also be expressed by infiltrating inflammatory 
cells.  
 Nrp2 regulation  
Zebrafish Nrp2a and Nrp2b C-termini protein sequences are homologous and share 
82.9% sequence similarity with Human NRP2 implicating important evolutionary 
conservation of the NRP2 cytoplasmic domain. Unfortunately, antibodies used for NRP2 
Western blot analysis of ventricle lysates failed to demonstrate specific cross-reactivity 
to zebrafish NRP2 orthologues and was not quantifiable. However, a signal was detected 
using immunofluorescent staining and Nrp2 localisation was therefore evaluated in 
zebrafish heart sections using this approach.  
Under sham-operated conditions, Nrp2 expression was evident within the myocardium, 
with low basal expression by the endocardium and epicardium. Following cardiac 
damage, I noted Nrp2 being expressed by infiltrating leukocytes, suggesting its role for 
the initial inflammatory response after cardiac damage. The majority of leucocytes in 
the inflammatory response are innate immune cells such as macrophages and 
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monocytes derived from circulating blood (Chablais and Jazwinska, 2012; Evans et al., 
2013), and my results suggest these cells either constitutively express Nrp2, or 
upregulate Nrp2 after recruitment to the damaged area. Evidence from other models 
and tissues suggests that Nrp2 is constitutively expressed by inflammatory cells (Aung 
et al., 2016; Ji et al., 2009; Stepanova et al., 2007). The ISH staining that identified nrp2a 
and nrp2b mRNA within and proximal to the injury at 1 dpci may therefore be due to 
infiltrating leucocytes. Thus Nrp2 upregulation and mRNA re-distribution to the injury 
area indicates a role for Nrp2 in inflammation following cardiac injury. 
Injury-activated epicardium and endocardium, identified by Raldh2 expression, also 
expressed Nrp2. Additionally, NRP2 was constitutively expressed by viable 
cardiomyocytes in normal conditions and following cardiac damage, including in 
migrating cardiomyocytes that infiltrate the injured area. Thus, Nrp2 likely plays a 
homeostatic role in zebrafish cardiomyocytes but also has an injury-induced role in 
inflammation and endocardial and epicardial EMT. 
It is uncertain whether immunofluorescent staining exclusively detected zebrafish Nrp2 
in my studies, or may also reflect non-specific protein binding. However, Nrp2 
immunofluorescent staining was located to similar regions of the heart that were 
highlighted using ISH patterns supporting the conclusion that immunofluorescent 
staining reflected genuine Nrp2 detection. For example, small round Nrp2 positive cells 
within the injury express the leucocyte marker L-plastin and are also present within the 
injury-activated epicardium, which reflects observations of nrp2 gene localisation in ISH 
(Figure 32). Nrp2 mRNA expression was observed within the myocardium using ISH, 
which is further supported by Nrp2 immunofluorescent staining which appeared to 
detect sarcomeric structures in cardiomyocytes (Figure 44F). Therefore, Nrp2 antibody 
likely cross-reacts with zebrafish Nrp2 in immunofluorescent staining, but not using 
immunoblotting, perhaps due to antibody epitope recognition of zebrafish Nrp2 in the 
more native rather than the reduced unfolded state.   
 187 
 
 Summary 
In this chapter I have established the following: 
 Zebrafish NRPs are upregulated in response to cardiac damage, and may 
therefore play positive roles in the zebrafish regenerative response.  
 Nrp1 and Nrp2 display differential expression patterns in basal conditions and in 
regenerating zebrafish hearts 
 These data suggest that the isoforms carry out specific roles and have differing 
physiological responses in homeostasis versus regeneration.  
 Expression patterns reflected ISH mRNA detection confirming ISH data to 
accurately predict Nrp protein regulation in the zebrafish heart.  
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5 Results Chapter 3: Heart Regeneration in nrp1a mutant 
zebrafish 
Thus far, my data has demonstrated that all neuropilin orthologs are acutely 
upregulated in response to cardiac damage at both the mRNA and protein levels 
suggestive that they play a positive role in zebrafish heart regeneration. Neuropilins 
localise in close proximity to the damaged tissue or within the injury during the 
inflammatory and reparative phases of the regeneration process, with marked 
expression in the endocardium and epicardium. To investigate Nrp1 function in 
zebrafish heart regeneration, I studied a nrp1a mutant fish expressing a truncated and 
thus non-functional Nrp1a. This chapter focuses on the characterisation and 
regenerative capacity of this nrp1a mutant fish. 
5.1 nrp1a mutant fish identification 
The Sanger Wellcome Trust zebrafish mutagenesis project (ZMP) has generated several 
fish lines with point mutations in the sequence of protein encoding genes. The N-ethyl-
N-nitrosourea (ENU) mutagen has been used to treat male zebrafish to create random 
mutations in the genome during spermatogenesis. Male zebrafish were then bred with 
wild type females and offspring screened for genetic mutations and a founder fish that 
transmit the mutation through the germline was identified (See section 1.3.1.2). 
I obtained the nrp1asa1485 mutant zebrafish line from the ENU ZMP. This mutant fish 
encodes a nonsense point mutation (where a Cytosine replaces an Adenine base) 
resulting in the generation of an early stop codon at amino acid 206 out of 923 amino 
acids of the Nrp1a sequence (Figure 46A). This mutation yields a truncated Nrp1a 
protein lacking the cytoplasmic C-terminus, transmembrane domain, MAM domain, b1, 
b2 and half of the a2 ligand interacting domains, resulting in a non-functional and 
soluble Nrp1a fragment (Figure 48A). At the time when I acquired the nrp1asa1485/sa1485 
mutant fish, no other fish neuropilin mutant lines were available. Initially, genomic DNA 
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extracted from adult fish fin clips was used to identify heterozygous nrp1asa1485/+ mutant 
fish via sequencing. Heterozygous fish were then incrossed, and a random selection of 
48 hpf embryos were genotyped from the offspring (Figure 46A). The offspring 
genotypes followed a Mendelian ratio distribution of the three genetic outcomes 
indicating that homozygous inheritance of the nrp1a mutation is not embryonic lethal 
by 48 hpf (Figure 46B). Because of the occurrence of evolutionary genome duplication, 
four neuropilin isoforms are encoded by the zebrafish genome (Postlethwait et al., 
1998); thus redundancy due to the presence of the nrp1b ohnolog may compensate for 
the loss of full-length Nrp1a function during development.  
Embryos were raised to adulthood and homozygous mutants were identified via 
sequencing. This further confirmed that the homozygous inheritance of the mutation 
and loss of Nrp1a function is not embryonic lethal. The homozygous mutants were 
incrossed to establish a homozygous nrp1asa1485/sa1485 line. A 42% survival rate of the 
offspring was noted, which is significantly lower than the ~90% survival rate observed 
for established wild type lines. This suggests possible underlying complications during 
development that were not detected by my initial observational and qualitative analysis.  
5.2 nrp1a mutant line characterisation 
Nrp1a gene expression was assessed by RT-qPCR in adult nrp1asa1485/sa1485 zebrafish 
heart lysates (Figure 47A) and expression patterns were evaluated in nrp1asa1485/sa1485 
24 hpf embryos using ISH (Figure 47B). Both showed a marked reduction of nrp1a mRNA 
expression (Figure 47), suggesting that the nonsense mutation results in downregulation 
of nrp1a mRNA expression. This may be due to an adaptive response to loss of Nrp1a 
function. According to previous reports, nrp1a is expressed during embryogenesis and 
in wild type adult hearts (Yu et al., 2004). However, nrp1asa1485/sa1485 mutant embryos 
displayed no obvious morphological abnormalities in the absence of full-length Nrp1a. 
These results strongly suggest that genetic redundancy occurs: the presence of the 
nrp1b ohnolog might compensate for the reduced Nrp1a activity required for heart 
development. These data also confirm that the point mutation has a sustained and 
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marked effect on nrp1a gene expression from early development continued throughout 
adulthood.  
Figure 46 nrp1a mutant sequencing 
(A) Sequencing chromatograms of wild type, heterozygous (nrp1asa1485/+) and 
homozygous (nrp1asa1485/sa1485) mutant embryos 48 hpf. An Adenine replaces a 
Cytosine base causing the generation of the early stop codon (nonsense mutation) 
TAA, rather than the Tyrosine (TAC) codon at amino acid 206. (B) The table displays the 
genotypes of 14 zebrafish embryos 48 hpf alongside the expected mendelian ratio 
occurrence after heterozygous fish incross. Wild type and homozygous mutants are 
expected to account for 25% of the genotypes each (~3.5 out of 14), whereas 
heterozygous mutants should account for 50%. The outcome of genotyping is 
described in the third (actual fish number) column.  
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Figure 47 nrp1a mRNA expression in homozygous nrp1asa1485/sa1485 mutants 
(A) Absolute RT-qPCR of wild type (white bar) and nrp1asa14854/sa1485 homozygous mutant 
(black bar) adult zebrafish hearts under basal conditions. Data are represented as means of 
normalised copy numbers per reaction ± S.E.M (error bars) ***p<0.005 n = 4 with each n 
being a pool of 3 ventricles. (B) nrp1a anti-sense (AS) in situ hybridisation of wild type (upper 
row) and nrp1asa14854/sa1485 homozygous mutant (bottom row) 24 hpf embryos carried out 
simultaneously. Black dotted boxes indicate magnified region enlarged to the right.  
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5.3 Nrp1a expression in the nrp1asa1485/sa1485 mutant line 
Protein expression levels of adult ventricle lysates obtained from wild type and 
homozygous nrp1asa1485/sa1485 zebrafish hearts were evaluated using Western blot. An 
antibody targeting the human NRP1 C-terminus was used to detect Nrp1 ohnologs and 
verify the loss of full-length protein expression as a result of the mutation.  
Zebrafish Nrp1 is detected as a doublet on immunoblots, with a lower Nrp1a molecular 
weight band at ~120kDa, and a higher Nrp1b molecular weight band at ~140 kDa (Figure 
48A). The lower Nrp1a band is clearly not expressed by the nrp1asa1485/sa1485 mutants, 
confirming loss of the full-length Nrp1a protein expression.  
The Nrp1b protein was expressed by the nrp1asa1485/sa1485 adult hearts (Figure 48B) and 
though its expression appeared to be reduced compared to WT fish, this reduction was 
not statistically significant (Figure 48C). These data indicated that Nrp1b expression in 
the adult nrp1asa1485/sa1485 fish is not markedly affected by the mutation and that there 
is no compensatory upregulation of one Nrp1 ohnolog in response to the loss of the 
other.  
It is possible that alternative pathways mediate cellular mechanisms to compensate for 
loss Nrp1a loss in the adult zebrafish heart, or that the role of Nrp1a is redundant under 
basal conditions. 
5.4 nrp1asa1485/sa1485 anatomical characterisation  
The superficial anatomical measurements of wild type zebrafish were compared to 
those of age-matched nrp1asa1485/sa1485 mutants to identify any phenotypes that might 
arise from the mutation. Nrp1asa1485/sa1485 mutant fish were phenotypically 
indistinguishable from wild type fish (Figure 49A), they displayed normal behaviour and 
were fertile. There was no significant difference in fish body length (base of caudal fin 
to tip of mouth) (Figure 49B). Neither was there a difference in heart size when the area 
of whole ventricles collected were measured (Figure 49C) or the heart to body length 
ratio (Figure 49D). There was a trend for mutant fish to be smaller than wild type 
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controls but sample size was small and there were a few outliers in both groups. Thus, 
the loss of full length Nrp1a does not affect zebrafish growth or development. More 
detailed studies investigating the fish anatomical features and physiological functions 
that require full-length Nrp1a, such as the vessel development during embryogenesis 
and neuronal development, should be performed. 
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Figure 48 Nrp1a protein analysis of the nrp1a homozygous mutant 
(A) Schematic representation of wild type (WT) (left) and nrp1asa14854/sa1485 (right) Nrp1a 
structure. The point mutation results in the insertion of a premature stop codon at amino acid 
206, which generates a truncated Nrp1a fragment. The Nrp1a mutant encodes the a1 and 
part of the a2 extracellular semaphorin binding domain. (B) Western Blot of WT or 
nrp1asa14854/sa1485 homozygous mutant adult zebrafish ventricle lysates under basal 
conditions. Lysates were immunoblotted for the Nrp1 cytoplasmic domain and Gapdh. Note 
the absence of C-terminus detection in the nrp1asa14854/sa1485 samples (C) WT (white bars) and 
nrp1asa14854/sa1485 (black bars) adult zebrafish ventricle Western Blot quantification normalised 
to GAPDH, of Nrp1a band (left graph) and Nrp1b band (right graph). Data are represented as 
band density means ± S.E.M ****p<0.0001 n = 4 with each n being a pool of 3 ventricles.  
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Figure 49 Wild type and mutant fish measurements 
(A) Representative picture of WT (upper panel) and nrp1asa1485/sa1485 mutant zebrafish (lower 
panel) scale bar 1 cm. The body length, (B) and heart size (C) of age matched wild type (black 
dots) and nrp1a mutant (red dots) zebrafish were measured and comparison of body length 
to heart size made (D). Scatter graph values are displayed as means ±S.E.M and individual 
measurements of fish indicated as black (wild type) or red dots (nrp1asa1485/sa1485 mutants).  
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5.5 Regenerative capacity in nrp1asa1485/sa1485 
Under basal conditions the nrp1a mutants appeared normal and comparable to WT 
controls (Figure 50A and H). To evaluate the mutant response to cardiac damage, 
cryoinjuries were performed and the extent of the injury and viable cardiac tissue 
quantified using AFOG staining (Figure 50A-N). At 1 dpci both wild type and mutants 
sustained a similar proportion of damage to the heart (25.2 ± 5.5% and 22.6 ± 5.2%, 
respectively) (Figure 50O). The mutant heart demonstrated progressive reduction of 
injury size over time, confirming that they retain some regenerative capacity in the 
absence of full length Nrp1a (Figure 50O, black bars). However, my data revealed a clear 
reduction in the extent of decrease of the injured area in mutant as compared to WT 
hearts (Figure 50K-N). Statistical analysis of these data by two-way anova revealed a 
significant delay in regeneration of mutant hearts in comparison to wild type hearts (p 
= 0.038). Specific time-point comparison of injury size showed a significantly larger injury 
remaining at 14 and 30 dpci in mutant hearts compared to wild type hearts (Figure 50E,F, 
L and M), indicating Nrp1a is  required for efficient cardiac repair (Figure 50O). 
Additionally, the mutants displayed abnormal epicardial morphology throughout 
regeneration. Wild type epicardium proliferates and encases the entire injured region. 
In the mutant fish, the epicardial response was abnormal: the epicardium appeared to 
proliferate, evident as a a thickened layer of cell on the surface of the heart, but did not 
consistently surround the injured region (Figure 50J and L). Rather, the epicardium 
clustered at the periphery of the injury, however further experiments would be required 
to confirm whether clusters of cells on the heart surface are of epicardial origin or blood 
cells. Moreover, the scar resolution process in the mutants also differed from that in 
wild type fish. The fibrin cap is the first fibrotic tissue cleared from the scar, but fibrin 
deposits (observed as red staining in injury area denoted by black dotted line) were still 
evident at 30 and 60 dpci in mutant fish though not in wild type (Figure 50F, G, M and 
N). 
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Figure 50 Recovery from cryoinjury is delayed in the nrp1a mutant 
Wild type (A-G) and nrp1asa1485/sa1485 mutant (H-N) fish were cryoinjured and injury size (denoted by black dotted line) determined with AFOG 
staining. Black arrows indicate adipose deposits. White arrows indicate epicardial clusters (O) Total ventricle injury area was quantified and % 
ventricle damage presented as mean percentage (± S.E.M) n = 4-6 *p<0.05. V- ventricle, A-atrium, ba- bulbus arteriosus  
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Additionally, I also observed differences in regeneration of the compact layer and 
wound closure. The compact myocardium regenerates simultaneously to the removal 
of the fibrin cap (Gonzalez-Rosa and Mercader, 2012; Kikuchi et al., 2010). When a 
continuous layer of cardiomyocytes encloses the residual collagen scar, the wound is 
regarded as closed, whereas incomplete compact myocardial coverage is described as 
an open wound (see Figure 51A). In the advanced stages of regeneration (30 and 60 
dpci), a larger proportion of mutant hearts remained as an open wound compared with 
wild type hearts at 30 and 60 dpci (Figure 51B). This indicates a failure of the compact 
myocardium to migrate and/or proliferate efficiently towards the subepicardial layer in 
order to close the wound in nrp1a mutant fish.  
Mutant sham-operated hearts also displayed abnormal fat deposits rarely observed in 
wild type fish (Figure 50A and H, black arrows). Adipose tissue composition and 
morphology were not quantified, however.  
These data indicated that after cryoinjury, loss of full-length Nrp1a impairs the 
regenerative response, and results in abnormal epicardial morphology and scar 
composition in comparison to WT fish hearts. This points to a key role of Nrp1a in 
epicardial response and scar resorption during the regenerative process.   
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Figure 51 Wound closure in nrp1a mutant 
A) Example of a closed (upper image) and open (bottom image) adult cryoinjured zebrafish 
heart. The compact layer of the myocardium regenerates initially and encloses the fibrotic 
scar tissue (black arrow); open wounds do not display a continuous myocardial compact layer 
and the wound remains at the surface of the ventricle (white arrow).  (B) Open (white) and 
closed (grey) wounds were quantified in wild type (WT) and nrp1a mutant (Mut) hearts at 30 
and 60 dpci. Values are displayed as percentage of samples in either category. A – atrium, V- 
ventricle, ba – bulbus arteriosus  
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5.1 Discussion 
In this chapter I set out to identify and characterise a nrp1a mutant zebrafish line 
reported to express a nonsense mutation resulting in truncated Nrp1a molecule. The 
mutation generates a soluble Nrp1a fragment that cannot interact with intracellular 
scaffolding proteins or receptors, nor bind any known ligands. After identification of 
homozygous mutants via sequencing, I analysed nrp1a mRNA and Nrp1a protein 
expression in the zebrafish and evaluated regenerative capacity. 
5.1.1 Nrp1a mutants are viable 
Mutant fish are viable, present no gross phenotype under basal conditions and the 
genotype is detected at expected mendelian ratio from a heterozygous cross. However, 
there may be undetected underlying problems encountered during development as the 
nursery survival rate is approximately half to that of wild type fish. It is well established 
that nrp1a is expressed in several other organs during zebrafish development, especially 
in the nervous system (Bovenkamp et al., 2004; Martyn and Schulte-Merker, 2004; Yu 
et al., 2004). The phenotype of nrp1asa1485/sa1485 fish described here is not in line with 
previous studies that investigated the effects of nrp1a knock down using morpholinos, 
and showed abnormal vessel growth and high embryonic lethality (Bovenkamp et al., 
2004; Dell et al., 2013), features not recapitulated in the ENU nrp1asa1485/sa1485 mutants. 
Conflicting observations between morpholino gene silencing and germline-acquired 
mutations are common, and the morpholino approach is likely to have deleterious off-
target effects (Kok et al., 2015; Schulte-Merker and Stainier, 2014). Additionally, 
morpholinos could have off target and toxic effects that also affect development (Rossi 
et al., 2015). A zebrafish embryo encompasses 500 ng of total RNA, 2-5% of which is 
mRNA (25 ng). Assuming that at any given time there are more than 100 different and 
equally represented mRNA transcripts present in a cell (Dawid, 1987), only 2.5 pg of a 
specific mRNA species is available for targeting. MO injections typically deliver a 
minimum of 1 ng anti-sense oligonucleotide (Nasevicius and Ekker, 2000). Assuming 
further that the target mRNA has an average length of 1.25 kb, whereas the MO is a 25-
mer, this equates to a 20,000-fold molar excess of MO versus target mRNA. It is 
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therefore most likely that this vast excess of MO will bind other RNA or other 
macromolecules resulting in false positive phenotypes. Conversely, a recent study 
examined intersegmental vessel (ISV) sprouting in a nrp1a mutant embryo generated 
via TALEN mutagenesis. The mutation also results in a truncated soluble Nrp1a fragment 
and showed no adverse defects in ISV growth (Kok et al., 2015), in agreement with my 
observations that show no deleterious or obvious morphological abnormalities caused 
by nrp1a gene disruption in the nrp1asa1485/sa1485 fish under basal conditions.  
The nrp1asa1485/sa1485 mutants expressed a truncated and soluble Nrp1a, which could 
potentially retain some physiological activity by associating with some unknown 
molecules, which may in part explain the viability of these mutants. Soluble Nrp1a is 
endogenously expressed in the zebrafish (Bovenkamp et al., 2004), however the 
physiological function of this splice variant has not been investigated. Nevertheless, my 
data shows that full length Nrp1a is not essential for normal zebrafish development, 
implicating possible redundancy due to genome duplication and the existence of the 
nrp1b ohnolog or other compensatory adaptions and mechanisms. Further work is 
required to investigate this, including examination of the phenotype and response to 
cardiac injury of nrp1b mutant fish, and evaluation of expression and function of other 
pathways that could potentially compensate for loss of Nrp1a, such as components of 
Vegf angiogenic signalling pathways. Alternatively, Nrp1a signalling and activity may not 
have a role in embryonic development and in homeostasis in the adult zebrafish heart, 
and these roles may be performed by Nrp1b. Analysis of nrp1b mutant fish would reveal 
such a role. Nrp1b is the ohnolog of Nrp1a and theoretically could compensate for Nrp1a 
activity loss, however it has been suggested that the two genes have undergone 
extensive genetic drift to the extent that they demonstrate different embryonic 
expression profiles and post-translational modifications, which gives them 
distinguishably different molecular weights (Bovenkamp et al., 2004)(Figure 48A). They 
present differential localisation in the developing zebrafish embryo and during cardiac 
regeneration, implicating distinct roles for the two isoforms. Nrp1b protein expression 
is unaffected by the loss of function of Nrp1a in adult ventricle lysates, indicating that 
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Nrp1b is not upregulated to compensate for the limited Nrp1a activity, but any 
compensatory ability of this ohnolog cannot be precluded. 
5.1.2 Nrp1a expression downregulated in homozygous mutants  
It is clear that from an early developmental stage (24 hpf) the mutant fish actively 
downregulates nrp1a expression. This might be due to a negative feedback, perhaps 
from the truncated mutant protein, or exerted during protein translation, that results in 
constitutive downregulation of nrp1a gene expression; the mechanisms behind this 
remain unclear.  
Despite the gene and protein regulation of neuropilin1a being reduced in mutants, wild 
type and mutant adult fish are very similar suggesting that, under physiological 
conditions mutants that survive to adulthood are healthy. The adult fish showed a trend 
to be smaller than wild type fish, but were indistinguishable from wild type fish in other 
measurements and observations; thus the nrp1a mutation does not seem to trigger a 
detrimental adult phenotype. My examinations were mainly focused on cardiac and 
body size. Therefore, because the mutation is a global knockout, and nrp1a is expressed 
by many tissues, I cannot rule out the existence of a phenotype resulting from loss of 
function Nrp1a (for example within the nervous system) that I did not investigate. 
5.1.3 Nrp1a mutants have reduced survival and delayed regenerative response 
Mutant nrp1a hearts show a delayed regenerative response after cryoinjury, supporting 
the conclusion that full-length Nrp1a is required for normal heart regeneration. Since 
regeneration did occur in the nrp1a mutants, this isoform is not essential for the 
regenerative process. However, the nrp1a mutants also exhibited delayed recovery of 
the compact myocardium illustrated by an impaired ability of the compact myocardium 
to migrate and/or proliferate efficiently towards the subepicardial layer in order to close 
the wound. Furthermore, nrp1a mutants displayed abnormal scar resolution indicated 
by the persistence of fibrin deposits at later stages of the regenerative process (30 and 
60 dpci). Abnormal protrusions of proliferating epicardium were occasionally observed 
in the regenerating mutant hearts that may indicate a further consequence of functional 
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Nrp1a loss in the regenerating heart (Figure 50J and L). These findings, together, indicate 
a key role for nrp1a in zebrafish heart regeneration. 
The mutant zebrafish heart did finally regenerate overall, though this may be due to 
compensation by nrp1b, which was expressed in the mutant hearts. It is possible 
therefore, that Nrp1 may play a more vital role in heart regeneration, obscured by loss 
of only a single ohnolog. This could be examined in double nrp1a/nrp1b mutants, though 
these would be predicted to be embryonic lethal. However, this could be circumvented 
using an inducible (e.g. by tetracycline, or tamoxifen) knock-out. 
I also observed that mutant sham-operated hearts displayed abnormal fat deposits 
rarely observed in wild type fish (Figure 50A and H), though these were not quantified. 
Cardiac adipose tissue characterisation is limited in the literature, being briefly 
described in one publication (Hu et al., 2001). NRP1 is proposed to play a role in white 
adipose tissue nerve growth in conjunction with sema3A (Giordano et al., 2003) and 
macrophage recruitment through sema3E secretion(Shimizu et al., 2013), therefore 
neuropilin may regulate white adipose tissue of the heart. These observations regarding 
adipose morphology may shed light on possible phenotypes caused by lack of full-length 
Nrp1a in the zebrafish heart under resting conditions, but require further investigation. 
 Summary 
In this chapter I have demonstrated: 
 nrp1asa1485/sa1485 homozygous mutant zebrafish are viable and appear normal 
under physiological conditions. 
 Heart regeneration was severely delayed in mutant following cryoinjury. 
  Mutant hearts indicate an impaired epicardial phenotype in response to injury.  
. 
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6 Results chapter 4: Role of NRP1 in the epicardium 
In the previous chapters have described the upregulation of the different neuropilin 
isoforms in the cryoinjured zebrafish heart. I have noted a clear expression of Nrp1 in 
uninjured heart and found that its expression was notably increased by both the 
epicardium and the endocardium following injury. I have characterised a nrp1a mutant 
fish line expressing a non-functional soluble Nrp1a fragment. The nrp1asa1485/sa1485 fish 
exhibited a delayed resolution of the cryoinjured lesion; displayed an impaired 
regeneration of the compact myocardium layer as well as an abnormal epicardial 
morphology. Therefore, my results in the preceding chapters suggest a functional 
epicardial role for Nrp1. In this chapter I decided to further investigate the role of Nrp1 
in the epicardium in more detail using primary epicardial cells. 
6.1 Neuropilin activity in epicardial cells 
 Epicardial in vitro assay validation 
During the reparative phase of regeneration, a fibrin cap is laid down in the injured area, 
below the epicardium (Chablais et al., 2011; Manuel Gonzalez-Rosa et al., 2011). A 
subset of epicardial cells undergoes EMT, migrates through the subepicardial fibrin scar 
matrix (as shown in Figure 40) and eventually transdifferentiate into mural or fibroblasts 
cells (Lepilina et al., 2006; Manuel Gonzalez-Rosa et al., 2012).  
Primary epicardial cells from zebrafish ventricle explants can be cultured in vitro on fibrin 
gels that mimic in vivo conditions of cardiac repair (Kim et al 2012). The zebrafish 
ventricle apex is placed on a fibrin gel and left to adhere for a short period before 
medium is added to the sample (see section 2.5). Within 24 hours, epicardial cells can 
be seen infiltrating the matrix surrounding the apex tissue (Kim et al 2012) and, after a 
week, larger outgrowths can be visualised (Figure 52A). I performed this procedure with 
three transgenic lines (Tg(fli1a:GFP), Tg(cmlc2:GFP), and Tg(wt1b:GFP)) and imaged 
outgrowths using fluorescence microscopy to identify the population of migrated cells 
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(Figure 52B). No GFP signal was detected in the outgrowths from Tg(fli1a:GFP) or 
Tg(cmlc2:GFP) apices strongly indicating that the outgrowths do not contain endothelial 
cells or cardiomyocytes (Figure 52B). GFP positive cells were evident in the outgrowths 
from Tg(wt1b:GFP) zebrafish ventricle apices (Figure 52B), confirming that the method 
yields an epicardial population.  
To confirm the identity of the outgrowing cell population, I immunostained the samples 
for Raldh2 and found that all cells were Raldh2 positive (Figure 53 green panel upper 
row), further validating their epicardial identity. In Tg(wt1b:GFP) apices, the degree of 
GFP expression was heterogeneous, all cells showing some GFP expression, but only a 
proportion of outgrowing cells were strongly GFP-positive (Figure 53 green panel, 
second row); this is consistent with previous reports showing that only a subpopulation 
of epicardial cells express wt1b after cardiac damage (Manuel Gonzalez-Rosa et al., 
2011; Peralta et al., 2014). Staining of F-actin cytoskeletal filaments was used to 
highlighted the epicardial cell morphology, a cobblestone-like appearance was observed 
and the cells grow as a monolayer, similar to that described by Kim et al. (2012) (Figure 
53). F-actin staining also revealed the cells are in close contact between each other, 
characteristic epithelial cell monolayers (Figure 53). Taken together, these results 
strongly indicate that the outgrowths consist primarily of an epicardial cell population.
  
I also examined Nrp1 expression in these epicardial outgrowths and observed that all 
cells were Nrp1 positive (Figure 53), which is in line with immunofluorescence images of 
heart sections, described earlier (see 4.3.3),showing Nrp1 positive epicardial cells in 
both cryoinjured and sham operated hearts in vivo. These observations support the 
conclusion that Nrp1 is expressed in epicardial explants and that this model would allow 
me to examine the functional role of Nrp1 in epicardial cells. In zebrafish epicardial cell 
outgrowths, Nrp1 was localised predominantly to the perinuclear region, but also within 
the cytoplasm and at the membrane as suggested from its co-localisation with F-actin 
(white arrows, Figure 53).  
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Figure 52 Epicardial outgrowth in vitro assay validation 
(A) Schematic representation of epicardial cell in vitro culture. The ventricle apex 
is placed into a tissue culture well onto a fibrin gel matrix (ensuring epicardium 
contact with matrix). Once adhered, culture medium is added and  epicardial cells 
migrate radially onto the matrix away from cardiac tissue. An optional cover glass 
slip can be inserted into the gel for histological assays. (See 2.5.1 for detailed 
assay description). Star indicates damaged area. image modified from Kim et al. 
(2012). (B) Epicardial outgrowths from Tg(fli1a:GFP) (upper row), Tg(cmlc2:GFP) 
(middle row), and Tg(wt1b:GFP) (bottom row) cryoinjured fish after 7 days in 
culture. Outgrowths are displayed under phase light (left column), GFP 
fluorescence (middle column) and overlaid images (right column), black dotted 
lines indicate outgrowth boundary.  Scale bar 500µm. 
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Figure 53 Epicardial outgrowth immunofluorescent cytochemistry 
Ventricle apices were collected 5 dpci and cultured in vitro for 7 days from wild type (first 
and third row), Tg(wt1b:GFP) (second row), and nrp1asa1485/sa1485 (bottom row) fish. 
Epicardial outgrowths were immunostained for either Raldh2 (first row) (n = 3), GFP 
(second row) (n = 2) or NRP1 (third (n = 4) and fourth (n = 2) row) (green) and phalloidin 
conjugated to Alexa-555 to identify F-ACTIN cytoskeleton (red). DAPI (blue) staining was 
applied to help locate individual cells and overlaid with green and red channels (third 
column). White arrows indicate regions of colocalisation. Scale bar 20 µm. 
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Epicardial outgrowth morphology and Nrp1 expression were also examined in explants 
from nrp1asa1485/sa1485 mutant hearts (Figure 53 bottom row). Nrp1 showed that Nrp1 
expression was much weaker in the mutant compared to wild-type hearts, (Figure 53 
bottom row), indicating that Nrp1a is the Nrp1 isoform predominantly expressed in 
epicardial outgrowths. It was also observed that, although the nrp1asa1485/sa1485 mutant 
epicardial cells presented a cobblestone morphology, however, the F-actin staining 
pattern was altered, suggestive of discontinuous cell-cell adhesions, possibly due to 
disruption of tight junctions. 
 Cryoinjured heart epicardial expansion 
Injury-induced epicardial activation, proliferation and migration (Lepilina et al., 2006) 
results in increased epicardial expansion from resected hearts compared with sham 
operated hearts as previously reported (Kim et al., 2012). Nevertheless, there has been 
no previous description of the effect of cryoinjury on epicardial outgrowths in vitro, thus 
I compared the outgrowths of cryoinjured hearts against sham-operated hearts (Figure 
54A). I quantified the epicardial expansion area from the apex circumference and found 
that cryoinjured samples expanded to approximately double the area (3.9 ± 0.37 mm2) 
of outgrowths from sham-operated apices (2.01 ± 0.23 mm2) (Figure 54 B). The 
significant increase (p = 0.0003) in epicardial outgrowth following cardiac damage 
supports previous observations in resected hearts (Kim et al., 2012). Additionally, I 
assessed the extent of epicardial activation in sham and cryoinjured outgrowths from 
Tg(wt1b:GFP) apices (Figure 54A). A clear trend for increased fluorescence in cryoinjured 
hearts was observed, however, a single outlier in both treatment groups caused large 
variation, and thus, the data recorded was not statistically significant (p = 0.0713, n = 4) 
(Figure 54C). Increasing the number of experimental repeats may lead to statistically 
significant GFP signal increase.  
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Figure 54 Cryoinjury induces epicardial expansion and activation. 
(A) The apices of Tg(wt1b:GFP) zebrafish ventricles were collected 5 days post sham 
surgery or cryoinjury and cultured on fibrin gels for 7 days. Preparations were imaged 
under phase and green-fluorescence microscopy, then overlaid to visualise GFP-
positive epicardial outgrowth (white arrows). Scale bar 500µm. (B) Epicardial 
outgrowths from sham (white bar) and cryoinjury (grey bar) surgeries in wild-type 
zebrafish hearts were quantified. Data are represented as mean outgrowth areas in 
mm2 ± S.E.M ***p ≤ 0.0005 (p = 0.0003), n = 10-12. (C) Epicardial outgrowth GFP-
positive signal was measured in explants from sham (white bar) and cryoinjured (grey 
bar) Tg(wt1b:GFP) zebrafish hearts. Data are represented as mean GFP-positive areas 
in mm2 ± S.E.M (p = 0.0713), n = 4 (D) Lysates obtained from sham-operated (Sh) and 
cryoinjured (CI) in vitro epicardial outgrowths from wild-type zebrafish hearts were 
immunoblotted for Nrp1 and Gapdh n = 2  
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Following 7 days in vitro culture, sham-operated and cryoinjury epicardial samples were 
harvested and protein lysates examined by Western blot analysis. The lysates were 
immunoblotted for Nrp1, using Gapdh as a loading control (Figure 54D).  Epicardial 
lysates obtained from cryoinjured samples expressed increased Nrp1 levels compared 
with sham-operated samples. However, statistical analysis of the Western blot data was 
not possible due to the insufficient number of experimental replicates. Observations 
from immunofluorescence images that displayed increased Nrp1 levels in the 
epicardium after cardiac damage (see Figure 32 and Figure 40) would support higher 
Nrp1 expression in cryoinjured outgrowth lysates; however, I could not draw a definitive 
conclusion from the current n numbers. 
 Epicardial outgrowth is impaired in the absence of nrp1a  
I next examined the epicardial outgrowths in wild type and nrp1a mutant fish apices 
following sham surgery and cryoinjury (Figure 55A-D). Epicardial outgrowths were 
observed in nrp1a mutant fish samples from both surgical procedures (Figure 55B and 
D). Epicardial outgrowth area quantification revealed no increase in epicardial 
expansion following cryoinjury in mutant zebrafish (p = 0.859), whereas a significant 
increase was displayed by explants from wild type cryoinjured hearts as compared with 
sham-operated hearts consistent with data in Figure 54 (Figure 55E; p = 0.0061). Wild 
type and mutant epicardial expansions from sham-operated explants were similar (p = 
0.9732). Furthermore, a significant decrease in cryoinjury-induced epicardial expansion 
was observed in mutants when compared with wild type (p = 0.0203): wild type 
outgrowth area (4.35 ± 0.53 mm2) was almost two times greater than that of mutants 
(2.65± 0.46 mm2). These observations indicate that cryoinjury-induced epicardial 
expansion is severely impaired in the absence of full-length Nrp1a, but that under basal 
conditions, Nrp1a activity is dispensable for epicardial outgrowth in vitro. The data 
indicate a role for Nrp1a in either epicardial migration or proliferation after cardiac 
damage. 
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Figure 55 Epicardial migration is impaired in nrp1a mutants 
The apex of wild type (A, C) and nrp1asa1485/sa1485 (B, D) zebrafish ventricles were collected 5 days post sham surgery (A, B) or 
cryoinjury (C, D) and cultured on fibrin gels for 7 days. Epicardial cells migrate into the fibrin gels (dotted black lines). Scale bar 
1 mm. (E) Epicardial outgrowths were measured for each condition after 7 days culture, data are represented as mean 
outgrowth ± S.E.M (n = 5-12) *p < 0.05, **p < 0.001 
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 Epicardial proliferation is unaffected by Nrp1a 
To investigate whether the lack of injury-induced epicardial expansion observed in nrp1a 
mutants is due to impaired proliferation or migration, I assessed epicardial cell 
proliferation in heart sections. Samples obtained from WT and mutant hearts 7 dpci 
were immunostained for proliferative cell nuclear antigen (PCNA) and Raldh2 (expressed 
in activated endocardium and epicardium following injury)(Figure 56A). Raldh2 positive 
cells of the epicardium were counted, and the proportion of PCNA positive cells 
calculated. Quantification showed no significant difference in epicardial proliferation 
between WT and nrp1a mutant cryoinjured hearts (p > 0.999) (Figure 56B). These 
observations suggest that Nrp1a does not play a role in injury-induced epicardial 
proliferation, and that, therefore, the impaired expansion is likely a result of 
compromised migration and/or EMT that enhances the migratory potential of the 
epicardium.  
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Figure 56 Epicardial proliferation in nrp1a mutants 
(A) Immunofluorescence of wild type and mutant hearts 7 dpci 
immunostained for PCNA and Raldh2. White dotted line demarcates 
Raldh2 positive epicardium border, arrows indicate PCNA positive 
epicardial cells. IA‐ injured area. (B) Percentage of PCNA positive 
epicardial cells in WT versus mutant hearts 7dpci. n=3 where each n is 
a mean of 3 fields of view from one heart. p>0.05  
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 Rat epicardial cell in vitro studies 
Reagents and pharmacological inhibitors specific to zebrafish are limited. Additionally, 
the culture of epicardial cells is an intricate procedure and requires a minimum of 3 to 5 
hearts to generate sufficient protein lysate usable for Western blotting. Therefore, to 
better understand the role of NRP in the regulation of candidate signalling pathways in 
the epicardium, I carried out in vitro experiments using adult rat epicardial cells (these 
cells were a generous gift from Dr Nicola Smart and were previously described in Wada 
et al. (2003)). Cells were infected with adenovirus containing either scrambled (Scr) or 
NRP1 targeted (Sh1) short hairpin (Sh) RNA (shRNA) (viruses were generated as 
described in Pellet-Many et al. (2015)). Upon stimulation by growth factors, cells were 
lysed and immunoblotted for ERK phosphorylation. 
VEGF is a well characterised ligand for NRP1 (Soker et al., 1998) and has been associated 
with mammalian embryonic epicardial EMT (Tomanek et al., 2006) and migration (Tao 
et al., 2013). Therefore, I assessed the effect of NRP1 knockdown on epicardial VEGF 
response. There was a trend for an increased ERK phosphorylation following VEGF 
stimulation (Figure 57A), but this did not reach statistical significance (p = 0.1179, n = 3) 
(Figure 57B). Similarly, a trend for reduced VEGF response was observed after NRP1 
knockdown (Figure 57A), but was not found to be statistically significant (p = 0.5122). 
These experiments are in the process of being repeated using siRNA, which may lend 
greater statistical weight to the results generated so far and decipher whether VEGF 
signalling is being mediated by NRP1 in the epicardium. 
Pdgfbb was demonstrated to mediate epicardial EMT via Pdgfrβ following ventricular 
resection essential for cardiac repair in zebrafish. PDGF is also a recognised NRP1 ligand 
(Banerjee et al., 2006; Dhar et al., 2010; Pellet-Many et al., 2011). Thus, I examined rat 
epicardial cell responses to PDGFBB. I assessed the phosphorylation of one of the PDGF 
downstream targets, ERK, following PDGF stimulation. PDGFBB clearly increased ERK 
phosphorylation indicating that rat epicardial cells respond to PDGF and target the 
MAPK/ERK pathway (Figure 57C). PDGFBB stimulation induced a significant increase in 
ERK phosphorylation when compared with serum free (SF) conditions (p = 0.0367) 
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(Figure 57D). NRP1 knockdown showed reduced ERK phosphorylation after PDGFBB 
stimulation when compared with scrambled RNA in 2 out of the three repeated 
experiments (Figure 57C). However, a large variation in protein band quantification and 
the low number of repeat experiments resulted in no clear trend or overall effect after 
NRP1 knockdown on PDGFBB in rat epicardial cells (p = 0.1529) (Figure 57D). 
It has been previously reported that Fgf signalling in the epicardium is essential for 
zebrafish epicardial EMT to mediate neovascularisation of the injured area (Lepilina et 
al., 2006); moreover, FGF is implicated as a NRP1 ligand (West et al., 2005). Therefore, I 
further examined rat epicardial cell responses to FGF. Both Scr and Sh1 treated rat 
epicardial cells demonstrated a robust increase in ERK phosphorylation upon FGF 
stimulation (Figure 58A). This demonstrated that ERK is a downstream target of FGF 
signalling in epicardial cells, as previously characterised in proepicardial cells (van Wijk 
et al., 2009; Vega-Hernandez et al., 2011). Indeed, FGF stimulation induced a significant 
increase in ERK phosphorylation when compared with serum free (SF) conditions (p 
≤0.0001). NRP1 knockdown did not affect ERK phosphorylation after FGF stimulation 
when compared with Scr-treated rat epicardial cells (p = 0.3770 n = 3) (Figure 58) 
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Figure 57 Rat epicardial signalling in vitro 
Western blot analysis of rat epicardial cells infected with adenovirus containing either 
scrambled (Scr) control or NRP1 (Sh1) short hairpin RNA and stimulated with VEGF (A) or 
PDGFBB (C). Quantification of band intensities are represented as phosphorylated ERK/total 
ERK ratios ±S.E.M (B and D). White bars represent scrambled samples; grey bars represent 
Sh1 samples. Solid fill bars represent non-stimulated cells (SF- serum free) and striped bars 
represent growth factor stimulated samples. n= 3 *p ≤ 0.05 
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Figure 58 Rat epicardial FGF signalling in vitro 
(A) Western blot analysis of rat epicardial cells infected with adenovirus containing either 
scrambled (Scr) control or NRP1 (Sh1) short hairpin RNA and stimulated with FGF (B) 
Quantification of band intensities are represented as phosphorylated ERK/ERK ratio ±S.E.M. 
White bars represent scrambled samples; grey bars represent Sh1 samples. Solid fill bars 
represent non-stimulated cells (SF- serum free) and striped bars represent growth factor 
stimulated samples. n= 3 ****p < 0.0001, ***p ≤ 0.0001 
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6.2 Discussion 
 Epicardial cells are cultured in vitro from ventricle apices  
Because the heart contains a heterogeneous population of cells, I used three transgenic 
GFP reporter lines to confirm the identity of the outgrowth cell population from 
cryoinjured ventricle apices. Outgrowth GFP signal was exclusively detected in 
cryoinjured Tg(wt1b:GFP) samples in agreement with data showing that Wt1b is 
expressed by a subpopulation of activated epicardial cells in vivo after injury (Peralta et 
al., 2014). Wt1b encodes a transcription factor that drives expression of EMT markers 
such as snai1 and N-cadherin in mammals (Martinez-Estrada et al., 2010).  
Retinaldehyde-specific dehydrogenase type 2 (Raldh2) is a cytosolic enzyme that 
produces the hormone, retinoic acid. In zebrafish, it is expressed in the epicardium and 
endocardium during cardiogenesis and re-expressed after cardiac damage (Keegan et 
al., 2005; Kikuchi et al., 2011b). Epicardial outgrowths from cryoinjured hearts displayed 
uniform cytoplasmic Raldh2 protein expression, indicating they are made of cells of 
epicardial lineage (Figure 53). Raldh2 is also expressed in the endocardium after injury 
(Kikuchi et al., 2011b), therefore Raldh2 positive cells could also originate from the 
endocardium. Nevertheless, given the absence of GFP signal from Tg(fli1a:GFP) apices 
(Figure 52B,) and by ensuring that only the ventricle apex outer surface is in contact with 
the fibrin gel matrices, it is unlikely that the Raldh2 positive cells represents an 
endocardial-derived population. Though it cannot be ruled out that some minimal cell 
contamination by other cell types, such as fibroblasts, might be present. The 
‘cobblestone’ monolayer morphology of the explant outgrowths was strongly indicative 
of an epicardial phenotype, and did not suggest contamination by mesenchymal cells. 
Together, these data validated the presence of epicardial cells in the outgrowths, 
demonstrated the induction of Wt1b expression after cryoinjury in the in vitro heart 
explant setting, and confirmed that this was a useful model for examining the role of 
Nrp1 in epicardial outgrowth and associated cell functions.   
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 Epicardial expansion is increased in cryoinjured ventricle apices in vitro 
The finding in this chapter that cryoinjured explants undergo significantly larger 
epicardial expansions compared to shams agrees with observations from the authors 
who developed the cardiac explant protocol using resected hearts. In resection, as in 
cryoinjured hearts, the epicardium proliferates extensively and, a subpopulation 
delaminates from the epicardial layer to migrate into the subepicardial fibrin scar 
(Lepilina et al., 2006; Poss et al., 2002). The injury-induced increase in epicardial 
expansion observed in vitro cultures likely recapitulates the epicardial cell behaviour, 
exhibiting a migratory phenotype following injury. These cells move into the fibrin gel 
that mimics the subepicardial fibrin scar tissue produced following cardiac damage. It is 
interesting to note that epicardial cells migrate outwards, in the direction of the matrix, 
whereas in vivo they migrate into the sub epicardial space. The cardiac tissue is present 
throughout the protocol, yet the epicardial cells migrate into the matrix. Endogenous 
paracrine signals that direct epicardial cells into the underlying damaged region may 
compete with the culture medium growth factors or external gel fibrin to influence 
epicardial cells to migrate into the gel.  
Given that the epicardial cells of damaged hearts exhibit a migratory phenotype, it is 
intriguing that cells also migrate from sham-operated hearts. Indeed, the epicardium 
initiates a robust response after extensive cardiac damage, but sham operations have 
also been demonstrated to elicit an epicardial response, though to a lesser extent (Itou 
et al., 2014). Therefore, the epicardium is likely partially activated during the sham-
operation following tissue handling and the opening of the chest cavity during the 
preparation of the sham protocol. Furthermore, the process of making explants and 
culturing them will likely induce some degree of activation and outgrowth. As sham 
surgery inflicts less extensive tissue damage in comparison with cryoinjured samples, 
the epicardium is only mildly activated and expands to a lesser extent than injured heart 
epicardial cells. This is supported by observations of sham versus cryoinjured hearts 
from Tg(wt1b:GFP) fish. A clear increase of GFP signal was detected in cryoinjured 
explant outgrowths when compared with shams, indicating greater epicardial activation 
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following cardiac damage. This system provides a good model to study epicardial 
activation whereby cells exhibit a similar physiological response to injury in vitro.  
 Epicardial cells express Nrp1 in vitro 
All epicardial cells from the zebrafish cardiac explants were Nrp1 positive and were 
localised to the cytoplasm, the perinuclear region and at the membrane. Epicardial cells 
derived from nrp1asa1485/sa1485 mutant hearts were immunostained with an antibody 
specific for the NRP1 C-terminus. Nrp1 signal from immunostained mutant epicardial 
cells was notably decreased in comparison with WT hearts. Moreover, Nrp1 signal 
localised at the membrane and perinuclear region observed in WT outgrowths, was no 
longer evident in the mutants. This suggests that Nrp1a localises, at least, to the 
membrane and perinuclear region in zebrafish epicardium, and also likely within the 
cytosol. The data also implies that the most predominantly expressed Nrp1 isoform in 
zebrafish epicardial cells is Nrp1a. This observation is also supported by Western blot 
experiments that showed a stronger Nrp1a band in epicardial cell lysates (Figure 54D) 
and strong nrp1a mRNA localisation in the epicardium using ISH (see Figure 32).  
Nrp1a mutant epicardial outgrowths displayed abnormal F-actin filament morphology 
that could point to a role for Nrp1a cell-cell or cell-ECM interactions. 
Immunofluorescence demonstrated co-localisation of Nrp1 with F-actin at the cell-cell 
contact edges of membranes. Additionally, NRP1 is implicated in cytoskeleton regulation 
and focal adhesion turnover activity, via p130Cas and synectin interactions (Naccache 
et al., 2006; Seerapu et al., 2013). An abnormal F-actin cytoskeleton was observed twice 
in the two experiments performed. Nevertheless, it cannot be ruled out that the fibrin 
gel in these preparations was distorted and that this affected cytoskeleton organisation. 
Further experiments are required to determine whether the cytoskeleton of nrp1a 
mutant fish consistently display abnormal morphology. Additional staining with tight 
junction markers present in the epicardium such as E-cadherin and Zonula occuldens-1 
(ZO-1) could be carried out to obtain a clearer tight junction structure. A role for Nrp1a 
in epicardial cell integrity and cytoskeletal function could provide explanation for the 
abnormal epicardial phenotype occasionally observed in vivo (see Figure 50). 
 220 
 
 Nrp1a is required for injury-induced epicardial activation 
Under basal conditions nrp1a does not affect in vitro epicardial migration suggesting 
alternative pathways, or that compensation by Nrp1b is sufficient to mediate epicardial 
expansion from sham operated apices. As described in section 6.2.2, following 
cryoinjury, the epicardium becomes activated, thus enhancing the migratory response 
of epicardial cells. This injury-induced increased epicardial expansion does not occur in 
nrp1asa1485/sa1485 outgrowths, suggesting a requirement for Nrp1a in injury-induced 
epicardial activation. Outgrowth occurs via epicardial cell migration and proliferation. 
My data implicate a role for Nrp1a in the migration of epicardial cells rather than in their 
proliferation, since the latter was shown to be unaffected in the absence of Nrp1a in 
vivo. Several reports have associated NRP1 activity with EMT and cell migration in 
mammalian cells (Chu et al., 2014; Evans et al., 2011; Pellet-Many et al., 2011; Tao et 
al., 2013; Tomanek et al., 2006), two mechanisms key to the epicardial response to 
cardiac damage. It is unclear, at this stage, whether Nrp1a plays a role in epicardial EMT 
initiation and/or migratory potential. Thorough characterisation of the expression of 
EMT and mural cell markers (such as snail, slug, N-cadherin and alpha fibronectin, 
smooth muscle actin), and of components of signalling pathways involved in migration, 
both in cultured epicardial cells and in vivo in WT and nrp1a mutant fish, will be 
necessary to clarify Nrp1 cellular and molecular mechanisms involved in epicardial 
migration and/or EMT.  
 Candidate signalling pathways mediated by NRP1 in rat epicardial cells 
Unfortunately, more extensive studies using the rat epicardial cells were prevented due 
to time constraints and difficulties with reproducibility during protocol optimisation 
(virus titres and availability). Nevertheless, the data hint at a role for NRP1 in the 
regulation of epicardial cell VEGF and PDGFBB responses. NRP1 not does not appear to 
modulate FGF-induced MAPK/ERK signal pathway in rat epicardial cells. FGF2 was used 
in this study as it has been previously characterised to induce an epicardial response in 
vitro (van Wijk et al., 2009), whereas Fgf17b was identified as the isoform required for 
zebrafish heart regeneration in vivo (Lepilina et al., 2006); thus the different FGF 
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isoforms may induce differential pathway stimulation and vary in their NRP1 
dependence. 
Further analysis of the rat epicardial cells stimulated with other candidate signal 
molecules (such as TGF) could shed light on molecular pathways activated in zebrafish 
epicardial cells during regeneration. I examined solely the MAPK/ERK signal pathway, 
however, this is only one of the many downstream pathways triggered following growth 
factor stimulation. The MAPK/ERK signal pathway is associated with cell proliferation. 
From my previous observations in zebrafish heart sections, it seems unlikely that NRP1 
is required for epicardial proliferation; hence, the lack of significant effect on ERK 
phosphorylation following NRP1 knockdown in rat epicardial studies support these data. 
The role of Nrp1a in zebrafish injury-activated epicardium was deduced to be more likely 
due to modulation of EMT and/or migration; therefore, it would be important to study 
candidate downstream targets associated with EMT (such Snail and Vimentin) and 
migration (such as p130Cas, Focal adhesion kinase and Paxillin). Lastly, NRP1 is a co-
receptor, and likely enhances the RTK ligand interaction response, and may facilitate 
receptor autophosphorylation. Therefore, examining the extent of receptor 
phosphorylation in the NRP1-depleted cells may give an indication as to whether NRP1 
plays a direct role in receptor activation. 
The rat immortalised epicardial cell line was derived from embryonic samples (Wada et 
al., 2003), and will likely model the embryonic-profile adopted by epicardial cells 
following cardiac damage. In vitro studies in zebrafish epicardial cells present several 
problems. First of all, the number of zebrafish hearts required for epicardial protein and 
signalling analysis is impractically large due to the small cell numbers generated from a 
single apex. Additionally, pharmacological reagents and antibodies specific to zebrafish 
are limited, but more readily accessible for mammalian samples. As the rat epicardial 
cell line is immortalised, signalling data can be obtained at high throughput and at a 
greater scale. On the other hand, a cell line does not exactly recapitulate the behaviour 
of primary cells. The intention was to take the data collected from rat epicardial 
signalling studies and validate them in zebrafish epicardial physiology. Although 
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conservation of key signal pathways amongst vertebrates seem largely conserved, it is 
uncertain whether the rat epicardial cell line initiates the same signal pathways that 
would occur in vivo in the zebrafish.  
6.3 Summary  
In this chapter I have demonstrated that: 
 I can successfully carry out an in vitro assay to culture epicardial cells from adult 
zebrafish heart explants 
 Cryoinjury increases the rate of in vitro epicardial expansion 
 Epicardial cells express Nrp1 in the perinuclear region, cytosol and at the 
membrane and its expression increases after cardiac damage 
 Nrp1a is required for injury-induced epicardial expansion, likely linked to 
migration and cell-cell junction regulation.  
 NRP1 may be important for the mammalian epicardium response to PDGFBB and 
VEGF, but current data is too limited to be able to draw firm conclusions. 
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7 Discussion 
The candidate pathways and molecular mechanisms that govern zebrafish heart 
regeneration remain poorly characterised. It is recognised that during regeneration, the 
heart adopts a more embryonic profile and that cell signals produced by 
cardiomyocytes, inflammatory cells, endocardium and the epicardium co-ordinate many 
key cellular responses essential to regeneration  (de Preux Charles et al., 2016a; Evans 
et al., 2013; Kikuchi et al., 2011b; Lepilina et al., 2006). Amongst the cardiac repair-
promoting cytokines are Vegfaa, Pdgfbb, Tgfβ and Fgf, required to orchestrate epicardial 
activation, neovascularisation and cardiomyocyte proliferation, key aspects of 
regeneration (Chablais and Jazwinska, 2012; Kim et al., 2010; Lepilina et al., 2006; Marin-
Juez et al., 2016). All of these growth factors are implicated as neuropilin ligands (Glinka 
and Prud'homme, 2008; Pellet-Many et al., 2011; Soker et al., 1998; West et al., 2005). 
Neuropilins are multifunctional co-receptors initially identified for axonal guidance and 
vascular development, and have since been linked to regulation of other physiological 
processes (Kawasaki et al., 1999; Kitsukawa et al., 1995; Takashima et al., 2002). 
Neuropilins have not previously been investigated in the context of zebrafish heart 
regeneration, and neuropilin activity in the zebrafish heart is poorly characterised. To 
build upon current knowledge of the regenerative response, I set out to characterise the 
expression and function of neuropilins during zebrafish heart regeneration. The key 
findings of this PhD study are as follows: 
 Neuropilin isoforms are upregulated within the injured area of the ventricle. 
 Nrp1 localises to the active endocardium and epicardium, neovasculature and 
migrating subepicardial cardiomyocytes during the regenerative process. 
 Mutant nrp1a zebrafish, lacking full length Nrp1a, are viable and present no 
morphological phenotype, but display a delayed and aberrant regenerative 
response. 
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 I have identified a novel role for Nrp1a in the epicardial activation associated 
with zebrafish heart regeneration. 
7.1 Relevance and quantification of the zebrafish cryoinjury model  
I chose to perform the cryoinjury model of cardiac damage in the zebrafish because, 
unlike the resection model (another very commonly used regeneration technique), 
cryoinjury damages the heart in a localised region without the removal of cardiac tissue. 
However, thermal shock-induced cardiac damage by the cryoinjury model does not 
exactly recapitulate the ischemic injury and the pathophysiological mechanisms of 
myocardial infarction (MI)-induced cardiac damage in humans. Both result in 
inflammation and a similar fibrotic tissue composition, and cause necrosis and apoptosis 
of cardiomyocytes amongst other cardiac cell types (Christia et al., 2013; Dobaczewski 
et al., 2010; Manuel Gonzalez-Rosa et al., 2011). Coronary vessel occlusion would be the 
most appropriate procedure to induce cardiac damage, however this is technically 
impossible to achieve in the zebrafish. The zebrafish heart is very small, approximately 
1 mm in width, location and ligation of the major coronary vessels would be technically 
challenging and difficult to create a reproducible injury. Moreover, the zebrafish heart 
is highly trabeculated, therefore the coronary vasculature is not the only means by 
which the cardiomyocytes have access to oxygen which could diffuse from the blood 
present in the ventricle.  
The physiology of the zebrafish heart differs to mammalian hearts, they have a two-
chambered heart that beats at a lower pressure and higher frequency than typically 
observed in humans, however these parameters are comparable considering the 
differences in organism size (Tsai et al., 2011). These functional differences could 
contribute to conditions that favour regeneration in the zebrafish over that of adult 
mammals. Additionally, although the zebrafish heart is proportional for its size, the 
number of cardiomyocytes lost after cardiac damage in the zebrafish is minimal in 
comparison to humans after MI. The sheer number of cardiomyocytes required to 
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replenish cardiac damage in humans may also contribute to the limited regenerative 
response, whereas zebrafish have less cardiomyocytes overall to replace.  
In this study, heart regeneration was measured using sections of several different 
hearts; this required the sacrifice of each fish before analysing the cardiac damage, 
rather than monitoring regeneration of the same heart in a longitudinal study. This 
means that variations between surgeries may not be accounted for, although initial 
analysis of my surgical technique showed that I could injure the heart in a reproducible 
manner. One way to monitor regeneration the zebrafish longitudinally would be to use 
optically clear fish, such as the TraNac, expressing a cardiomyocyte reporter, such as 
cmlc2: GFP and capture heart fluorescence of the same fish at different time points 
following the injury. However, as the heart is beating in the live animal, an algorithm 
would have to accurately image and quantify fluorescence.   
I selected 6 serial sections that span across the entire heart to quantify overall injury 
size. It would be possible quantify injury of all sections of the entire heart, however, in 
order to comply with the principles of the 3Rs (Replacement, Reduction and 
Refinement), I used some of the serial heart sections for other staining procedures, such 
as immunofluorescence and in situ hybridisation. Therefore, injury size may not be 
exact, but will be an accurate representation of the percentage of the heart damaged. 
Although software plugins are available to quantify scar tissue in an automated manner, 
the quantification was carried out manually because it is technically more accurate. As 
a result, some small degree of bias may inadvertently have been introduced, as I was 
not fully experimentally blinded for the quantification of the heart injuries. 
Nevertheless, I have discussed the quantification method with Prof Nadia Mercader, 
who first established the model, and followed the technique reported in the literature. 
I did not specifically and systematically record additional measurements for every single 
fish used in the study. For example, the length and weight of each fish was not recorded 
for each corresponding heart collected and the exact size of the heart before sectioning 
was not recorded. Heart size is correlated to animal size; therefore, some animals may 
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sustain different extents of injury due to natural variations in size. Nevertheless, we used 
animals of similar ages and sizes. Overall anatomical features and comparison of heart 
size were recorded and analysed for a representative sample of individuals (WT and also 
mutant fish) and we did not find any difference between the groups of animal used. 
Finally, I did not record fish density in the tank following the surgeries. The number of 
fish in the tank would affect how much food each of them receive as a similar ration is 
given to each tank regardless of fish density. It is not known if nutritional access affects 
regenerative capacity.  
Quantification of the cryoinjuries showed that, although the size of the injured area 
reduced over time, 100% of hearts did not fully recover and on average at 60 dpci 2% of 
the ventricle mass remained with a scar. This is a minimal scar; however, it does highlight 
that the extent of some injuries may have been more severe than others or that the 
regenerative capacity of fish varies slightly between animals. Previous studies on 
zebrafish heart regeneration report complete regeneration between 60 and 130 dpci 
depending on extent of lesion and injury method (Manuel Gonzalez-Rosa et al., 2011; 
Poss et al., 2002)  
7.2 Neuropilins are upregulated after cardiac damage 
Neuropilin expression has been characterised in the embryonic zebrafish heart 
(Bovenkamp et al., 2004; Martyn and Schulte-Merker, 2004; Yu et al., 2004). In this 
project I provide the first description of neuropilin expression in the uninjured and 
regenerating injured adult zebrafish heart at both the mRNA and protein levels. Data 
gathered throughout this study show that several cells types are Nrp-positive pre- and 
post-cardiac damage (Table 9). Evidence for a possible homeostatic role of nrp1a and 
nrp2b in the normal uninjured heart is provided by expression of these isoforms in 
uninjured hearts. Following cardiac damage all nrps exhibited localised expression 
adjacent to or within the injury, indicating an injury-induced response and a likely 
positive role of Nrps in heart regeneration.  
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I have demonstrated for the first time that 3 of the 4 neuropilin isoforms are upregulated 
in the zebrafish ventricle within the first three days of cryoinjury. The first three days 
following cardiac damage mark the inflammatory phase of regeneration. During the 
inflammatory response after cardiac injury, leucocytes infiltrate the injured area 
(Chablais and Jazwinska, 2012; de Preux Charles et al., 2016a; Fang et al., 2013); 
concomitantly,  neovessels invade the lesion (Marin-Juez et al., 2016), and the 
epicardium is activated (Kikuchi et al., 2011b; Wang et al., 2013b), these events are 
essential to propagate subsequent regenerative processes. Neuropilins have been 
implicated in the innate and adaptive immune response (Dejda et al., 2014; Fantin et al., 
2010) and could serve to modulate Vegf signals secreted by and leucocytes and hypoxic 
cells at the inflammation site (Leibovich et al., 1987; Yoshida et al., 1997). Furthermore, 
NRP is associated with vascular permeability increase in a VEGF- dependent and 
independent manner (Roth et al., 2016; Wang et al., 2003). These reports support a 
possible link of the neuropilin contribution to the inflammatory component of cardiac 
damage via response to locally secreted Vegf, that facilitate leucocyte migration and 
extravasation from circulating blood through Nrp1 positive endocardium.  
Furthermore, neovascularisation, which commences within 15 hours of cardiac damage, 
has recently been shown to depend on Vegfaa signalling (Marin-Juez et al., 2016). 
Immunofluorescence imaging of Tg(fli1a:GFP) zebrafish hearts at 1 dpci revealed that 
neovessels infiltrating the injured area express Nrp1. NRPs form holoreceptors with 
VEGF and VEGFRs to mediate angiogenesis (Soker et al., 1998; Takashima et al., 2002) 
and have been shown to regulate vessel development in the zebrafish embryo (Martyn 
and Schulte-Merker, 2004). These reports support the potential role of Nrps in 
mediating neovascularisation in the injured area in response to VEGF.  
Over 600 genes are differentially expressed after cardiac damage in the zebrafish heart  
(Lien et al., 2006). Of the selected genes examined through qPCR in this study, vegfc was 
one of the most strikingly upregulated. Increase of VEGFC in ischaemic tissue has also 
been previously identified in other species (Witzenbichler et al., 1998). Interestingly my 
mRNA analysis showed that the temporal patterns of nrp2a and vegfc expression 
 228 
 
paralleled each other. Convincing evidence exists for NRP2 in VEGFC-mediated 
lymphangiogenesis and EMT (Gemmill et al., 2017; Jeltsch et al., 1997; Kawakami et al., 
2002; Parker et al., 2015) and could point to Vegfc/Nrp2-mediated lymphangiogenesis 
via the VEGF-C receptor, vegfr3, though the latter was not measured. Re-establishment 
of lymphatic vessels is necessary for draining excess fluid after inflammation and aids 
cardiac recovery (Klotz et al., 2015). It is possible Vegfc could form a complex with Vegfr3 
and Nrp2 to replenish lymphatic vessel supply to the injury lesion in zebrafish heart 
regeneration to aid cardiac repair.  In zebrafish hearts, both vegfc upregulation and 
neovascularisation are stimulated within a day of the injury, concomitantly with nrp2a 
expression. Furthermore, VEGF-C stimulates endothelial PDGFbb expression to regulate 
capillary integrity (Onimaru et al., 2009). An additional function of Vegfc in zebrafish 
response to cardiac damage could be to enhance Pdgfbb secretion that induces 
epicardial EMT and cardiomyocyte migration.
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Table 9 Cellular expression of nrps in adult zebrafish heart 
 Basal Cardiac damage 
Cell type Nrp1 Nrp2 Nrp1 Nrp2 
Cardiomyocytes - + + + 
Endocardium + - ++ - 
Epicardium + - ++ ++ 
Leucocytes ? ? ? + 
Fibroblasts ? ? ? ? 
Endothelium + - + - 
Lymphatic vessels ? ? ? ? 
Nerves ? ? ? ? 
Mural cells ? ? ? ? 
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7.3 Regeneration is delayed in Nrp1a mutant  
I established a homozygous nrp1a mutant fish line and confirmed that the mutation 
resulted in the loss of full length Nrp1a. No morphological abnormalities were identified 
upon superficial examination of mutants, and growth and behaviour were similar to 
those of wild type fish. However, it was noted that nrp1a mutant survival to adulthood 
was approximately half that seen in wild types. Therefore, homozygous inheritance of 
the nrp1asa1485/sa1485 mutation is not embryonic lethal in zebrafish, but does compromise 
survival to maturation, possibly suggesting some effect on development. The mutation 
is global; therefore, all tissues in the nrp1asa1485/sa1485 zebrafish express the truncated 
Nrp1a. It is possible that other organ systems, that require nrp1a, don’t fully mature 
until adulthood such as the nervous system and adaptive immune system, but these 
were not investigated in this study. Depending on the mutagenesis method employed 
and gene targeted, disruption of one allele in a zebrafish may result in clear phenotypes, 
or does not induce deleterious phenotypes due to genome duplication and redundancy 
(Kok et al., 2015; Postlethwait et al., 1998; Schulte-Merker and Stainier, 2014). Despite 
the presence of nrp1b in the nrp1asa1485/sa1485 mutants there must be underlying late 
stage developmental events that require nrp1a and cannot be compensated for by 
nrp1b, resulting in premature mortality. Further investigations are required to 
understand why survival to adulthood is diminished in the nrp1a mutant zebrafish.  
Following cardiac damage, the mutants demonstrated delayed compact layer recovery 
and scar resolution when compared with wild types. This is, to my knowledge, the first 
report of an impairment of heart regeneration resulting from ENU mutagenesis of a 
single allele. At this stage, it is not certain how regeneration is delayed, nor were there 
any indications as to why the delay does not cause mortality. It could be postulated that 
Nrps are required for efficient signal interpretation and enhanced sensitivity to growth 
factors to mediate heart regeneration, thus loss of Nrp1a causes regeneration to take 
place over a longer duration. It is interesting to note that while in situ hybridization of 
wild type hearts revealed overlapping nrp isoform expression in the first 3 days following 
cardiac damage, only nrp1a remained expressed in the epicardium proximal to the 
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lesion at 14 dpci, coincident with the time at which nrp1a mutants begin to present 
delayed regeneration. It could be possible that overlapping expression by other nrp 
isoforms in the early stages of cardiac repair can compensate for full length Nrp1a loss. 
Upon the time point by which nrp1a is exclusively expressed in the epicardium, a 
phenotype arises due to lack of other nrp isoforms available to carry out compensatory 
mechanisms.  
It is also plausible that evolutionarily genetic drift between Nrp1a and Nrp1b has 
resulted in loss of gene redundancy. The two genes diverged over 100 million years ago 
(Postlethwait et al., 1998) and have since acquired different post-translational 
modifications that have resulted in distinct protein mass and  present differential 
developmental tissue expression. During cardiac regeneration, the isoforms do not 
display identical localisation, exemplified by their differential expression in epicardial 
cells. Moreover, Nrp1b is not upregulated in response to loss of full-length Nrp1a. These 
differences point to divergent physiological roles for the two Nrp1 ohnologs, and could 
potentially lead to an inability to fully compensate for one another.  
Nrp1a mutants presented impaired compact myocardium recovery following cardiac 
damage. After cryoinjury, new myocardium is derived from pre-existing spared 
cardiomyocytes at the periphery of the lesion. The cardiomyocytes dedifferentiate, 
proliferate and invade the subepicardial fibrin deposits to enclose the collagen scar 
tissue and heal the compact myocardium (Jopling et al., 2010; Kikuchi et al., 2010). 
According to immunofluorescence co-staining generated in this study, cardiomyocytes 
are for the most part Nrp1 negative, and Nrp1 expression was observed exclusively in 
the migrating cardiomyocytes in the subepicardial space. It was more recently shown 
that cardiomyocytes migrate toward PDGF signals produced by endocardial progenitor 
cells during embryonic development (Bloomekatz et al., 2017). Furthermore, Pdgfbb 
signalling is essential for zebrafish heart regeneration, perturbed cardiomyocyte 
recovery and wound closure impairment were reported in the absence of PDGF signals 
(Kim et al., 2010). NRP is a co-receptor for PDGF and has been demonstrated to 
modulate chemotaxis in response to PDGF in smooth muscle cells and metastatic breast 
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cancer cells (Banerjee et al., 2006; Pellet-Many et al., 2011). Zebrafish cardiomyocytes 
adopt an embryonic profile after cardiac damage (Jopling et al., 2010) and therefore 
likely recapitulate developmental cardiomyocyte behaviour during regeneration. 
Therefore I present a model whereby the dedifferentiated migrating subepicardial 
cardiomyocytes express Nrp1 in order to enhance PDGF-induced chemotaxis (Figure 59A 
and B). In nrp1a mutants the loss of full-length Nrp1a impedes this mechanism and limits 
efficient cardiomyocyte migration, and results in delayed wound closure observed in the 
mutants.  
 
Pdgfbb 
Migration
cytoskeleton
Pdgfrβ
Nrp1
Epicardium and 
endocardium  
secreted Pdgfbb
Injury-activated epicardium
Cardiomyocyte 
chemotaxis
Subepicardial space 
fibrin matrix
lesion
cardiomyocyteA) B)
p130Cas?
synectin?
Figure 59 Pdgf-induced cardiomyocyte migration 
Schematic representation of (A) Pdgf signalling in Nrp1-positive dedifferentiated 
cardiomyocytes. Pdgfbb form holoreceptor complexes with Pdgfrβ and Nrp1. The signal is 
propagated by Nrp1 via intracellular docking protein p130Cas and synectin to rearrange 
cytoskeleton and focal adhesions to (B) mediate cardiomyocyte chemotaxis in the direction 
of Pdgfbb gradient. Activated endocardium and epicardium proximal to injury lesion secrete 
Pdgfbb and direct migrating cardiomyocytes through the fibrin matrix into the underlying 
subepicardial space leading to the recovery of compact myocardium and wound closure.  
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7.4 Novel Nrp1 role in epicardium 
Epicardial activation is a central mediator of cardiac repair paracrine and autocrine 
signals that coordinate cardiomyocyte proliferation, revascularisation and induce 
epicardial EMT (Lepilina et al., 2006). The epicardial in vitro studies carried out in this 
study report previously undescribed neuropilin expression in the adult zebrafish 
epicardium, and the first description of neuropilin expression in the epicardium of any 
adult species. A novel neuropilin role in the injury-activated response is supported by 
impaired epicardial outgrowth after cardiac damage in the absence of full-length Nrp1a. 
These data also for the first time identify a perturbed epicardial function resulting from 
a single allele mutation.  
Loss of full-length Nrp1a impaired epicardial expansion, but did not alter epicardial 
proliferative capacity. Given that NRPs influence cell migration and EMT in other 
physiological settings (Chu et al., 2014; Evans et al., 2011; Frankel et al., 2008; Pellet-
Many et al., 2011), I propose that Nrp1a enhances migratory signals from the underlying 
injured tissue and facilitates directed epicardial cell movement (Figure 60). Furthermore 
it is possible that epicardial EMT governed by FGF and PDGF require Nrps to act as a co-
receptor for these signals (Figure 60).   
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Figure 60 Nrp1a function in the epicardium 
Diagrammatic representation of hypothesised epicardial neuropilin functions in zebrafish 
quiescent and injury-activated epicardium. Nrp1a is endogenously expressed in the 
epicardium of uninjured hearts to regulate cardiac homeostasis. Upon injury, activated 
epicardium increase Nrp1a (and Nrp2a) in order to enhance epicardial sensitivity to paracrine 
signals and increase EMT potential. Nrp1a facilitates epicardial derived cell (EPDC) chemotaxis 
into underlying subepicardial space towards neovessels and mediate transdifferentiation to 
pericytes to support vessel maturation. It is unclear at this stage whether Nrp1a may induce 
EPDC transdifferentiation to cardiac fibroblasts to produce extracellular matrix (ECM) that 
provide scaffolding for neomyocardium.  
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7.5 Future directions 
I have characterised neuropilin expression patterns in the adult zebrafish heart under 
basal conditions and during regeneration. I then followed on to describe regenerative 
phenotypes observed in mutants lacking nrp1a. I was unable to fully define the 
molecular pathways Nrps modulate and what roles Nrps mediate in the cell types 
identified to express them during regeneration. Taking into consideration the data 
gathered throughout my thesis, several questions remain and additional experiments 
could help further characterisation of the role of neuropilins in zebrafish heart 
regeneration.   
 Neuropilin mutant lines  
To understand neuropilin functions in zebrafish heart regeneration, I used nrp1a 
mutants, primarily due to availability of this line. Data generated in this project with in 
situ and qPCR support previous studies that document differential expression patterns 
of all four nrps (Bovenkamp et al., 2004; Martyn and Schulte-Merker, 2004; Yu et al., 
2004), and point to distinct nrp isoform physiological functions. Generating fish with 
functional mutations in the nrp1b gene could provide complementary information and 
help to define the nrp1 ohnolog-specific contribution to zebrafish heart regeneration. A 
nrp1bfh278 fish is now available for purchase from the Zebrafish International Resource 
Center (ZIRC) ENU project. A point mutation induces in a non-sense mutation codon at 
amino acid 116 resulting in a premature stop in the a1 (first CUB) domain in the 
nrp1bfh278 mutant allele. This will likely yield non-functional soluble Nrp1b fragments 
that cannot interact with known Nrp1 ligands. I began to establish the nrp1bfh278 mutant 
fish line towards the end of my project; however, identification of a homozygous mutant 
was not achieved before my studies concluded. Availability of the nrp1bfh278 line creates 
the possibility to generate nrp1a and nrp1b double mutants, although complete nrp1 
deletion will likely cause lethality as seen in nrp1 mammalian mutants (Takashima et al., 
2002) and morpholino knockdown (Martyn and Schulte-Merker, 2004). However, if the 
zebrafish survive to adulthood in the absence of both nrp1 ohnologs, it would also be 
interesting to study regenerative mechanisms in Nrp1-/- fish, which would likely cause 
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a more robust phenotype and better reflect a mammalian NRP1 null physiological 
response. 
Due to fish line availability and antibody compatibility, nrp1 was the primary focus of 
this study; however, nrp2 isoforms also show regulated expression in the adult zebrafish 
heart after cardiac damage. Additionally, nrp2b is the dominantly expressed isoform of 
all four nrps in the cardiac tissue under healthy and injured conditions, consistent with 
developmental cardiac expression of nrp2b (Bovenkamp et al., 2004). Moreover, nrp2b 
was not upregulated in qPCR, but showed clear redistribution of expression to the 
endocardium and within the lesion using in situ hybridisation. Nrp2a was strikingly 
upregulated at 1 and 3 dpci in the qPCR and at 3 dpci nrp2a was exclusively epicardial in 
expression. This presents another example of likely differential roles of nrp ohnologs; it 
appears that nrp2b may constitutively regulate cardiomyocyte activity, whereas nrp2a 
plays a role in injury-activated epicardium. Publications describing NRP2 activity in the 
adult myocardium and epicardium have not been described, other than in development, 
where NRP2 is expressed by a sub-population of cardiovascular precursors that can 
differentiate to endothelial, smooth muscle and cardiomyocyte cell types (Ding et al., 
2015). Mutant fish for nrp2a are now available to purchase through ZIRC, but a mutant 
for nrp2b is still unidentified. I attempted to generate nrp2b mutant zebrafish using 
CRISPR technology but was unsuccessful at inducing disruption of the genomic DNA 
sequence. Compelling evidence suggests a role for nrp2 in zebrafish heart development, 
adult homeostasis and regenerative processes, its role in heart regeneration warrants 
investigation. I predict a phenotype would arise from the disruption of the nrp2 genes 
that would present cardiac deformities and altered function in the absence of nrp2b, 
and lymphatic vessel supply and epicardial EMT may also be impaired without nrp2a.  
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 Role of neuropilins in specific cells types 
Neuropilins were identified in several cardiac cell types in the zebrafish heart during this 
study (Table 9); however the Nrp functions in these cells remain to be elucidated. 
Further validation of the nrp1a mutant phenotypes could be performed with rescue 
experiments. For example, in the in vitro epicardial outgrowth assay, transfection of cells 
with nrp1a transcript could be performed. If injury-induced epicardial expansion is 
restored upon exogenous nrp1a mRNA delivery in nrp1asa1485/sa1485 mutants, it would 
confirm Nrp1a a key regulator of this process.  
To extend my current observations in the nrp1a mutant it would be beneficial to 
generate cell-type specific reporter lines in the mutants or carry out immunofluoresence 
with cell-type specific markers. Nrp1 was shown to be constitutively expressed by 
endocardium and coronary vessels and likely plays a role in angiogenesis after cardiac 
damage. Using a Tg(fli1a:GFP):nrp1a mutant or immunostaining for endothelial-specific 
markers such as Tie2 or ERG would enable me to visualise vessels. Quantification of 
neovessels would allow me to compare vascular density in the injured area at varying 
timepoints in both wild type and mutant hearts, and conclude whether Nrp1a is 
necessary for revascularisation. These studies have been commenced, but are currently 
at a preliminary stage. 
Cardiomyocyte proliferation and migration could also be assessed in the mutants and 
compared with wild type. I hypothesise Nrp1a to play a role in dedifferentiated 
subepicardial cardiomyocyte migration towards Pdgfbb gradient in the injury (Figure 
59). To test this hypothesis, I could generate a nrp1a mutant that expresses the 
Tg(cmlc2:GFP) and isolate and culture primary cardiomyocytes in vitro (Figure 
61)(Sander et al., 2013). They could then be stimulated with different growth factors 
and their cell movements tracked by images captured at regular intervals using a tissue 
incubator installed with a fluorescent microscope (such as the Incucyte Zoom, Essen 
Bio). The imaging software could then calculate rates of migration and compare 
different treatments. I have carried out the cardiomyocyte in vitro culture as 
demonstrated in Figure 61, but no functional studies have commenced using this model. 
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I could support in vitro observations with tropomyosin immunostaining of regenerating 
wild type and mutant heart sections; these data could then be used to calculate and 
compare subepicardial cardiomyocyte numbers in the different genotypes. Moreover, 
an in vitro model of myocardial infarction in zebrafish cardiomyocytes has been 
developed using hypoxic chambers: hypoxia stimulates cardiomyocyte proliferation 
(Sander et al., 2013). I could investigate how loss of Nrp1a affects cardiomyocyte 
proliferation in response to ischemic stress. 
This study revealed that epicardial migration was perturbed in nrp1a mutant 
outgrowths. Understanding the role of full-length Nrp1a in epicardial activation could 
be expanded by generating a mutant that expresses an activated-epicardial reporter 
transgene such as Tg(wt1b:GFP), in which the GFP signal would be detected in activated 
epicardial cells undergoing EMT only. Comparison of activated epicardial-specific GFP 
Figure 61 Zebrafish cardiomyocyte in vitro 
culture 
Image captured of primary cardiomyocyte 
culture derived from Tg(cmcl2:GFP) adult 
zebrafish hearts visualised under green 
fluorescence. Cells can be isolated and cultures 
for several weeks on fibrin gels. Scale bar 
250µm. 
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expression in wild type and nrp1a mutant cryoinjured heart outgrowths would provide 
some evidence as to whether Nrp1a is required for epicardial wt1b expression, and thus 
likely regulate EMT. I would predict that Nrp1a plays a role in EMT and that the GFP 
signal would be reduced in nrp1a mutant outgrowths. Other EMT markers could then 
be analysed using Western Blot or immunofluorescent staining to compare EMT markers 
of the epicardial outgrowths.   
Neuropilins were originally identified in brain and nervous tissue; nerves innervate the 
subepicardial and subendocardial tissue to regulate heart rate according to physiological 
demands (Volders, 2010; Zipes, 2008). After cryoinjury transmural damage causes death 
of all cardiac layers in the affected region; thus nerves will likely need to regenerate in 
the repairing cardiac tissue. During embryonic development semaphorin3a (SEMA3A) is 
expressed in the heart to mediate innervation of cardiac tissue (Chen et al., 2013; Ieda 
et al., 2009). It could be expected that Sema3a will be re-expressed during regeneration 
of the zebrafish heart. Type 3 semaphorins (such as SEMA3A) require neuropilins as 
obligate co-receptors to signal through plexin receptors and mediate axonal guidance 
(Gu et al., 2002; Takahashi et al., 1999). It would be interesting to investigate re-
innervation of cardiac tissue following cryoinjury and monitor nerve induced regulation 
of cardiac electrophysiology in the heart in the absence of nrp isoforms. Furthermore 
SEMA3C has been associated with endothelial to mesenchymal transition during 
embryogenesis (Plein et al., 2015), and its expression could be recapitulated in the 
zebrafish activated endocardium that also undergoes endoMT in response to cardiac 
damage to contribute mural cells and fibroblasts (Kikuchi et al., 2011b).  
 Neuropilin signalling and function in heart regeneration 
Persistent scar, delayed wound closure and impaired epicardial expansion were the 
main functional phenotypes identified during regeneration in the nrp1a mutants. It is 
unclear from my studies whether these would cause impaired cardiac function after 
regeneration in nrp1a-deficient fish. I would like to apply further organ functional assays 
to the mutants such as ECG, echocardiography or MRI to assess cardiac output 
parameters and electrical conductivity after cryoinjury.    
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The ultimate aim of this project was to dissect the mechanisms underlying zebrafish 
heart regeneration. However, the results from this study may have implications for 
human heart regeneration, and therefore future work should seek to test the 
applicability of my findings to humans recovering from MI. It will therefore be important 
to characterise and evaluate mammalian neuropilin expression and function in the adult 
mammalian heart. I’d like to translate the findings of this thesis to mammalian models 
of regeneration. Neonatal mice can regenerate heart tissue up to seven days following 
birth (Porrello et al., 2011) and have shown partial regeneration after cryoinjury 
(Mizutani et al., 2016; Polizzotti et al., 2016; Strungs et al., 2013). I could assess NRP 
expression profiles in neonatal mammals and generate inducible cell type-specific NRP 
knockouts to investigate whether NRP function is important in mammalian heart 
regeneration. 
Functional assays and signalling experiments of adult zebrafish primary epicardial 
cultures is limited due to low cell numbers in outgrowths and lack of reagents specific 
to zebrafish proteins and pathways. One way to circumvent limitations of epicardial in 
vitro zebrafish studies, would be to model epicardial physiology in an established and 
immortalised rat embryonic epicardial cell line (Wada et al., 2003). These studies were 
commenced during the thesis, but it was not possible to generate data supporting 
robust conclusions. The intention of these studies was to identify candidate epicardial 
signal pathways modulated by NRPs using pharmacological agents and transfections. 
Neuropilin expression can be manipulated using siRNA and adenovirus in vitro and 
growth factors can be exogenously supplied into the culture medium to stimulate 
isolated pathways. This permits the opportunity to characterise NRP activity in response 
to specific signals. Additionally, functional assays are possible in the rat epicardial cell 
line. For example, NRPs are regulators of cell migration and the transwell migration 
assay could be applied to epicardial cells in vitro to monitor epicardial cell chemotaxis 
towards a gradient of candidate chemokines (Figure 62) following NRP-knockdown or 
upregulation. The number of migrated cells toward stimulant could help deduce the 
physiological role of neuropilins in epicardial migration. I would expect the chemotactic 
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response to be impaired in the absence of NRPs and provide a mammalian system that 
supports observations in zebrafish epicardial outgrowths.  
 
 Implications for translational research 
Given that Nrp1a and possibly other Nrps are important for cardiac recovery, they could 
serve as therapeutic targets in mammalian cardiac repair post-MI. This would require 
strong pre-clinical evidence for a role of NRPs in mammalian heart regeneration, which 
could be obtained in the neonatal mouse model, and also evidence that NRPs are 
implicated in the human heart following MI. For example, it could be examined whether 
NRP expression changes in human hearts after MI, if samples were available. Direct 
targeting of Nrps to promote a regenerative response would be difficult to achieve 
unless a way could be found specifically to ‘activate’ NRPs. NRP expression could be 
increased by delivery of viral vectors encoding NRPs. However, previous attempts to 
Upper 
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Migrating cells
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chamber 
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Tissue culture 
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Figure 62 Schematic representation of transwell migration assay 
An insert containing cells intended for assessment of migration properties in a serum-free 
medium is placed into a tissue culture plate well. The well contains either serum-free medium 
(for control experiments) or serum-free medium supplemented with chemotactic stimuli 
(such as growth factors). Cells that respond to the chemoattractant migrate through the insert 
pores towards the chemotactic signals and adhere to the other side of the membrane.  
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stimulate therapeutic angiogenesis in ischaemic heart disease by over-expressing VEGF-
A, for example, has not produced clear patient benefit (Zachary and Morgan, 2011). 
7.6 Conclusions 
The current models I propose for the role(s) of neuropilins in zebrafish heart 
regeneration are as follows. Nrp1a contributes to quiescent epicardial homeostasis, 
whereas Nrp2b is required for cardiomyocyte maintenance.  Following cardiac damage, 
Nrp1a and Nrp2a are upregulated in the epicardium to increase epicardial sensitivity to 
injured tissue paracrine and autocrine factors. Their targeted expression also serves to 
enhance EMT and mediate chemotaxis of EPDCs into lesions to contribute mural cells 
and facilitate neovasculature maturation. The epicardial EMT response is likely 
recapitulated in the endocardium to promote endothelial to mesenchymal transition 
and this also requires Nrps to detect cellular cues. Invading neovessels require Nrp1 to 
respond to Vegfaa signals that induce angiogenesis to replenish blood supply in the 
injury lesion. Furthermore, Nrp1 expression is implicated in the response of migrating 
cardiomyocytes to mediate Pdgfbb-induced cell migration into the subepicardial fibrin 
matrix to facilitate compact myocardium recovery. Loss of nrp1a results in reduced 
compact myocardium replenishment and dampened epicardial activation and 
outgrowth expansion, which ultimately delay cardiac regeneration.  
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